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General introduction 
HONEUR 
 
HONEUR stands for ‘Huisartsen Onderzoeks Netwerk Erasmus Universiteit Rotterdam’, 
which translates to ‘General Practitioners Research Network Erasmus University 
Rotterdam’. This network was founded in 2001 for the purpose of facilitating patient 
based research into subjects that are relevant to general practice. The following 
HAGROs (HuisArtsenGROepen, i.e. collaborating GPs) are represented in HONEUR: 
 
Brielle, since October 2001 
Capelle aan den IJssel, since Februari 2002 
Etten-Leur, since May 2002 
Krimpen aan den IJssel, since August 2002 
Hillegersberg (Rotterdam), since October 2002 
 
These practices represent a population of around 84,000 patients in the south-west of 
the Netherlands. The first study to start in HONEUR was the knee cohort. 
 
 
Background of the HONEUR knee cohort 
 
A recent nationwide study in Dutch general practice states that non-specific knee 
complaints form the 17th most frequent reason for consulting the general practitioner 
(GP), with an incidence of 13.7 per 1000 patients per year1. Combined with specific knee 
complaints the incidence is 24.6 per 1000 per year. 
 
The Dutch College of General Practitioners (NHG) is the scientific organization of GPs. 
The NHG has developed Practice Guidelines for specific complaints or diagnoses 
reflecting the 'state of the art' in medical science. The NHG also attempts to identify 
lacking evidence in the field of general practice. 
For knee complaints the NHG has developed 3 guidelines. The guideline 'non-traumatic 
knee complaints in children and adolescents'2 deals with genua vara and valga, Osgood-
Schlatter's disease, jumper's knee and patellofemoral pain syndrome, the most frequent 
diagnoses in patients under 25 years of age. The guideline 'non-traumatic knee 
complaints in adults'3, deals with bursitis prepatelllaris, iliotibial friction syndrome, Baker's 
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cyste and knee osteoartritis. The guideline 'traumatic knee complaints'4 deals with 
distorsions, contusions, patellar luxation and ligament and meniscus lesions.  
For all three guidelines research questions have been formulated addressing the lacking 
evidence. These questions often concern the unknown effectiveness of treatments, for 
which new clinical trials are needed. Designing clinical trials requires background 
information about the natural course of complaints and possible prognostic determinants. 
However, in 2000 no prospective studies of patients with knee complaints presenting in 
general practice were available in scientific literature. This is why the HONEUR knee 
cohort was conceived.  
 
The overall aim of the HONEUR knee cohort is to describe the prognosis and to study 
the prognostic factors of knee complaints. This will provide the GP information for 
advising their patients. It may also serve as basis for future trials addressing the 
effectiveness of interventions.  
Analogous to the NHG guidelines the HONEUR knee cohort was divided into traumatic 
and non-traumatic knee complaints, and non-traumatic knee complaints were further 
divided into different age groups. Since osteoarthritis is the only diagnosis of a 
progressive nature, we used the age from which osteoarthritis starts to play a role as the 
cut-off point. This resulted in three subgroups of the cohort: 
 
1. Non-traumatic knee complaints in adolescents and young adults (aged 12 to 
35) 
2. Non-traumatic knee complaints in adults (aged 36 and over) 
3. Traumatic knee complaints. 
 
This thesis first gives an overview of the entire cohort, before focussing on the subgroup 
of adolescents and young adults with non-traumatic knee complaints.  
 
 
Non-traumatic knee complaints in adolescents and young adults 
 
The incidence of non-traumatic knee complaints in adolescents and young adults (aged 
12 to 35 years) in general practice is estimated at 19 per 1000 per year and the 
prevalence at 27 per 1000 per year 1. The guidelines state that the prognosis of these 
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patients is good2. What that statement means in terms of duration or severity of 
complaints is not specified. The statement is consensus rather than evidence based. 
With regard to the management of complaints, conservative treatment is advised, in 
which knee loading and knee loading capacity are adapted to each other.  
 
In our prospective cohort study5, we aim to describe the course of non-traumatic knee 
complaints in adolescents and young adults, aged 12 to 35 years, over the course of one 
year by actively tracking their symptoms and limitations. Our second objective is to 
determine any prognostic factors for persistent knee complaints. Identification of 
prognostic factors is important in order to improve the advise the GP may give to the 
patient, and if any of the prognostic factors are modifiable this may offer potential ways 
to develop new interventions in order to avoid chronicity of the complaints.  
Our third objective is to give insight into the burden of non-traumatic knee complaints in 
adolescents and young adults compared to other subgroups. In order to do so, validation 
of the questionnaires used to assess functional disability is necessary, since no knee 
specific questionnaire has been validated in this population so far. We chose the 
WOMAC Index6 because it is widely used to assess disability in osteoarthritis, an 
important diagnosis in the older subgroup of non-traumatic complaints. For traumatic 
knee complaints the Lysholm scale is widely used. This questionnaire has also been 
applied in patients with chondral lesions7 and patients with patellofemoral pain 
syndrome8. 
 
With respect to the effectiveness of treatments we performed two systematic reviews 
focussing on treatments for patellofemoral pain syndrome. This is the diagnosis with the 
highest incidence in this subgroup9. 
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Overview of the contents of this thesis 
 
Chapter 2 presents the design and methods of the knee cohort study. It also presents 
the distribution of patients over the subgroups and additional measurements of the 
cohort and compares participants with non-participants to determine if the cohort is an 
adequate representation of patients consulting the GP for knee complaints.  
 
Chapter 3 compares the different subgroups of the cohort with respect to patient 
characteristics, the severity of knee complaints and initial management by the GP. 
 
In chapter 4 we analyse the validity and responsiveness of WOMAC index and Lysholm 
scale to clinically relevant changes in functional knee status over time in patients aged 
12 through 35 in general practice. 
 
Chapter 5 describes the course of knee complaints in adolescents and young adults with 
non-traumatic knee complaints consulting the GP. Prognostic factors associated with 
persistence of knee complaints are identified. 
 
Chapter 6 contains a systematic review of available evidence for the effectiveness of 
exercise therapy for patients with patellofemoral pain syndrome (PFPS). Exercise 
therapy is the most widely accepted treatment of PFPS. PFPS is the most common 
diagnosis in adolescents and adults with non-traumatic knee complaints. 
 
Chapter 7 reviews the evidence for the effectiveness of pharmacotherapy for patients 
with patellofemoral pain syndrome (PFPS). Though not advised in NHG guidelines, 
prescriptions for pain medication are often given.  
 
Chapter 8 summarises the findings. 
 
Chapter 9 discusses the findings, limitations and implications for clinical practice of this 
thesis. 
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Abstract 
 
Background 
Knee complaints are a frequent reason for consultation in general practice. These 
patients constitute a specific population compared to secondary care patients. However, 
information to base treatment decisions on is generally derived from specialistic settings. 
Our cohort study is aimed at collecting knowledge about prognosis and prognostic 
factors of knee complaints presented in a primary care setting. This paper describes the 
methods used for data collection, and discusses potential selectiveness of patient 
recruitment.  
Methods 
This is a descriptive prospective cohort study with one-year follow-up. 40 Dutch GPs 
recruited consecutive patients with incident knee complaints aged 12 years and above 
from October 2001 to October 2003. Patients were assessed with questionnaires and 
standardised physical examinations. Additional measurements of subgroups included 
MRI for recent knee traumas and device assessed function measurements for non-
traumatic patients.  
After the inclusion period we retrospectively searched the computerized medical files of 
participating GPs to obtain a sample to determine possible selective recruitment. We 
assessed differences in proportions of gender, traumatic onset of injury and age groups 
between participants and non-participants using Odds Ratios (OR) and 95% confidence 
intervals.  
Results 
We recruited 1068 patients. In a sample of 310 patients visiting the GP, we detected 
some selective recruitment, indicating an underrepresentation of patients aged 12 to 35 
years (OR 1.70; 1.15-2.77), especially among men (OR 2.16; 1.12-4.18). The 
underrepresentation of patients with traumatic onset of injury was not statistically 
significant. 
Conclusions 
This cohort is unique in its size, setting, and its range of both age and type of knee 
complaints. We believe the detected selective recruitment is unlikely to introduce 
significant bias, as the cohort will be divided into subgroups according to age group or 
traumatic onset of injury for future analyses. However, the underrepresentation of men in 
the age group of 12 to 35 years of age warrants caution. Based on the available data, we 
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believe our cohort is an acceptable representation of patients with new knee complaints 
consulting the GP, and we expect no problems with extrapolation of the results to the 
general Dutch population.  
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Background 
 
Knee complaints rank among the most frequent reasons for consulting primary care 
physicians. A nationwide study into the incidence and prevalence of diseases and 
complaints in Dutch General Practices revealed that the incidence of unspecified knee 
complaints in General Practice is 13.7 per 1000 patients per year, ranking 16th in the list 
of most frequent reasons for visiting the General Practitioner (GP). Specified knee 
complaints (knee distortion, acute injury to meniscus or ligaments, chronic internal 
traumatic knee injuries, knee osteoarthritis, and Osgood Schlatter) account for an 
incidence 11.3 per 1000 on top of that1. 
Nonetheless, clinical research in this area is usually carried out in hospital settings and 
only covers serious or persistent injuries, usually meeting stringent inclusion criteria. The 
applicability of results from this research to patients presenting knee complaints in 
general practice is therefore limited. Open population studies2,3 offer a broader view of 
knee complaints, but often target specific age groups and also include patients that do 
not seek medical care for their complaints. To our knowledge, publication of studies 
dealing with patients with knee disorders in general practice is limited to cross-sectional 
registration studies that report incidence and prevalence of diagnostic codes and their 
corresponding referral rates to physical therapy or specialist care1. This type of study is 
not informative with respect to disease burden, the (natural) course of complaints, 
treatments strategies or even diagnosis, because the diagnostic codes are often non-
specific. As a result, our understanding of knee complaints in primary care is far from 
complete. But knowledge about the determinants of the clinical course is essential for 
making management decisions and to inform patients about their prognosis. 
Furthermore, decisions about management and referral of knee complaints in primary 
care are to a large extent based on test results from physical examination. Physical signs 
and symptoms may also play an important part in predicting the course of knee 
complaints. Nevertheless, the value of physical examination in general practice has 
never been evaluated. 
 
To fill in the gaps in the information available to GPs, we performed a prospective, 
observational cohort study including the whole range of incident knee complaints 
presented to the GP, by adolescents as well as adults. The primary objectives of our 
cohort study are as follows: 
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What type of knee complaints are presented to the GP, and what is their severity and 
impact on daily activities? 
What is the one-year prognosis of knee complaints presented to the GP? 
What are the factors predicting prognosis? 
How are knee complaints managed by GPs? 
 
The wide range of knee complaints included in our cohort study enables us to focus on 
specific aspects for specific subgroups and on the validity of measurement tools in a 
primary care setting. Therefore our secondary objectives for specific subgroups are as 
follows: 
What is the predictive value of physical examination and history taking for detecting 
lesions that can be seen with Magnetic Resonance Imaging (MRI) in patients with acute 
traumatic knee injuries in General Practice? 
1. What is the additive predictive value of MRI over physical examination and history 
taking for the prognosis of knee complaints in patients with acute traumatic knee 
injuries in General Practice? 
2. What is the validity and responsiveness of disease specific questionnaire assessed 
disability measurements compared to device assessed disability measurements?  
 
In this paper we will outline the composition of our cohort and define its subgroups. The 
objectives of our cohort demand that we give an accurate account of the population of 
patients that visit the GP with knee complaints. As we depended on active cooperation 
from the GPs for recruitment of patients, we need to ascertain that our cohort represents 
this population. Therefore objectives for the present paper are twofold: 
 
1. To describe the methods used for data collection 
2. To determine whether the recruitment procedures resulted in a patient selection that 
accurately represents the patients visiting the GP. 
 
 20 
Knee disorders in primary care: design and patient selection of the HONEUR knee cohort 
Methods 
 
Design 
This is a prospective, observational cohort study, with a follow-up period of one year. 
Data were collected using questionnaires and physical examinations. The researchers 
did not interfere with usual care with respect to advice, diagnostics or treatment. The 
study was approved by the ethics committee of the Erasmus Medical Centre Rotterdam.  
 
Inclusion criteria 
Patients aged 12 years or above, consulting their GP for a new episode of knee 
complaints, were invited to participate in the study. New complaints were defined as 
complaints that were presented to the GP for the first time. Recurrent complaints for 
which the GP was not consulted within the last 3 months were also considered new 
complaints. Knee complaints that required urgent medical attention, such as fractures or 
infections were excluded. Patients with malignancies, neurological disorders or systemic 
musculoskeletal diseases that affect the outcome measures used in this study (i.e. 
Parkinson's disease, Rheumatoid Arthritis, Amyotrophic Lateral Sclerosis, etc.), as well 
as patients that were incapable of understanding the ramifications of participation, were 
excluded from participation.  
 
Recruitment 
40 GPs from 5 municipalities in the southwest region of the Netherlands, connected to 
the Erasmus Medical Centre GP Research Network HONEUR and representing a total 
patient population of around 84,000 patients, participated in this prospective cohort 
study. We started recruitment in October 2001 in 1 municipality and a new municipality 
was added approximately every 3 months. All GPs recruited up to October 2003. 
Patients were alerted to the existence of the study through posters in the waiting room. 
Participation of patients was voluntary and did not affect the care given to the patient. 
Patients received no compensation for participation. During consultation, the GP briefly 
informed the patient of the existence of the study and handed over written information 
and a baseline questionnaire. Interested patients forwarded their contact details to the 
researchers. The researchers contacted the patients to further inform patients of the 
study and to make an appointment for signing informed consent and performing a 
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comprehensive standardized physical examination of both knees. Informed consent 
forms for minors (aged 12 through 17) were co-signed by a parent or guardian. 
Participating GPs agreed to note the following items in their computerised medical files: 
relevant anamnestic findings, treatment details, a preliminary prognosis, and a diagnostic 
code from the International Classification of Primary Care (ICPC)4, chosen from a list 
provided by the researchers.  
 
Table 1: Item list for physical examination 
inspection18,19 palpation18,19 specific diagnostic tests  
coloration temperature sustained flexion test20  
valgisation/varisation swelling: balottable patella sign patellar grinding test19
overextension / limited  
   extension 
swelling: fluid shift /  
   fluctuation sign 
patellar axial pressure test21
tibial tuber swelling pain tibial tuber patellar apprehension test21
atrophy quadriceps pain joint line Steinmann II test22
flexion contracture hip pain patellar edges McMurray test23
internal/external rotation femur pain patellar ligament Apley's grind/traction tests24
internal/external rotation tibia pain collateral lateral / 
   medial ligaments 
valgus / varus test25
foot pronation  pain insertion pes anserinus  anterior drawer test25
leg length difference pain insertion iliotibial band  Lachman test26
 swelling fossa poplitea /  
   Baker's cyst 
pivot shift test27
function assessment  hypertrophy synovial plica  posterior drawer test25
flexion / extension  
   active / passive  
bursa prepatellaris pain /  
   swelling 
tibial posterior sag28
resisted flexion / extension bursa infrapatellaris pain / 
swelling 
 
 
Physical examination 
Two physiotherapists employed as research assistants (DC and EB) developed the 
standardized protocol for physical examination under supervision of two physiotherapists 
with over ten years of experience in both physiotherapy and research (SMAB and HW). 
Standardisation of the examinations among research assistants was accomplished by a 
series of training sessions before starting the inclusion of patients. These training 
sessions were repeated regularly over the course of the inclusion period. In total five 
physiotherapists (DC, EB, CV, AV and RvB) with clinical experience varying from one to 
14 years performed the physical examinations of the patients. 
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The physical examination was planned as close to the date of consultation of the GP as 
possible. Irrespective of the type of symptoms presented, a standard range of tests was 
performed on both knees. The physical examination covered inspection of postural 
aspects, signs of inflammation, tests of swelling, locating tender areas, patellofemoral 
joint compression, crepitus, knee extensor and flexor strength, joint laxity, range of 
motion and meniscus tests (see table 1).  
Discussion about diagnosis and/or appropriate management between patient and 
physiotherapist was discouraged, to avoid influencing the management initiated by the 
GP. The physical examination was repeated after one year, to enable comparison of 
perceived recovery with changes in test results.  
 
Self-report questionnaires 
Baseline questionnaires were filled in by the patients before the baseline visit, and 
checked for completeness by the physiotherapist during the baseline visit after physical 
examination. Any uncertainties on behalf of the patient were discussed at that point and 
any necessary corrections made accordingly. The three monthly follow-up 
questionnaires were mailed to the participants, and returned by mail, except for the last 
questionnaire, which coincided with the follow-up physical examination. The 
questionnaires included possible prognostic factors as well as outcome measures. 
Details of questionnaire items are listed in table 2. For possible prognostic factors we 
enquired after socio-economic status, comorbidity, history of knee complaints, 
characteristics of the knee complaints, daily activities and coping behaviour. To 
determine whether the complaints were recurrent, we asked patients if they had 
experienced similar knee complaints in the past, with complaints disappearing at least 
several weeks before returning again now. We also asked if they had consulted the GP 
for that previous episode. Occupations were accredited with a level of knee loading 
ranging from 1 (e.g. office jobs) to 3 (e.g. construction workers and mail men) and sports 
activities with a level from 1 (strolling and swimming) to 5 (contact sports). Physical 
activities from level 2 upward are considered substantial knee loading sports activities. 
Contact sports and sports involving rapid changes of direction are considered heavy 
loading activities (levels 4 and 5).  
Medical advice and interventions by the GP were recorded at baseline. During follow-up 
patients also recorded visits to other medical professionals with a short description of 
interventions. 
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Table 2. Questionnaire items 
 evaluation 
at (months) 
validation / reliability 
demographics   
age, gender 0 - 
composition of the household 0 - 
type of medical insurance, education level 0 - 
comorbidity 0 - 
knee complaints   
history, duration, recurrence, consultation 
previous episode, perceived cause of knee 
complaint, mechanism of traumatic injury 
0 - 
pain 11 point numeric rating scale 0 3 6 9 12 numeric rating scales have com-
pared favourably to visual analogue 
scales for children and adults5-7  
Lysholm knee scale8 0 3 6 9 12 developed for ligament ruptures, 
sensitive and reliable for meniscus 
tears, (patellar) chondral 
disorders11,12
Knee Society Score29 
- function score (patient, questionnaire) 
- knee score (observer, physical exam) 
0 12 intra- / interobserver reliability poor30 
- function score moderate agreement 
- knee score poor agreement 
WOMAC osteoarthritis index9,10 0 3 6 9 12 validated and reliable for 
osteoarthritis 10
pain and difficulty with cycling, running, 
jumping, squatting, kneeling 
0 3 6 9 12  
knee loading   
daily activities: employment, volunteer 
jobs, household chores, study:  
0 3 6 9 12 - 
physical exercise / sports participation 
frequency, intensity, duration, association 
with knee complaints 
0 12 - 
impact of knee complaint   
hindrance during daily activities  
sick leave from daily activities 
0 3 6 9 12  
health related quality of life   
SF-3631-33 0 3 6 9 12 sensitive to change in common 
orthopaedic diagnoses14,  
invalid for adolescents15
COOP/WONCA charts34,35 0 3 6 9 12 valid for adults34
treatment   
advise given by the GP 0 - 
medication for knee complaint 0 3 6 9 12 - 
medication for comorbidity 0 3 6 9 12 - 
visits to health care professionals 3 6 9 12 - 
operations 3 6 9 12 - 
coping   
Tampa Kinesiofobia Scale, (TKS)36
catastrophizing 
0  
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Outcome measures  
Patients filled in their experienced recovery after one year on a 7 point Likert scale, 
ranging from 'fully recovered' to 'worse than ever'. Pain intensity was determined using a 
numeric rating scale (NRS) ranging from 0 (no pain) to 10 (unbearable pain). Numeric 
rating scales have compared favourably to visual analogue scales for children5,6 as well 
as adults7, though the number of points on these scales differed. Function assessments 
on disability level were determined using the Lysholm knee scoring scale (0-100)8 and 
the WOMAC Hip and Knee Osteoarthritis Index (0-100)9,10. The Lysholm knee scoring 
scale was developed for ligament injuries, but was validated for use in various other 
knee disorders as well11,12. The questions from the WOMAC Hip and Knee Osteoarthritis 
Index were adapted to specifically address only the knee complaints.  
The SF-36 was chosen for the assessment of health related quality of life because of its 
responsiveness13 and its sensitivity to change in common orthopaedic diagnoses14, 
though it has been shown to be invalid in adolescents15. We therefore also included the 
COOP/WONCA charts, which have not been validated in adolescents, but can be easily 
interpreted through illustrations. From the age of 18, patients filled in both SF-36 and 
COOP/WONCA charts, younger patients only filled in the COOP/WONCA charts. 
 
Definition of subgroups 
As different pathologies are expected to show different prognoses, we defined three 
subgroups. Patients with non-traumatic knee complaints are divided into a group aged 
12 to 35 (I) and a group aged 36 years and over (II), because around 35 years of age the 
predominance of specific diagnoses shifts from patellofemoral pain syndrome16 to 
osteoarthritis17. The group of patients with traumatic knee complaints (III) includes all 
patients whose knee complaints were caused by a sudden impact or wrong movement 
within one year before consulting the GP. All other patients were considered to have 
non-traumatic complaints, based on the assumption that the immediate effects of 
traumatic injuries will have worn off after one year.  
 
Additional MRI 
Patients aged between 18 and 65 years of age with an onset of trauma up to 5 weeks 
before consulting the GP were invited to participate in an additional MRI study. 
Participants were informed that patient and GP would not be informed of the presence or 
absence of detected lesions to prevent influencing the treatment strategy employed by 
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the GP. Exceptions to this rule were lesions where urgent intervention was deemed 
necessary. For this additional study patients signed an additional informed consent form. 
MRI was performed between 3 to 6 weeks after the initial trauma, to allow swelling to 
subside while still observing the relatively acute stages of trauma. Following MRI a 
trained physiotherapist repeated the standardised physical examination. The assessors 
performing MRI and physical examination were blind to each other's results. The patients 
themselves recorded pain intensity and Lysholm score. After one year MRI and physical 
examination were repeated. If participants consulted medical specialists at a later date, 
the specialists were able to request MRI reports to prevent unnecessary duplication of 
diagnostic procedures. 
 
Device assessed disability 
Adult patients with non-traumatic knee complaints living in three municipalities close to 
the research facility were invited to participate in the additional device assessed disability 
measurement using the Dynaport knee scoring system17. This system registers 
accelerations of torso, hip, upper and lower legs during simulations of daily activities like 
walking stairs, sitting down, or walking with grocery bags or loaded trolleys. 
Measurements were repeated after 6 months.  
 
Assessment of selective recruitment 
To check whether the cohort adequately represents the patients that consulted the GP 
with a new episode of knee complaints during the inclusion period, the GPs 
computerized patient records were searched retrospectively for all occurrences of the 
relevant ICPC codes after the inclusion period had ended. As data collection from 
medical files is very labour-intensive, the search in each general practice was limited to a 
randomly assigned 4-month period within the total recruitment period. Within each 
municipality we made sure the 4-month periods covered all seasons. From all identified 
patients ICPC-code, diagnosis, age, sex and possible reasons for exclusion were 
registered anonymously on structured forms. ICPC-code and textual notes were both 
taken into account to determine whether onset of symptoms was considered traumatic 
by the GP. From the collected data we determined whether patients were eligible for 
inclusion in the cohort study. Eligible patients were then dichotomized according to age 
(12 to 35 years or above), gender, and traumatic onset of knee complaints. Participation 
rates within these dichotomized subgroups were compared using Odds Ratios (OR) and 
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95% confidence intervals, indicating their relative chances for inclusion into the study. 
Within each dichotomised subgroup we again compared the participation rates for the 
two other patient characteristics. 
As the randomly chosen sample period was in itself a potential cause for bias of our 
analysis, we also compared the proportions of age, gender, and traumatic onset of knee 
complaints between participants from the sample periods and participants from the rest 
of the inclusion period. Furthermore, we compared proportions of ICPC codes in 
participants and non-participants from the sample periods, and in the participants of the 
sample periods and participants of the rest of the inclusion period, using Chi-square 
tests. For the statistical analyses we used SPSS for Windows, release 11.0.1. 
 
Study sample 
 
General cohort 
Of the 1261 patients that forwarded their contact details to the researchers, 1068 (85%) 
signed informed consent. Reasons stated by contacted patients for non-participation are 
listed in table 3. The majority stated lack of time for participation (37%) or lack of 
personal gain (24%). The category miscellaneous included family circumstances, other 
health problems, language problems, and several patients judged themselves too old for 
participation. Ten patients were excluded: five because they were under 12 years of age, 
three because their complaints were not new, one because of rheumatoid arthritis and 
one patient was hospitalized with a bacterial infection of the knee.  
 
Table 3 Reasons for non-participation of patients that forwarded their 
contact details to the researchers 
 N 
Lack of time / could get no time off from work /  
   could not make an appointment for examination 72 
No personal gain / too much bother 47 
No longer any complaints at time of contact and no longer interested 19 
Could not be contacted 15 
Miscellaneous 30 
Non-compliance with inclusion criteria 10 
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The flow diagram (fig. 1) shows the distribution of participants over different subgroups of 
the cohort and the additional measurements. 51% of the participants were assigned to 
the subgroup of non-traumatic knee complaints in patients aged over 35 years of age. 
18% were assigned to the group of non-traumatic knee complaints in the age of 12 to 35 
years. 31% were assigned to the traumatic knee injury subgroup. Figure 2 shows the 
age distribution of the entire cohort, identifying subgroups and additional measurements. 
The percentage of female participants in each subgroup was 50%, 47% and 44% 
respectively.  
 
Figure 1. Patient recruitment and subgroup assignment 
age
12-17
18-35 
36-65 
66-85
non-traumatic subgroups
all patients with knee complaints 
consulting GP
contact details forwarded      contact details not forwarded     
1261 estimated: 2575
participants non-participants
1068 193
baseline assessments:
questionnaire
physical examination
traumatic onset no trauma
351 717
no trauma
16 4 1 4 52
< 3  weeks 3 weeks -   3 months -  > 1 year
129
129 34 15 10 440
88 12 1 7
96
traumatic subgroup
aged 12-85 aged 12-35 aged 36-85
18 8 1 3
327 192 549
3-6 weeks after trauma: within 3 weeks after
MRI
134
baseline: Dynaport
87  
 
 
Of 1031 of the 1068 participants both questionnaire and physical examination results are 
available; 27 (2.5%) underwent a physical examination, but did not return their baseline 
questionnaire. Ten patients (0.9%) underwent no physical examination due to external 
circumstances like holidays and intervening commitments, but did return their baseline 
questionnaire. Data from the computerized medical files of 13 patients were not 
available. 
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Figure 2. Age distributions of subgroups 
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Additional assessments 
Since starting inclusion for the MRI study in April 2002 there were 184 eligible patients, 
of which 134 patients participated. Reasons for non-participation were (in order of their 
contributions) unwillingness or inability to find time for these extra measurements, 
distance to the research facility, and the fact that detected lesions would only be reported 
to the patient and their GP if urgent intervention was deemed necessary.  
Since starting inclusion for the knee function assessments study in August 2002 there 
were 330 eligible patients, of which 87 patients participated. Reasons for non-
participation were unwillingness or inability to attend the extra visits required for these 
measurements.  
 
Patient selection 
The search in the computerized patient records for occurrences of defined ICPC codes 
during the 4-month sample periods identified 310 eligible patients. 153 (49%) of those 
forwarded their contact details to the researchers, and 130 (42%) were included in the 
study and signed informed consent. The actual number of patients from which we 
received contact details during those same sample periods was 176, of which 150 
patients were included in the cohort study (15% declined). When we looked up the 
nu
m
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trauma + MRI
trauma
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medical files of the 150 participants we found that 20 of them lacked ICPC codes, 
explaining the 130 participants that were identified during the search. Likewise, a lack of 
ICPC coding in the medical records explains the discrepancy between the 176 contacted 
patients and the 153 that were identified in the search. Over the entire inclusion period 
the medical files of 15% of all participants lacked ICPC-codes.  
Comparing the 130 participants and 180 non-participants identified through ICPC codes 
in the sample periods, we find significant selection with respect to age groups (table 4): 
we recruited relatively more patients over 35 years of age (OR 1.70; 1.15-2.77). This 
selective recruitment was more pronounced in the male population (OR 2.16; 1.12-4.18), 
than the female population (OR 1.22; 0.58-2.55). Overall, participation rates of women 
were not significantly higher than that of men (OR 1.13; 0.72-1.78). Participation rates of 
traumatic patients were lower than those of non-traumatic patients, though not 
significantly (OR 0.60; 0.26-1.43). Figures 3 and 4 show graphical representations of the 
proportions of included patients for each age group, subdivided for gender and traumatic 
onset of complaints. 
 
Figure 3. Inclusion rate of eligible patients  Figure 4. Inclusion rate of eligible patients 
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When comparing participants from the sample periods with participants from the entire 
inclusion period, we found equal proportions of gender and age groups (see table 4). 
However, the proportions of traumatic injuries differed significantly: 12% of the patients in 
the sample periods were labelled 'traumatic injury' against 19% in the rest of the 
inclusion period (OR 0.59; 0.35 - 0.98).  
We compared ICPC codes of participants and non-participants from the sample periods 
with a Chi-square test, pooling the codes L15 and L94.2 to prevent empty cells. We 
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found a significant difference between the groups (Chi-statistic 11.2, p = 0.025). The 
differences are caused mainly by codes L78 and L96 for acute traumatic injuries and 
code L90 for osteoarthritis of the knee, all of which are less frequent in the participants. 
Comparison of ICPC codes of participants from the sample period with those of the rest 
of the inclusion period using the Chi-square test reveals no significant difference (Chi-
statistic 5.6, p = 0.234). 
 
Table 4 Patient characteristics of participants and non-participants 
 
all participants 
in cohort 
participants 
in sample 
non-participants
in sample 
comparison# of 
particpation rates 
 N n 
(%) 
N n 
(%) 
N n 
(%) 
OR 
(95% CI) 
gender  (nwomen) 1045 494 
(47%) 
150 76 
(51%) 
180 83 
(46%) 
1.20 
(0.78-1.85) 
age  (n>35 years) 1045 741 
(71%) 
150 110 
(73%) 
180 109 
(61%) 
1.79 
(1.12-2.86)* 
 in men 551 380 
(69%) 
74 51 
(69%) 
97 50 
(52%) 
2.08 
(1.11-3.93)* 
 in women 494 361 
(73%) 
76 59 
(78%) 
83 59 
(71%) 
1.41 
(0.69-2.90) 
 in traumatic  197 134 
(68%) 
18 13 
(73%) 
34 17 
(50%) 
2.60 
(0.80-8.98) 
 in non-traumatic 848 607 
(72%) 
132 97 
(73%) 
146 92 
(63%) 
1.63 
(0.98-2.72) 
trauma$ (n positive) 1045 197 
(19%) 
150 18 
(12%) 
180 34 
(19%) 
0.59 
(0.32-1.09) 
 in men 551 109 
(20%) 
74 10 
(12%) 
97 20 
(21%) 
0.60 
(0.26-1.38) 
 in women 494 88 
(18%) 
76 8 
(11%) 
83 14 
(17%) 
0.58 
(0.23-1.47) 
      
ICPC codes      
L15 unspecified 519 
(50%) 
84 
(56%) 
82 
(46%) 
 
L78 acute knee distortion 107 
(10%) 
8 
(5%) 
20 
(11%) 
 
L90 osteoarthritis 77 
(7%) 
10 
(7%) 
28 
(16%) 
 
L94.2 Osgood-Schlatter 10 
(1%) 
1 
(1%) 
0 
(0%) 
 
L96 acute meniscus /  
 ligament ruptures 
87 
(8%) 
13 
(9%) 
14 
(8%) 
 
L97 chronic internal trauma 245 
(23%) 
 34 
(23%) 
 36 
(20%) 
 
$  patient described onset of complaints in questionnaire as immediate, due to impact or twisting, 
maximally 1 year before consultation 
# comparing participation rates of age groups and traumatic injuries in sample 
* p-value < 0.05 
N = total number of patients  
n = number of patients in a subset 
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Discussion 
 
We succeeded in starting a unique cohort study of patients with incident knee complaints 
in general practice. From October 2001 to October 2003 we included 1068 patients. 
Apart from its size, this cohort is unique in the range of knee complaints we studied: we 
included all ages from adolescents to the elderly, and we included both traumatic and 
non-traumatic complaints. Furthermore, this is the first cohort to include a standardised 
physical examination as well as questionnaires in patients who seek medical care for 
their knee complaints in general practice. We therefore think our cohort has a high 
potential for giving insight into the natural course of a range of knee complaints, and will 
give valuable information to base future effectiveness studies in primary care on. But in 
order to extrapolate the results of future publications ensuing from this cohort to clinical 
practice, we need to determine whether selective recruitment could induce bias.  
 
Selective recruitment  
Patients below the age of 36 years were significantly less inclined to participate in our 
cohort study, and this trend was even stronger in the male population. Other 
comparisons did not produce statistically significant differences. However, the sample 
size may have been too small to prove that patients with traumatic injuries were 
underrepresented, again to a greater extent in the younger age group. Comparison of 
ICPC codes of the non-participants with those of the participants from the sample 
periods using a Chi-square test reveals a significant difference with respect to types of 
knee complaints. The difference is mainly caused by lower frequencies of the codes for 
the acute traumatic injuries L78 and L96, but lower frequencies of osteoarthritis of the 
knee (L90) also contribute. 
The lack of ICPC codes in 15% of the participants indicates that our method for 
determining patient selection depends on the coding behaviour of the GPs. So is our 
sample a good representation of the situation during the entire inclusion period? We 
cannot identify the non-participants without ICPC codes to verify that, so we compared 
the proportions of gender, age groups and traumatic injuries of cohort and sample (table 
4). We found a significantly smaller proportion of participants with traumatic injuries in 
the sample (12%) than in the cohort (19%) (OR 0.59; 0.35 - 0.98). As we made sure that 
the 4-month sample periods were distributed over all seasons in each municipality before 
randomly assigning them to the resident practices, we have ruled out seasonal 
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fluctuations as a possible cause. But the working definition of 'traumatic injury' might 
explain something. In the medical records traumatic injuries can be recognised either by 
their ICPC code, or by the textual notes made by the GP. Some GPs tend to choose 
non-specific codes (L15) for any knee complaint, in which case recognition of traumatic 
injuries depends on the amount of detail in the textual notes. However, for further 
analyses in our cohort we use the patients perceived cause of the knee complaint 
together with the duration of the complaint to determine whether the complaint was of 
recent traumatic onset. With this definition we no longer detected any differences (29% 
in sample versus 31% in cohort). This indicates that the seemingly low participation rates 
of traumatic patients may have been an artefact caused by variations in the amount of 
detail in the medical files, rather than reflecting a non-representative sample. 
Furthermore, comparison of ICPC codes from the sample period with those of the rest of 
the inclusion period using the Chi-square test revealed no significant difference. One 
limitation remains: we have no insight into the possible differences in severity of knee 
complaints of participants and non-participants. 
Comparing our results with those reported for the nationwide registration study1, we 
found similar distributions of ICPC codes, suggesting that our population does not 
substantially deviate from patients with knee complaints in other Dutch general practices.  
 
Conclusion 
 
Based on these results, we expect that the effects of selective recruitment will not cause 
significant bias, as future analyses will be performed separately for subgroups of 
patients, and adjustments will be made for gender and other possible risk factors and 
confounders.  
We are confident that the present cohort study will provide new insights into the 
prognosis and management of knee complaints in primary care, and that the results can 
be extrapolated to all Dutch general practices.  
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Management, characteristics and impact of knee complaints in general practice 
Abstract 
 
Background 
With an incidence of around 25 per 1000 patients per year knee complaints in Dutch 
general practice are common. Nevertheless, no prospective studies of knee complaints 
presented in general practice were available that described the three major subgroups of 
knee complaints outlined in Dutch GP guidelines. 
Aim 
To determine the relative severity, impact and management by the GP of patients with 
traumatic and non-traumatic onset of knee complaints and of different age groups of 
patients consulting the GP for new episodes of knee complaints. 
Design and setting 
Cohort study in general practice. 
Methods 
We recruited 1042 patients consulting the GP with new episodes of knee complaints. 
Non-traumatic knee complaints were divided in two groups according to age, the third 
group consisted of traumatic injuries. We compared knee characteristics, severity 
measures and initial management by the GP, extracted from self-administered 
questionnaires.  
Results 
Traumatic patients reported shorter duration of complaints before consultation, less 
recurrences and less bilateral complaints. Pain, WOMAC, and Lysholm scores were 
worst for the traumatic group. X-ray requests and prescribed pain medication were most 
frequent in the older non-traumatic subgroup, referral to orthopedic surgeons in the 
traumatic group, and  
advice to exercise knee extensors and referral to physiotherapists in the younger non-
traumatic subgroup. 
Conclusion 
The severity and impact of knee complaints was greatest in the traumatic group, and 
smallest in the younger non-traumatic age group, although differences between the non-
traumatic groups may not be relevant. The amount of interventions by the GP exceeds 
expectations based on guidelines for GPs.  
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Introduction  
 
A recent report of incidence and prevalence of diseases in Dutch general practices 
shows that musculoskeletal complaints are the most frequent reason for consulting the 
GP. After back pain, knee complaints show the highest incidence figures, with around 25 
in 1000 patients consulting the GP for knee complaints each year 1. Guidelines for Dutch 
GPs2-4 assume prognoses for the most common non-traumatic knee complaints other 
than osteoarthritis are good, and advise a 'wait and see policy' for most knee complaints. 
However, little is known about disease burden, prognosis and actual management of 
knee complaints presented in general practice, and the guidelines are based on 
consensus rather than evidence. A search of the literature for studies of knee complaints 
in general practice reveals one retrospective study of patients with retropatellar 
chondropathy5, a prospective cohort of a heterogeneous group of knee complaints 
presented to the GP6, a trial for the effectiveness of patients with hip or knee 
osteoarthitis7, and open population studies using general practice records for 
identification of elderly patients to be screened for knee complaints8-10. The focus on 
elderly patients was prompted by the fact that the disease burden of osteoarthritis and 
associated health care use is considerable. We do not know the impact of knee 
complaints in  younger patients with non-traumatic knee complaints or patients with 
traumatic complaints. Therefore we started a cohort of three major groups of knee 
patients outlined in the practice guidelines for Dutch GPs2-4: traumatic injuries, and non-
traumatic knee complaints divided in a younger and an older age group. In this paper we 
compare these subgroups to determine actual differences in disease burden and initial 
management by the GP, and we evaluate to what extent the guidelines are followed. 
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Methods  
 
The design and methods of data collection of this cohort are described in detail 
elsewhere 11. We summarise the relevant items for this paper below. 
 
Participants 
Forty GPs in the southwest of the Netherlands recruited consecutive patients consulting 
for incident knee complaints from October 2001 up to October 2003, during an average 
period of 1.5 years per practice. Incident complaints were complaints for which the GP 
had not been consulted in the past 3 months and which the GP recorded as a new 
episode. The Medical Ethics Committee of Erasmus Medical Centre approved the study 
and informed consent was obtained at baseline. Informed consent forms for minors were 
co-signed by a parent or guardian.  
 
Subgroup definition 
As different pathologies are expected to show different prognoses, we defined three 
subgroups in our cohort. Patients with non-traumatic knee complaints are divided into a 
group aged 12 to 35 (I) and a group aged 36 years and over (II), as around this age the 
predominance of specific diagnoses shifts from patellofemoral pain syndrome12 to 
osteoarthritis1. The group of patients with traumatic knee complaints (III) includes all 
patients whose knee complaints were caused by a sudden impact or wrong movement 
within one year before consulting the GP. All other patients were considered to have 
non-traumatic complaints, based on the assumption that the immediate effects of 
traumatic injuries will have worn off after one year.  
 
Questionnaires 
Patient characteristics 
From the baseline questionnaires we extracted patient characteristics such as age, 
gender, education level, type of health insurance and co-morbidity. Recorded daily 
activities included daily duties (i.e. paid employment, studies, household chores and 
volunteer jobs), and participation in exercise. Any exercise except those requiring 
minimal knee loading forces (e.g. strolls and swimming) were considered activities with 
substantial loading. Contact sports and sports involving rapid changes of direction are 
considered heavy loading activities[13].  
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Characteristics of knee complaints  
These include duration of the knee complaint before consulting the GP, the perceived 
cause of the complaint (traumatic or not), bilateralism and recurrence (i.e. experiencing 
similar knee complaints in the past, with previous consultation of the GP at least 3 
months ago and complaints disappearing at least several weeks before returning 
presently). Previous consultation of the GP for recurrent episodes was also recorded.  
Impact of knee complaints  
We asked patients if they were bothered by their knee complaints during daily duties 
such as paid employment, volunteer jobs, studies and housekeeping. We also asked if 
they refrained from these duties because of their knee complaints. Employment was also 
evaluated separately. 
Severity 
Pain intensity over the last 48 hours was assessed with a numerical rating scale (NRS), 
ranging from 0 (no pain) to 10 (unbearable pain)14,15.We evaluated disability due to 
compromised knee function using the WOMAC hip and knee Osteoarthritis Index, 
adapted to assess knee complaints alone16,17 and the Lysholm knee score13. All scores 
ranged from 0 (worst) to 100 (best), and were obtained from self-administered 
questionnaires. The validity of these questionnaires for each of the subgroups has been 
described elsewhere18. Patients with bilateral complaints filled in pain and function 
scores for the most affected knee. 
Management by GP 
Patients checked the option boxes provided in the baseline questionnaire as to which 
treatment or advice was given by the GP.  
 
Statistical analysis 
Frequencies of demographic and knee-specific characteristics as well as management of 
the complaint are presented as percentages of the number of patients within each 
subgroup of our cohort, where informative subdivided by gender. No statistical 
comparisons were performed for demographics, general knee characteristics and 
management of the complaints. Differences in impact of knee characteristics on daily 
duties, between traumatic and non-traumatic patients, and between age groups, are 
expressed as Odds Ratios (OR) with 95% confidence intervals. OR of > 1 indicate a 
higher frequency of the item in the traumatic group and the younger age group 
respectively. 
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To determine whether pain score, Lysholm score and WOMAC score showed 
differences for traumatic onset or age group, we used an ANOVA model (SAS 8.2 
statistical software package, proc GLM) initially containing the factors trauma (yes/no), 
age (≤35 / >35) and gender and their interaction terms. Gender was included because 
women generally report more pain for musculoskeletal disorders, for which we wanted to 
adjust (ref). An interaction between age and trauma indicated different effects of age on 
severity in traumatic and non-traumatic patients. We then analysed the effect of age on 
severity measures adjusted for gender in traumatic and non-traumatic patients 
separately.  
 
Table 1 Patient characteristics 
 
non-traumatic 
aged 12-35 
non-traumatic 
aged 36-85 
traumatic* 
aged 12-83 
questionnaire available (n) 184 540 318 
age (mean (sd)) 24.1 (7.7) 53.8 (11.4) 41.9 (15.6) 
gender (% male) 52 50 57 
health insurance (% public) 40 47 52 
level of education (%)    
 low 14 30 19 
 intermediate 38 37 42 
 high 48 33 40 
paid employment (%)    
 male   75 77 85 
 female   70 50 67 
regular physical exercise (%)    
 male none 20 41 28 
  light loading 5 4 3 
  moderate loading 20 37 20 
  heavy loading 55 18 49 
 female none 30 39 33 
  light loading 4 9 6 
  moderate loading 39 39 38 
  heavy loading 27 13 23 
musculoskeletal comorbidity (%)    
 male 48 33 29 
 female 61 49 25 
BMI (%)    
 male <25  healthy 61 28 41 
  25-30  overweight 30 53 40 
  > 30   obese 9 18 19 
 female <25  healthy 70 38 42 
  25-30  overweight 24 40 41 
  > 30   obese 7 22 17 
* traumatic injuries occurring maximally 1 year before consultation 
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Results  
 
A detailed flow chart for inclusion is published elsewhere 11. Baseline questionnaire data 
of 1042 patients were available, but the number of patients per analysed item may vary 
because of varying response rates. The traumatic subgroup comprised 31% of our total 
cohort. The non-traumatic group aged  36 to 85 makes up 50% of the cohort, and the 
group aged 12 to 35 makes up 19%. Gender proportions are not significantly different 
among the groups. 
Patient characteristics 
Patient characteristics per subgroup are stated in table 1. Subgroups show comparable 
gender ratios. Co-morbidity of the musculoskeletal system is more frequently seen in 
women in both non-traumatic subgroups. Younger patients with non-traumatic 
complaints have the highest co-morbidity rate. Heavy loading sports activities are more 
frequent in the male population, especially in the younger age group of the non-traumatic 
patients.  
 
Table 2 Characteristics of knee complaints 
 
non-traumatic 
aged 12-35 
non-traumatic 
aged 36-85 
traumatic* 
aged 12-83 
questionnaire available (n) 184 540 318 
bilateral knee ocomplaints (%) 45 32 15 
recurrent knee complaint (%)  
 first time consulting GP 23 19 9 
 consulted GP before 29 24 18 
duration before consulting GP (%)    
 <1 week 13 18 40 
 1-3 weeks 25 25 37 
 3 weeks - 3 months 29 29 18 
 3 months - 1 year 19 16 6 
 >1year 15 13 0 
did your knee complaint  
 make you refrain from:  (% 'yes')$  
  any daily duties# 19 16 36 
  employment alone 16 12 35 
 bother you during (% 'yes')$    
  any daily duties 57 64 70 
  employment alone 51 50 64 
* traumatic injuries occurring maximally 1 year before consultation 
$ ratio of the number of participants reporting bother or sick leave to the number of participants that 
   report performing these activities  
# daily duties include employment, volunteer work, studies and housekeeping  
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Characteristics of knee complaints 
The characteristics of knee complaints are stated in table 2. 77% in the traumatic 
subgroup and 42% in the non-traumatic subgroup consult the GP within 3 weeks of the 
onset of knee complaints. Bilateral knee complaints are more common for non-traumatic 
knee complaints (42% versus 15% in traumatic patients), and even more so in the 
younger age group (45%). Patients with non-traumatic complaints indicate having had 
previous episodes of similar knee complaints more often (45%) than patients with 
traumatic injuries (27%). 25% of the patients with non-traumatic complaints and 18% of 
the traumatic group visited the GP in previous similar episodes. The duration of knee 
complaints before consulting the physician is considerably shorter for traumatic patients. 
Impact 
Patients with traumatic complaints significantly more often refrain from daily duties (OR 
2.80; 2.07-3.79) and employment specifically (OR 3.65; 2.50-5.31). The differences 
between traumatic and non-traumatic patients are less pronounced for bother caused by 
the knee complaints (ORdaily duties 1.74; 1.26-2.38 and ORemployment 1.41; 1.06-1.87).  
 
Table 3. Mean knee severity measures and gender adjusted mean differences between  
 age groups of patients with non-traumatic knee complaints 
 
Non-traumatic  
aged 12-35 years 
Non-traumatic  
aged 36 and over 
difference  
12-35 years - 36 and over 
 n mean   95% CI  n mean  95% CI mean 95% CI P-value 
pain intensity 185 4.00 (3.70;4.30) 540 4.32 (4.14;4.50) -0.32 (-0.67;0.03) 0.089 
WOMAC 184 79.4 (76.7;82.1) 540 71.5 (69.9;73..1) 7.86 (4.73;11.0) <0.001 
Lysholm 185 73.3 (71.0;75.6) 540 68.6 (67.3;69.9) 4.66 (2.03;7.30) <0.001 
 
Table 4. Mean knee severity measures and gender adjusted mean differences between  
 traumatic and non-traumatic subgroups  
 traumatic group     non-traumatic group
difference  
traumatic - non-traumatic 
 n mean   95% CI  n mean  95% CI mean 95% CI P-value  
P-
value* 
pain intensity 318 4.51 (4.27;4.75) 725 4.24 (4.08;4.40) 0.27 (-0.02;0.55) 0.054 0.007 
WOMAC 316 66.7 (64.5;69.0) 724 73.5 (72.0;75.0) -6.75 (-9.44;-4.05) <0.001 <0.001 
Lysholm 318 67.1 (65.3;68.9) 725 69.8 (68.6;71.0) -2.69 (-4.87;-0.52) 0.008 <0.001 
* age adjusted 
 
Severity 
Outcome measures assessing the severity of knee complaints are summarised in table 3 
and 4. Women scored consistently worse on all severity measures, and therefore we 
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adjusted comparisons of the subgroups for gender. We found significantly worse 
Lysholm and WOMAC scores in the older non-traumatic subgroup compared to the 
younger one. For pain we found no significant difference, but we did find an interaction 
between age and gender, with male patients in the younger age group showing 
significantly lower pain scores (figure 1). The comparison of traumatic and non-traumatic 
complaints was adjusted for age groups because of the observed differences between 
the age groups in the non-traumatic subgroups. The traumatic subgroup showed 
consistently worse scores for all severity measures. 
 
Figure 1. Gender differences in pain intensity per subgroup 
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Management by GP 
The management of knee complaints is summarised in table 5. Referrals for diagnostic 
imaging are by far the most frequent in the older non-traumatic subgroup (21%), followed 
by the traumatic group (14%) and the younger non-traumatic group (4.4%). The majority 
(95%) of all imaging requests are for X-rays. Patients with non-traumatic knee 
complaints aged 36-85 are least often advised to give the knee some rest or to wait and 
see how the complaints will develop. This advice was more often given in patients with 
short duration of knee complaints. The proportion of patients advised to exercise knee 
extensors is greater in the younger non-traumatic subgroup, as is the proportion of 
referrals to physical therapy. The proportion of referrals to orthopaedic surgeons is 
greater in the traumatic subgroup. 
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30% of all patients report medication use for their knee complaints, 80% of which 
consists of pain medication. 86% of all taken pain medication is prescribed by the GP. 
Other medication includes muscle relaxants (prescribed), glucosamin and gels intended 
to improve blood circulation (self medication). Medication use (prescribed or self 
medication or both) in the younger non-traumatic subgroup was approximately half that 
of the other subgroups. 
The GP advised 20% of all patients with a BMI > 25 to lose weight. The advice to 
exercise was slightly less frequently given than referrals to physical therapists. Both were 
most often given to the younger non-traumatic age group.  
 
Table 5. Management of knee complaints 
 
non-traumatic 
aged 12-35 
% (N=182) 
non-traumatic  
aged 36-85 
% (N=523) 
traumatic 
aged 12-83 
% (N=312) 
Management / advice from GP    
X-ray / echo / MRI 4.4 21 14 
wait and see 28 18 31 
rest 26 15 42 
avoid knee loading activities 34 36 47 
reevaluation by GP at later date 3.3 4.7 11 
lose weight BMI < 25 0.0 1.8 3.3 
 BMI 25-30 2.0 2.8 4.9 
 BMI > 30 23 20 10 
exercise (no therapist) 26 20 21 
referral to physical therapist 32 26 26 
referral to orthopedic surgeon 11 11 15 
compresses 9.3 8.0 18 
intra-articular injection 0 0.6 1.0 
prescribed medication 14 29 25 
 NSAID  11 22 18 
 paracetamol  0.5 1.7 1.0 
 other medication / unknown 2.7 5.1 4.8 
    
Patient initiative    
Self medication 2.2 5.6 5.1 
 NSAID 0.5 3.8 1.9 
 paracetamol 1.1 1.1 2.2 
 other medication 0.5 0.8 1.0 
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Discussion 
 
Knee characteristics, severity and impact 
We found significant differences between the three major groups of knee complaints with 
respect to characteristics and severity of the complaints. The scores of the severity 
measures as well as the impact on daily activities were greatest in patients with 
traumatic injuries. Comparison of the age groups of the non-traumatic knee complaints 
revealed that the older group showed significantly worse pain and functional disability 
scores. The proportion of patients reporting that their knee complaints bother them 
during daily duties is also slightly larger in the older subgroup. However, the proportion of 
patients refraining from these daily duties because of the knee complaints is slightly 
larger in the younger age group. Therefore we suggest that although the difference 
between the age groups are significant, the relevance of these differences in terms of 
impact on daily activities may be limited. Age differences were only detected in the non-
traumatic group, which supports the idea that the subgroups of our cohort reflect different 
groups of knee complaints. This may also play a role in the way patients complete their 
questionnaires and may be a contributing factor to the significant differences we find.  
The function assessments are for a considerable part dependent on pain scores. 
However, the larger gender difference in the pain scores of the younger non-traumatic 
group (figure 1) is not reflected in the function scores. This suggests that the interaction 
between age and pain scores is not clinically relevant. The finding that female patients 
scored consistently worse on all severity measures is in line with reports in literature19.  
 
The proportion of bilateral complaints (15%) in the traumatic group seems rather high, 
although they are considerably greater in the non-traumatic groups. We cannot deduct 
from our data if both knee complaints are of traumatic origin, or if compensation for one 
knee causes complaints in the other. Another surprise was the high number of 
recurrences in the traumatic group (27%). A cross-check did not suggest any relation 
between participation in high risk sports activities (heavy loading, pivoting, contact 
sports) and recurrences. 
 
Management of knee complaints 
With respect to diagnostic imaging techniques, the practice guidelines developed by the 
Dutch College of General Practitioners2-4 only recommend X-rays when suspecting 
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fractures, osteomyelitis or tumours. It is not recommended for determining the extent of 
osteoarthritis (OA) because of the poor correlation between radiological signs and 
symptoms. However, the number of X-rays requested by the GP is rather high, 
especially in the non-traumatic subgroups. A British study20 showed that the decision to 
X-ray older patients with knee symptoms and subsequent referral rates to secondary 
care are not influenced by clinical features. Dutch practitioners may follow the same 
strategy, but we do not have data to verify this hypothesis.  
Exercising the musculature around the knee, and especially the quadriceps is 
recommended for nearly all knee complaints2-4, though for traumatic injuries and 
Osgood-Schlatter disease only after a period of rest. In patellofemoral pain syndrome 
and OA exercising can start immediately, though it is recommended to avoid pain-
provoking activities. Physical therapy is only recommended for patients with OA that 
have insufficient effect when exercising by themselves, and patients with traumatic 
injuries with high demands of their knees. Frequencies of rest, avoiding pain provoking 
activities and exercise reflect good compliance with these guidelines. However, the 
highest frequency of referral to physical therapy is observed in the younger non-
traumatic patients, in spite of the guidelines. The proportion of younger non-traumatic 
patients that is referred to orthopaedic surgeons is also rather high. The lower frequency 
of prescribed pain medication in the younger subgroup of non-traumatic patients is in 
concordance with the guidelines: pain medication would interfere with the advice to 
adjust activities to pain levels. The more frequent prescription of pain medication in the 
older non-traumatic group and the traumatic patients is in accordance with the 
guidelines, although the guidelines recommend paracetamol as a first choice, and 
prescriptions are mainly for NSAIDs.  
 
Strengths and limitations 
This is the first study to compare the management and impact of different subgroups of 
knee complaints in general practice. This study provides insight in the extent to which 
GPs adhere to the guidelines. In a previous publication [11] our cohort was shown to be 
an acceptable representation of the patients visiting the GP with incident knee 
complaints, though patients in the age of 12 to 35 were underrepresented, especially 
male patients of this age group. It is possible that the lower pain scores we found for 
male patients in the non-traumatic subgroup was influenced by that.  
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Conclusion 
 
As expected, the severity and impact on daily activities of patients with traumatic knee 
complaints at first consultation of the GP is greater than that of non-traumatic knee 
complaints. The severity of knee complaints seems higher in the older non-traumatic 
group than the younger one, but their impact on daily activities seems comparable. 
The proportion of younger non-traumatic patients referred to physical therapy or 
orthopaedic surgeon is rather high, and not in line with GP guidelines. The proportion of 
older non-traumatic patients referred for X-rays is high, considering the GP guidelines 
advise against it.  
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Abstract 
 
Objective 
To determine the construct validity and responsiveness of the Lysholm knee scoring 
scale and the WOMAC osteoarthritis index in adolescents and young adults with knee 
complaints in general practice.  
Study design and setting 
In the framework of a prospective cohort study with one year follow-up we included 314 
patients aged 12 through 35 consulting the general practitioner for incident knee 
complaints. Subgroup analyses of traumatic and non-traumatic knee complaints were 
performed.  
Results 
Construct validity was adequate for both the Lysholm scale and the WOMAC index in 
both subgroups. Effect size and standardized response mean were moderate in the non-
traumatic group (Lysholm 0.76 and 0.73, WOMAC 0.65 and 0.74) and large in the 
traumatic group (Lysholm 1.15 and 1.14, WOMAC 1.14 and 1.16) as well as the total 
population (Lysholm 0.92 and 0.86, WOMAC 0.83 and 0.84). Guyatt’s responsiveness 
statistic was high for both Lysholm and WOMAC global scores in both total population 
and subpopulations (ranging from 0.81 to 1.31), with lowest values for the traumatic 
group.  
Conclusion 
Though neither of the scales was specifically developed for use in adolescents and 
young adults in general practice, both scales show adequate content and construct 
validity and good responsiveness in this population. 
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Introduction  
 
Within the frame-work of a descriptive prospective cohort of knee complaints in general 
practice 1 we needed measures of knee function that could be self-administered by the 
patients. No questionnaires have been specifically developed for the wide variety of knee 
complaints encountered in general practice. We therefore chose two questionnaires that 
together largely covered the symptoms and problems we expected to encounter in a 
primary care population: the Lysholm knee scoring scale2 and the WOMAC hip and knee 
osteoarthritis index3,4. Both questionnaires are frequently used internationally and were 
validated to some extent in various study populations.  
The Lysholm score was developed to determine the functional status of patients with 
anterior cruciate ligament injuries of the knee. Validation studies in orthopedic clinics 
have shown that the questionnaire can also be used for evaluation of patients with 
patellofemoral pain syndrome, patellar tendinitis, meniscal injuries and various other 
chondral lesions of both traumatic and degenerative nature5-8. In fact, it was found to be 
more responsive for patellofemoral pain syndrome and meniscal tears than for anterior 
cruciate ligament lesions5. The WOMAC osteoarthritis index was developed for patients 
with hip or knee osteoarthritis. Validation studies in patients with osteoarthritis or 
rheumatoid arthritis have been summarised by McConnell9. Since the WOMAC index 
focuses on daily activities, it may also be applicable in patient groups with other knee 
complaints.  
In this paper we aim to determine the content validity, construct validity and 
responsiveness of the Lysholm knee scoring scale and the WOMAC osteoarthritis index 
in patients aged 12 through 35 consulting the general practitioner (GP) for knee 
complaints. Content validity implies that all relevant aspects are represented. All relevant 
aspects can either be interpreted as covering every aspect, or as representing all items 
affecting the overall outcome. Omission of items may still result in an acceptable 
assessment of knee complaints. Convergent construct validity exists when the measure 
to be validated performs as expected when compared to other measures. 
Responsiveness is established when an instrument is able to detect minimal clinically 
important differences, a requirement for measuring change within persons 1. This also 
implies that no floor or ceiling effects are present to prevent detection of further 
deterioration or improvement. We will determine these properties separately for knee 
complaints of traumatic and non-traumatic onset. 
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Methods 
 
Participants 
The HONEUR knee cohort consists of patients consulting the GP for new episodes of 
knee complaints. This cohort study was approved by the Erasmus MC ethics committee 
and all participants signed informed consent. Recruitment procedures are described 
elsewhere 1. All patients aged 12 through 35 are included in the present study. 
 
Data collection 
At baseline and 12 months follow-up patients filled in the Lysholm knee scoring scale 
and the WOMAC osteoarthritis index. Lysholm scores can range from 0 (worst score) to 
100 (best score). We used the Dutch Likert version of the WOMAC osteoarthritis index4, 
with answer categories none, mild, moderate, severe and extreme. We calculated 
standardized total scores and subscores for pain and function, all potentially ranging 
from 0 (worst score) to 100 (best score). Pain was measured on a numeric rating scale 
(NRS) ranging from 0 (no pain) to 10 (unbearable pain) over the last 48 hours. 
Patellofemoral pain syndrome, Osgood Schlater and jumper's knee are the most 
common diagnoses in adolescents and young adults with non-traumatic knee 
complaints10. Both Lysholm scale and WOMAC index do not include questions 
specifically aimed at the symptoms associated with these diagnoses. Therefore we 
added questions to our questionnaire about pain and difficulty when walking stairs, 
prolonged sitting with flexed knees, running, jumping, cycling, kneeling and squatting 
analogous to the Likert format used in the WOMAC questionnaire. We calculated the 
sum of these items to represent a patellofemoral pain syndrome score. Furthermore, we 
asked patients at each time point whether their knee complaints bothered them during 
daily activities (employment, school, study, household chores), and whether they 
refrained from those duties due to their knee complaints. We also determined the 
patient’s participation in sports activities, the extent to which this taxes the knee and 
whether patients adjusted their sports activities because of the knee complaints. At one 
year follow up we asked how patients rated recovery from their knee complaints on a 7 
point Likert scale (1 = total recovery, 2 = major improvement, 3 = minor improvement, 4 
= no change, 5 = minor deterioration, 6 = major deterioration, 7 = worse than ever). We 
tried to complete missing items by contacting the participants. If we failed to contact the 
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patient within one month after receiving the questionnaire, the question remained 
unanswered. 
 
Content validity 
The Lysholm scale2 evaluates functional disability of the knee using the items limp (5 
points), use of a support (5 points), locking (15 points), knee stability (25 points), pain (25 
points), swelling (10 points), stair climbing (10 points), and squatting (5 points). A 
summary score of 100 points represents excellent knee function. The WOMAC index 11 
consists of three domains: pain (5 items), stiffness (2 items) and function (17 items). The 
patient’s difficulty with a wide variety of specific activities are queried to assess knee 
function. Locking and instability as well as sports activities are not accounted for. In our 
population patients often report symptoms consistent with patellofemoral pain or 
jumper’s knee. These symptoms include pain when walking stairs, sitting with flexed 
knees for prolonged periods of time, squatting, running, jumping, cycling or kneeling. 
Though both Lysholm scale and WOMAC index include walking stairs, and the Lysholm 
scale includes squatting, other symptoms are not covered specifically by either 
questionnaire. However, these symptoms may be correlated to other symptoms that are 
represented. This way, the Lysholm scale and WOMAC index may still be able to 
distinguish between patients with less or more of these symptoms. This distinguishing 
ability reflects on the construct validity and will therefore be tested in one of the 
hypotheses. To that end we determined if patients reported moderate to severe pain on 
at least 4 of the seven symptoms. 
 
Construct validity 
To determine the construct validity we tested 7 hypotheses. To demonstrate satisfactory 
construct validity at least 75% (6) of these hypotheses should be confirmed. The 
hypotheses 1 and 4 to 7 cover aspects of cross-sectional discriminative ability, 
hypotheses 2 and 3 represent longitudinal convergence. For Pearson's correlation 
coefficients the following interpretation is suggested: 0.1-0.3 is small, 0.3-0.5 is moderate 
and >0.5 is large12. Because pain is related to the function of the knee, but is not equal to 
it, a moderate correlation is expected. The same holds for physical fitness. Recovery is 
expected to show a closer relation, and therefore it should be highly correlated. The 
following hypotheses were tested. 
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1. Baseline pain and instrument scores should be moderately correlated 
(Pearson’s r > 0.3) 
2. Changes in pain and instrument scores should be moderately correlated 
(Pearson’s r > 0.3) 
3. The correlation between recovery scores and change scores on the instruments 
adjusted for baseline scores should be high (Pearson’s r > 0.5) 
4. Patients with good baseline COOP/WONCA physical fitness scores should 
have better instrument scores than patients with poor physical fitness scores (t-
test, p<0.05) 
5. Patients refraining from daily duties because of their knee complaints 
(employment, domestic work, school) should show lower scores than patients 
that don’t (t-test, p<0.05) 
6. Patients bothered by their knee complaints during daily duties (employment, 
domestic work, school) should show lower scores than patients that are not (t-
test, p<0.05) 
7. Patients reporting moderate to severe pain with at least 4 out of 7 activities 
(walking stairs, prolonged sitting with flexed knees, running, jumping, squatting, 
kneeling and cycling) should show lower scores (t-test, p<0.05). 
 
Because for Lysholm scale and WOMAC index a high score represents good function, 
but for pain, COOP/WONCA and recovery scores low scores represent better results, we 
used 100 - the instrument score for the calculation of correlations. Because the 
magnitude of possible change scores depends on the magnitude of the baseline scores, 
we used a two way ANOVA to adjust the correlation coefficient for baseline scores in 
hypothesis 3. For hypothesis 4 the COOP/WONCA physical fitness score was 
dichotomized, combining light and very light exercise (i.e. being able to walk at a slow or 
medium pace) and moderate to very heavy exercise (i.e. being able to walk at a fast 
pace to running at a fast pace for at least two minutes). 
 
Responsiveness 
The effect size (ES) is calculated as the ratio of mean change scores over one year to 
the standard deviation of the baseline scores13. The standardized response mean (SRM) 
is calculated as the ratio of mean change scores over one year to the standard  
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deviation of those change scores12. Guyatt’s responsiveness statistic is calculated as 
xMSE*2 / x ∆ , in which ∆x denotes the minimal clinically important change, and 
MSEx denotes the mean squared error of the instrument scores obtained from a 
repeated measurements analysis of variance of stable patients14. Because this is a 
descriptive study with one group and only two measurement times, xMSE*2 can be 
substituted with the standard deviation of the change scores of stable patients15. The 
minimal clinically important change is estimated by the average change scores among 
patients reporting major improvement (recovery score 2) of their knee complaints minus 
the average change scores among those patients reporting minor or no change 
(recovery scores 3, 4 and 5). Although Guyatt’s responsiveness statistic is expected to 
be higher than ES and SRM, values of  >0.2 are regarded as low, >0.5 as moderate, and 
>0.8 as high for all three responsiveness statistics15. 
 
Ceiling and floor effects 
Ceiling or floor effects occur when large amounts of patients have a baseline score that 
leaves no room for improvement or deterioration, i.e. maximum or minimum scores. 
Floor and ceiling effects of < 30% were considered acceptable6,16. 
 
 
Results 
 
Participants 
Our cohort study included 314 first-consulters aged 12 through 35 with knee complaints 
in general practice 1. Baseline questionnaire data were available for 184 patients with 
non-traumatic knee complaints and for 117 patients with traumatic knee complaints. 
These patients were used in the hypotheses for construct validity. Their characteristics 
are listed in table 1. The mean age of the participants was 24.6 ± 7.5 years. The 
proportion of male participants was slightly higher in the traumatic group (62% against 
52% in the non-traumatic group). International Classification of Primary Care codes from 
the GP17 files show a predominance of unspecified knee complaints (52%) and chronic 
internal derangement (i.e. mainly retropatellar chondropathy, 34%) in the non-traumatic 
group. Predominant codes in the traumatic group are unspecified complaints (44%) and  
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distortion (22%). Patients reporting an instantaneous onset of complaints after impact or 
a wrong movement within one year before consulting the GP were assigned to the 
traumatic group, disregarding the ICPC codes. 
For responsiveness analyses we needed baseline scores, 1 year follow-up scores as 
well as perceived recovery scores, which were available for 137 non-traumatic patients 
and 91 traumatic patients. Characteristics of these patients are also provided in table 1. 
 
Construct and content validity 
The results of hypotheses testing are stated in table 2. All hypotheses were confirmed for 
both subgroups and both instruments, with one exception. Patients refraining from daily 
duties because of their knee complaints did not show significantly lower Lysholm scores 
in the non-traumatic group (p=0.11). For both traumatic and non-traumatic subgroups as 
well as the total population more than 75% of the hypotheses were confirmed, indicating 
that construct validity was adequate for both Lysholm and WOMAC index. 
 
Responsiveness 
Table 3 lists change scores and responsiveness statistics.  
Lysholm 
The Lysholm scale is moderately responsive for non-traumatic patients when overall 
change scores are considered (ES = 0.76, SRM = 0.73). Nevertheless, Guyatt’s 
response statistic is high (1.11), indicating that the ability to detect actual change is 
strong. Overall change scores in the traumatic group are larger, which is reflected in the 
higher overall responsiveness (ES = 1.15, SRM = 1.14). Though also high, Guyatt's 
responsiveness statistic is lower (0.94) due to the larger variability of scores in stable 
traumatic patients. In the total population all responsiveness statistics are high (ES = 
0.92, SRM = 0.86, Guyatt = 1.31).  
WOMAC 
The WOMAC index also shows moderate overall responsiveness for non-traumatic 
patients (ES = 0.65, SRM = 0.74). Again, the ability to detect actual change is strong 
(Guyatt = 1.04). In traumatic patients overall responsiveness is high (ES = 1.13, SRM = 
1.16), as well as the ability to detect change (Guyatt = 0.81). In the total population all 
responsiveness statistics are high (ES = 0.83, SRM  = 0.84, Guyatt = 1.27). 
In the non-traumatic subgroup the ES and SRM are low for stiffness and moderate for 
pain and function WOMAC subscores. Guyatt's statistic is moderate for stiffness and 
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high for pain and function. In the traumatic subgroup ES and SRM is high for all 
subscores, but Guyatt's statistic is low for pain, moderate for stiffness, and high for 
function. In the total population ES and SRM are moderate for pain and stiffness, and 
high for function, whereas Guyatt's statistic is high for all subscores.  
 
Table 3. Change scores and responsiveness 
 
meanchange  
overall 
(sd) 
meanchange  
stable 
(sd) 
meanchange  
major improvement
(sd) 
meanchange  
major improvement 
+ total recovery
(sd) mcid Guyatt ES SRM 
 
nnon-traumatic 137 
ntraumatic 91 
nnon-traumatic 64  
ntraumatic 13 
nnon-traumatic 38  
ntraumatic 40 
nnon-traumatic 69  
ntraumatic 75 
 
   
Lysholm         
non-traumatic 10.6 (14.5) 3.4 (11.7) 16.4 (11.8) 18.2 (12.9) 13.0 1.11 0.76 0.73 
traumatic 22.6 (19.9) 6.9 (21.8) 27.4 (20.7) 25.3 (18.4) 20.5 0.94 1.15 1.14 
combined 15.4 (17.8) 4.0 (13.8) 22.0 (17.7) 21.9 (16.3) 18.0 1.31 0.92 0.86 
WOMAC         
non-traumatic 10.5 (14.2) 5.4 (12.5) 18.3 (15.9) 15.6 (14.1) 12.9 1.04 0.65 0.74 
traumatic 28.5 (4.6) 15.0 (22.8) 33.6 (25.5) 30.9 (24.3) 18.6 0.81 1.13 1.16 
combined 17.6 (20.9) 7.1 (15.0) 26.1 (22.6) 23.6 (21.4) 19.1 1.27 0.83 0.84 
WOMAC pain         
non-traumatic 13.5 (17.2) 7.2 (16.0) 22.6 (17.6) 19.8 (16.2) 15.4 0.96 0.77 0.79 
traumatic 27.9 (22.8) 18.1 (25.9) 29.0 (21.9) 29.6 (22.0) 10.9 0.42 1.26 1.22 
combined 19.2 (20.8) 9.1 (18.3) 25.9 (20.0) 24.9 (20.0) 16.8 0.92 0.96 0.92 
WOMAC stiffness        
non-traumatic 9.6 (23.3) 2.9 (21.6) 16.8 (25.9) 16.1 (23.6) 13.8 0.64 0.42 0.41 
traumatic 30.3 (30.8) 17.3 (28.2) 34.1 (32.1) 32.5 (30.9) 16.8 0.59 1.02 0.98 
combined 17.7 (28.3) 5.4 (23.2) 25.6 (30.3) 24.7 (28.7) 20.3 0.87 0.66 0.62 
WOMAC function        
non-traumatic 9.7 (14.6) 5.2 (13.1) 17.2 (16.8) 14.3 (14.8) 12.0 0.92 0.57 0.66 
traumatic 28.5 (26.7) 13.8 (23.2) 34.8 (28.1) 31.1 (26.6) 21.0 0.91 1.04 1.07 
combined 17.1 (22.2) 6.6 (15.5) 26.3 (24.8) 23.0 (23.3) 19.6 1.27 0.75 0.77 
ES = Effect size = meanchange overall / sdbaseline 
SRM = Standardized Response Mean = meanchange overall / sdchange overall 
mcid = mean clinically important difference = meanchange major improvement - meanchange stable 
Guyatt = Guyatt's responsiveness statistic = mcid / sdchange stable  
 
Ceiling and floor effects 
Only one of the non-traumatic patients (0.5%) and one (0.9%) of the traumatic patients 
received the maximum Lysholm score. None of the patients received the minimum score 
for either the Lysholm scale or the WOMAC index total score. We did find minimum 
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scores in the subscales pain (1 traumatic patient (0.9%)), stiffness (2 traumatic patients 
(2%) and 2 non-traumatic patients (2%)) and function (2 traumatic patients (2%)). As this 
falls well below the acceptable limit of 30%, the floor effects were negligible. WOMAC 
subscales for stiffness and function did exceed the acceptable ceiling effect of 30% with 
72 (39%) and 26 (34%) patients in the non-traumatic group. The pain subscale and total 
score stayed below that limit with 12 (6.5%) and 17 (9%) patients respectively. The 
number of traumatic patients with ceiling scores was 3 (3%) for the WOMAC total score, 
6 (5%) for the pain subscore, 28 (25%) for the stiffness subscore, and  8 (7%) for the 
function subscore, all well below 30%. 
 
Discussion 
 
Content validity 
Content validity of the Lysholm knee scoring scale and WOMAC index was not self-
evident for adolescents and young adults in general practice. Nevertheless, both 
instruments proved able to distinguish between patients exhibiting symptoms that were 
not represented in their list of items, such as jumping, running, cycling and kneeling. We 
therefore concluded that although content validity is not optimal, it seemed adequate for 
use in this population. 
 
Construct validity 
Construct validity of the Lysholm scale as well as the WOMAC index was established for 
both the traumatic and non-traumatic subgroups, as at least 6 out of 7 hypotheses were 
confirmed for each combination of instrument and population. The small difference in 
Lysholm scores between patients refraining from daily duties because of their knee 
complaints and patients who don’t in the non-traumatic group, suggests that the specific 
activities that make patients refrain from duties may not be well represented in the 
questionnaire. The WOMAC index enquires about many more daily activities and shows 
greater discriminative ability in this respect. 
Responsiveness 
ES and SRM are both measures that consider the change scores of all patients in a 
population. This approach is appropriate when an instrument is used for evaluation of a 
treatment. However, in descriptive cohort studies the expectation that all patients will 
improve over time is not tenable. Guyatt’s responsiveness statistic uses the recovery 
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scores to distinguish between patients that consider their knee complaints improved and 
those who consider them relatively unchanged. Because the mean change and its 
variability in stable patients (noise) is taken into account, Guyatt’s responsiveness 
statistic is more appropriate to determine the usefulness of an instrument for evaluation 
of knee complaints in a cohort study.  
Our analyses clearly demonstrate the differences between the methods of determining 
responsiveness. For both the Lysholm scale and the WOMAC index the overall 
responsiveness (ES or SRM) was higher in the traumatic patients, due to the lower mean 
baseline scores and the higher mean follow-up scores. Nevertheless, Guyatt’s statistic 
shows that the ability to detect actual changes in the patient’s status is better in the non-
traumatic group, due to the smaller variability of stable patients in this group. When 
accepting Guyatt’s statistic as the superior responsiveness statistic in non-intervention 
studies, both Lysholm scale and WOMAC index total score are highly responsive in the 
total population as well as the traumatic and non-traumatic subgroups. The 
responsiveness of the WOMAC subscores stiffness and function is only satisfactory in 
the total population. This is due to the direct relation between Guyatt's statistic and 
sample size. Before considering the use of the WOMAC subscores in future studies, 
Guyatt's statistic should be used for power calculations14. 
 
Ceiling effect 
The proportion of patients with maximum scores at baseline ranged from 0.5% (non-
traumatic) to 0.9% (traumatic) for the Lysholm scale and from 2.6% (traumatic) to 6.6% 
(non-traumatic) for the WOMAC index. This is well within the acceptable range of < 30%. 
The WOMAC subscores for pain and function also showed acceptable ceiling effects 
ranging from 5.2% (traumatic) to 9.2% (non-traumatic) and from 6.9 (traumatic) to 14.2 
(non-traumatic) respectively. The stiffness subscore showed an unacceptable ceiling 
effect of 39.1 for non-traumatic patients (24.4% for traumatic patients). 
 
Context 
Lysholm 
Irrgang et al.18 reported effect sizes ranging from 0.82 to 1.13 in a heterogeneous 
population including ligament injuries, meniscal tears, arthritis, tendinitis and 
patellofemoral pain. This is very similar to our 0.76 to 1.15. Kocher et al.6 similarly 
reported an ES of 1.16 in patients with various chondral disorders of the knee and an 
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SRM of 1.10. Marx7,8 reported an SRM of 0.9 for a heterogeneous population of athletic 
patients. This corresponds to our overall SRM of 0.86. None of these studies have used 
Guyatt’s responsiveness statistic. No unacceptable ceiling effects were reported by any 
of these authors. Generally our findings are in line with those of other authors. 
WOMAC 
McConnell9 performed a structured literature review of the measurement properties of 
the WOMAC in a wide variety of intervention studies in patients with hip and knee 
osteoarthritis. She summarized effect sizes, standardized response means and Guyatt’s 
responsiveness statistics. Overall, the effect sizes of the WOMAC varied from small 
(0.07) to large (0.94) in drug studies (pain killers or glucosamine). One study reported 
effect sizes of 0.26 for placebo and 0.74 for glucosamine, with corresponding Guyatt’s 
responsiveness statistics of 1.8 to 4.14 for the total WOMAC score19. Mean change 
scores for glucosamine (9.8) were comparable to the change scores of our non-traumatic 
group (10.5), but with an ES of 0.65 and Guyatt’s statistic of 1.04 responsiveness was 
considerably smaller in our study. Effect sizes of two exercise studies ranged from 0 to 
0.32 for the placebo groups and from 0.28 (6 months) to 1.19 (4weeks) in the exercise 
groups20,21. Interestingly, one 6 month study found small effect sizes for pain (0.15) and 
function (0.10) subscores in patients with OA symptoms managed by the family doctor22. 
In this context the range of our effect sizes (0.42 - 0.77 in non-traumatic patients and 
1.02 - 1.26 in traumatic patients) indicates that the WOMAC may be more suitable for 
other diagnoses than osteoarthritis when measuring changes over time. 
 
Limitations 
Although we did not determine the test-retest reliability in our population, we assume it 
will be acceptable based on results of studies in other (heterogeneous) populations5-8.  
 
 
Conclusion 
 
Both Lysholm and WOMAC have shown sufficient construct validity and responsiveness 
for use in long-term evaluation studies of adolescents and young adults with knee 
complaints in general practice. 
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What this paper adds 
What is already known on this subject 
The incidence of adolescents and young adults consulting Dutch general practitioners for 
non-traumatic knee complaints is 19 per 1000 patients per year. The prognosis is 
generally assumed to be good, but no studies were available to confirm this belief. 
What this study adds 
In our cohort only 53% of incident patients report full recovery or major improvement 
after one year. Prognostic factors for persistence are a prominent tibial tuberosity, painful 
patellar ligament, bilateral complaints, locking of the knee, a history of knee operation 
and self-reported knee swelling. The assumption of a good prognosis may need to be 
revised.  
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Abstract  
 
Objectives 
Non-traumatic knee complaints of adolescents and young adults are common in general 
practice, and are presumed to have a good prognosis. However, no prospective studies 
in this setting are available to confirm this. We aim to describe the course of knee 
complaints and prognostic factors for persistence in this population.  
Design, setting and participants 
40 Dutch general practitioners included 191 consecutive patients aged 12 through 35 
consulting for knee complaints in a prospective cohort study. Participants received usual 
care from their general practitioner.  
Main outcome 
After one year patients rated their recovery on a 7 point scale, which was dichotomized 
into recovery or persistence. Prognostic factors for persistent knee complaints were 
identified through multivariate logistic regression using characteristics extracted from a 
baseline questionnaire and standardized physical examination. Three-monthly 
questionnaires provided pain and functional disability scores to describe the course of 
knee complaints during one year follow-up. 
Results 
26% of the patients reported major improvement and 27% total recovery. Prognostic 
factors for persistent knee complaints were poor overall health, a lower education level, a 
prominent tibial tuberosity, painful patellar ligament, bilateral complaints, locking of the 
knee, a history of knee operation and self-reported knee swelling. Improvement of pain 
and functional disability is greatest in the first three months after consultation. 
Conclusions 
After one year 47% of adolescents and young adults with incident non-traumatic knee 
complaints have persistent knee complaints. The assumed good prognosis should be 
reconsidered. These results emphasize the need for randomized controlled trials to 
assess the effectiveness of treatment options in order to improve the prognosis. 
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Introduction 
 
Knee complaints are one of the most frequently encountered reasons for consultation of 
the general practitioner (GP) 1(Heintjes EM et al., submitted data). Non-traumatic knee 
complaints include patellar chondropathy, jumper’s knee (tendinitis), Osgood-Schlatter 
disease, bursitis, iliotibial tract friction syndrome, popliteal cysts and osteoarthritis. 
Osteoarthritis is of progressive nature and becomes increasingly predominant from age 
35 onward. Non-traumatic knee complaints of adolescents and young adults are usually 
regarded as self limiting, and account for 20% of all non-traumatic knee complaints in 
general practice 1(Heintjes EM et al., submitted data). The incidence is estimated at 19 
per 1000 per year and the prevalence at 27 per 1000 per year 1. To our knowledge, no 
prospective follow-up studies of adolescents and young adults consulting the GP for 
knee complaints have been published so far. Evidence from controlled randomised trials 
for the effectiveness of interventions is also lacking. Dutch GP guidelines2-4 therefore 
generally advise GPs to inform patients of a good prognosis, to limit pain provoking 
activities for some time, and to gradually strengthen the knee musculature, preferably by 
providing advise on home exercises. Pain medication is not advised, and referral to 
physical therapists or orthopaedic surgeons should only be considered when complaints 
persist. 
Before setting up trials to determine the effectiveness of interventions basic information 
is required about the course of knee complaints with the current conservative treatment 
as well as insight into possible determinants for chronicity. Modifiable determinants may 
be targeted by interventions. Non-modifiable determinants should be stratified or 
corrected for in trials focussing on other aspects or may be used as basis for more 
adequate patient education. 
With our prospective cohort study5, we aim to describe the course of non-traumatic knee 
complaints in adolescents and young adults over the course of one year and to identify 
prognostic factors for persistent knee complaints. Furthermore we will compare the 
patients' perceived recovery at follow-up with the GPs expectations at baseline. 
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Methods 
 
Data collection 
We performed a prospective descriptive cohort study of consecutive patients, aged 12 
and over, visiting the GP for incident knee complaints. The ethics committee of Erasmus 
MC approved the study and all patients signed informed consent. The methods of 
recruitment and data collection have been described in detail elsewhere5. From our 
cohort (N=1068), we extracted all patients with non-traumatic knee complaints aged 12 
through 35 (N=191). Patients underwent a standardised physical examination at baseline 
and one year follow-up. Patient characteristics, medical history, knee anamnesis and 
other possible prognostic factors were recorded in the baseline questionnaire (table 2). 
Three monthly follow-up questionnaires recorded knee symptoms, functional disability 
and repeated GP consultations during the course of one year. We strived to contact 
patients dropping out during this period by telephone, to determine the state of their knee 
complaints at that point. 
GPs were also asked to note working diagnoses according to the International 
Classification of Primary Care (ICPC)6 and their predicted prognosis in the patient’s 
computerized medical file at first consultation. We dichotomised the GPs predictions into 
recovered (improvement or recovery within one year) and persistent (no change or 
worsening over the course of one year) for descriptive statistics. 
 
Course of knee pain and disability 
Pain over the last 48 hours was measured on a numeric rating scale ranging from 0 (no 
pain) to 10 (unbearable pain). The Lysholm scale7 and WOMAC osteoarthritis index8,9 
both evaluate functional disability of the knee with global scores ranging from 0 (poor) to 
100 points (excellent). Both Lysholm scale and WOMAC index were shown to be 
sufficiently sensitive to change in the present population (Heintjes EM, et al., submitted 
data). Means and 95% confidence intervals of each outcome measure at three-monthly 
intervals were displayed graphically to indicate the course of the knee complaints.  
 
One-year prognosis  
The primary outcome measure was experienced recovery after 12 months follow-up. We 
asked the patients how they rated their current knee complaints compared to baseline, 
measured on a 7-point Likert scale ranging from total recovery (=1) to worse than ever 
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(=7). The categories ‘total recovery’ and ‘major improvement’ represent clinically relevant 
improvement. All other categories represent persistent knee complaints.  
 
Prognostic factors  
Possible prognostic factors were assigned to one of 4 domains: patient characteristics, 
psychosocial factors, anamnesis, and physical examination (see table 1). To enable 
easy interpretation of prognostic factors in a clinical setting continuous variables were 
dichotomised based on the median, with the exception of body mass index (BMI), which 
was cut of at 30 (obesity). 
Prognostic factors for the outcome ‘persistent knee complaints’ were identified with 
univariate logistic regression using a threshold of p<0.15. Per domain we performed 
stepwise multivariate regression with the ‘backward Wald’ method to eliminate redundant 
factors (entry p<0.10, removal p<0.15). We subsequently combined the remaining 
factors of each domain into one model and repeated the elimination process, always 
adjusting for gender and age. 
 
Table 1. Possible prognostic factors tested with logistic regression 
Patient characteristics Psychosocial factors 
 gender  coping with pain score20 
 age (continuous or ≥ 24)  Tampa kinesiofobia score21 
 BMI ≥ 30  COOP-WONCA charts item 'feelings'22 
 COOP-WONCA charts item 'overall health'22  
 comorbidity of musculoskeletal system  
 other comorbidity  
Anamnesis and symptoms Physical examination 
 duration of complaint (< 3 weeks or < 3 
months) 
 postural aspects of foot, tibia and femur 
 bilaterality  quadriceps atrophy 
 history of non-traumatic knee complaints   raised knee temperature 
 history of knee trauma or knee operation  swelling: ballottable patella and fluctuation test 
 bothered by knee during daily activities  pain and crepitations during flexion and extension  
 knee locking or instability  pain or prominence of tibial tuberosity 
 intermittent or continuous knee swelling,  
    crepitations or raised temperature 
 pain at palpation of patellar edges, bursae, joint line  
     and ligaments 
 pain during prolonged sitting with flexed  
    knees,kneeling, squatting, cycling, running
    jumping  
 pain or crepitations during patellar axial pressure  
     test, apprehension test or patellar grind test 
 WOMAC total score and subscores8,9  muscle resistance tests 
 Lysholm total score7  laxity medial, lateral and cruciate ligaments 
 79 
Chapter 5 
Results 
 
Study population 
The mean age of the patients was 24.1 (±7.7), 53% was male. ICPC codes from the 
GP’s computerized medical files yielded 100 patients (52%) with unspecified knee 
complaints (L15), 74 patients (39%) with retropatellar chondropathy (L97), and 8 patients 
(4%) with Osgood-Schlatter disease (L94.2). The GPs diagnosed 9 patients (5%) with 
knee distortions or acute traumatic knee injuries (L78 or L96). Since these patients 
indicated that overuse rather than trauma caused the injuries, and no signs of recent 
trauma were evident during physical examination, they were included in the non-
traumatic subpopulation of the cohort. 
 
Table 2. Baseline characteristics  
  recovery  scores available 
 yes1  (N=165) no (N=26) 
general   
age, mean (sd) 24.2 (7.7) 23.7 (7.8) 
male, n (%) 84 (51%) 16 (62%) 
female, n (%) 81 (49%) 10 (38%) 
working diagnosis GP (ICPC2)   
unspecified (L15) , n (%) 86 (52%) 14 (54%) 
acute distortion (L78) , n (%) 2 (1%) 2 (8%) 
Osgood Schlatter (L94.2) , n (%) 8 (5%) 0 (0%) 
acute meniscus/ligament rupture (L96) , n (%) 4 (2%) 1 (4%) 
chronic internal trauma (L97) , n (%) 65 (39) 9 (35%) 
knee complaints   
duration at consultation < 3 months, n (%) 104 (65%) 18 (78%) 
bilateral , n (%) 71 (44%) 12 (52%) 
recurrent , n (%) 88 (55%) 10 (43%) 
measures of severity   
pain (0-10 numeric rating scale), mean (sd) 4.0 (2.2) 4.3 (2.4) 
Lysholm scale (0-100), mean (sd) 73.4 (14.7) 72.7 (15.7) 
WOMAC index (0-100), mean (sd) 79.9 (16.9) 75.5 (22.0) 
1 Patients included in prognostic analyses 2 ICPC = International Classification of Primary Care 
Due to missing data N may vary slightly per characteristic 
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Follow-up 
We obtained baseline questionnaires for 184 patients (96%), baseline physical 
examination for 187 patients (98%) and recovery scores for 165 patients (86%). All three 
were obtained for 158 patients (83%), thus meeting the requirements for logistic 
regression analysis to identify prognostic factors. Response rates for the follow-up 
questionnaires to determine the course of knee complaints, was 61%, 50%, 48% and 
74% for 3, 6, 9 and 12 months respectively.  
Comparison of baseline characteristics between dropouts and patients with recovery 
scores (table 2) revealed no statistically significant differences with respect to gender 
(OR 0.65, (95% CI 0.28 to 1.51)), age (mean difference (MD) -0.4 years, p=0.79), pain 
scores (MD=-0.3, p=0.48), Lysholm scores (MD=-4.4, p=0.84) or WOMAC scores (MD=-
12.1, p=0.27).  
Only 28% of all patients visited the GP again during one year follow-up, representing 
33% of patients with persistent complaints after one year and 23% of patients that had 
recovered. 
 
Figure 1. Course of knee complaints (mean scores and 95% CI) 
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Pain scores were multiplied with a factor 10 for graphical display 
 
Course and prognosis 
Mean pain and functional disability scores show the largest improvement in the first three 
months after consultation of the GP (figure 1). Distribution of the patients' perceived 
Chapter 5 
recovery after one year follow-up is displayed in figure 2. 27% reported total recovery 
(men 29%, women 24%) and 26% reported major improvement (men 20%, women 
32%), totaling 53% 'recovery'. The GP recorded the expected prognosis at baseline for 
only 78 patients (41%). The GP expected 77% of these patients to recover completely, 
and an additional 12% to improve within one year. 
 
Figure 2. Experienced recovery after 1 year 
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Prognostic factors 
Factors showing univariate and multivariate associations with persistence (α=0.15) are 
listed in table 1. Patients with a history of knee operation (n=15) were significantly more 
at risk of persistence (OR 5.56). Because this characteristic might be considered 
inappropriate for an analysis of non-traumatic knee complaints, we performed a 
secondary analysis without these patients. Their elimination resulted in the inclusion of 
self reported knee swelling (OR 2.45), but otherwise the model remained the same.  
 
 82 
Prognosis of non-traumatic knee complaints in adolescents and young adults in general practice 
 
Table 3. prognostic factors for persistent knee complaints 
frequency univariate 
multivariate¥
N = 155$
multivariate¥ 
without 
history of knee 
operation# 
N=140 
     
  OR (95% CI) OR (95% CI) OR (95% CI) 
patient characteristics     
low education level 50% 2.42 (1.29 to 4.57)3 2.56 (1.22 to 5.38)3 3.37 (1.48 to 7.64)3
BMI ≥ 30 8% 2.76 (0.81 to 9.35)2   
poor overall health 11% 3.69 (1.14 to 12.1)3 3.62 (0.99 to 13.2)2 6.88 (1.60 to 29.6)3
     
psychosocial factors     
-     
     
knee anamnesis     
duration >  3 months 34% 1.68 (0.87 to 3.22)1   
bilateral knee complaints 44% 2.05 (1.09 to 3.86)3 2.48 (1.16 to 5.35)3 2.85 (1.22 to 6.66)3
history of knee trauma 21% 1.92 (0.90 to 4.12)2   
history of knee operation 9% 5.10 (1.38 to 18.9)3 5.56 (1.33 to 23.3)3  
warm sensation of the knee 29% 1.82 (0.91 to 3.64)2   
self-reported knee swelling 34% 1.97 (1.01 to 3.84)3  2.45 (1.04 to 5.81)3
stiffness 47% 1.69 (0.90 to 3.17)1   
locking of the knee 16% 2.69 (1.09 to 6.67)3 3.13 (1.11 to 8.85)3 2.57 (0.87 to 7.73)2
pain when squatting 57% 1.67 (0.89 to 3.13)1   
difficulty with squatting 53% 1.86 (0.99 to 3.48)2   
difficulty with cycling 41% 1.63 (0.86 to 3.09)1   
knee bothersome during 
daily activities 57% 1.67 (0.89 to 3.14)1   
     
physical examination     
balottable patella 27% 2.00 (0.97 to 4.12)2   
painful patellar ligament  16% 2.43 (1.01 to 5.85)3 2.76 (0.95 to 8.00)2 3.08 (1.01 to 9.38)3
painful patellar edges  48% 1.89 (1.00 to 3.57)3   
prominent tibial tuberosity  6% 2.81 (0.70 to 11.2)1 6.67 (1.03 to 43.5)3 5.93 (0.93 to 37.7)2
only determinants with p-values < 0.15 are listed: 1 <0.15, 2 < 0.10, 3 < 0.05 
¥adjusted for gender and age 
$ due to missing values of variables, 3 patients were excluded from the logistic analysis 
# a history of knee operation might not be interpreted as non-traumatic knee complaints,  
  therefore this analysis was repeated without patients with a history of knee operation (n=15). 
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Other prognostic factors from anamnesis and history taking are bilateral knee complaints  
 (OR 2.48 to 2.85) and locking of the knee (OR 2.57 to 3.13). Patient characteristics 
associated with persistent complaints are lower education level (OR 2.56 to 3.37) and 
poor overall health (OR 3.62 to 6.88). No psychosocial factors were associated with 
persistence. From the physical examination only painful patellar ligament (OR 2.76 to 
3.08) and prominence of the tibial tubercle (OR 5.93 to 6.67) were associated.  
 
Discussion 
 
Course and prognosis 
Improvement in the mean pain and function scores was most pronounced in the first 
three months, but continued throughout the entire follow-up period. After one year only 
27% of all patients reported total recovery, and 26% reported major improvement. These 
patients showed improvement throughout the year, whereas the 47% with persistent 
complaints only showed some improvement in the first three months.  
In the sample for which the GP recorded the expected prognosis the GPs predicted 77% 
total recovery and 12% improvement, which is considerably less than the recovery rate 
of 47% recorded by the patients in that same sample. With a representative distribution 
of the ICPC codes, and predictions being done by two thirds of the participating GPs, we 
have no reason to believe that this sample does not represent the cohort’s patients or 
the GPs’ beliefs. In literature several studies with patients that represent at least part of 
our population have also found disappointing recovery rates. A retrospective study in 
general practice of older patients with retropatellar chondropathy reported 44% recovery 
after 6 months10. A review of exercise therapy in patients with patellofemoral pain 
syndrome in orthopedic clinics reveals the participant's duration of complaints often 
exceeds one year, and many participants retain symptoms11. Studies carried out in 
British orthopedic clinics also challenged the view that non-traumatic knee complaints  
have a good prognosis. They found that after 4 years 46% of the adolescents had less 
pain and 6% was pain free12. After 10 years 9% of the children was pain free13. One 
might expect a more favourable prognosis in our cohort, as populations in specialistic 
settings are likely to present more serious complaints, and in older populations 
osteoarthritis may contribute to the symptoms.  
So what explains the discrepancy between the GPs expectations and the patients' 
reported outcome? We found that only 1 in 3 patients with persistent complaints, and 1 in 
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4 of the patients that ultimately recover, return for follow-up consultations, mostly within 3 
months after the first consultation. The 'wait and see' approach of the GP and the advise 
that the complaints are self limiting may discourage patients to return to the GP with 
persistent complaints. The GP possibly assumes that patients who don't return have 
recovered. This may explain the optimistic views on prognosis of both the GP and the 
available clinical guidelines2,3.  
 
Prognostic factors 
A lower education level was found to be a risk factor for chronicity. In the literature lower 
school grades were given as part of an explanation for the relation between lower socio-
economic status and a higher frequency of musculoskeletal disorders at age 3014. Poor 
overall health is also associated with lower socio-economic status in the literature. The 
association between poor health and persistent knee complaints are likely to have 
common determinants. In fact, we also found an association between education level 
and poor health, but although comorbidity of the musculoskeletal system is associated 
with poor health, it is not with persistence of knee complaints. We found no association 
between persistence and any psychosocial factors.  
We did find a strong association with a history of knee operation. Knee operations in the 
past may be the cause of current non-traumatic knee complaints, but in a multivariate 
model may also obscure other factors that are associated with the persistence of other 
non-traumatic knee complaints. We therefore presented models with and without these 
patients. Exclusion of patients with a history of knee trauma led to the inclusion of self-
reported intermittent or continuous swelling as prognostic factor. As swelling usually 
indicates intra-articular pathology we determined how many patients also exhibited signs 
of patellofemoral pain syndrome. We found that 59% of the patients reporting swelling 
also have painful patellar edges, and the risk of persistence with swelling is twice 
increased in patients with concurrent painful patellar edges. It is noteworthy that overlap 
between self-reported swelling and balottable patella sign is only 40%, and balottable 
patella sign is not retained in the model. The GP would therefore be advised to take the 
patient's report of swelling rather than swelling during physical examination into account 
for prognostic purposes.  
The prognostic factor locking of the knee can be a sign of meniscal damage or 
patellofemoral complaints11. In our cohort it is a sign of patellofemoral complaints, since 
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only 2 out of 26 patients with locking reported a history of traumatic injury, whereas 19 
out of 26 reported painful patellar edges, of whom 14 had persistent complaints.  
Our finding that bilateral complaints are a risk factor for persistent knee complaints 
concurs with the findings of a seven-year follow-up study of patients with unilateral 
patellofemoral pain syndrome. Patients developing bilateral complaints during follow-up 
had worse pain and Lysholm scores15. 
Physical examination produced three univariate prognostic factors associated with the 
extensor mechanism of the knee: painful patellar edges, painful patellar ligament and a 
prominent tibial tuberosity. The patellar ligament connects the patella and tibial 
tuberosity. Painful patellar edges are a sign of retropatellar chondropathy, or 
patellofemoral pain, and painful patellar ligament for jumper's knee. Overloading the 
extensor mechanism may affect several structures simultaneously16, making it hard to 
distinguish between diagnoses17. GP guidelines2 propose similar treatments for these 
diagnoses: limiting exercise levels to acceptable pain levels in order to adjust physical 
knee loading to the actual loading capacity. So distinguishing between diagnoses has at 
present no bearing on treatment. But for prognostic purposes it seems useful to 
distinguish between isolated and combined symptoms: prognoses for patients with 
jumper's knee have been reported to be worse with concurrent symptoms of 
patellofemoral pain syndrome18. Upon closer inspection of our own data we found that 
76% of the patients with combined painful patellar ligament and painful patellar edges 
(n=21) had persistent complaints, versus 20% in patients with only a painful patellar 
ligament (n=5) and 52% in patients with only painful patellar edges (n = 54). This may 
indicate that although painful patellar edges were eliminated from the multivariate model 
because of the overlap with a painful patellar ligament, it is useful to look for the 
combination of both. 
A prominent tibial tuberosity is another sign of overloading the extensor mechanism. It 
may represent the end-stage of Osgood-Schlatter disease16, and in fact most affected 
patients had either a long duration of the complaints (over one year) or a history of non-
traumatic complaints. A prominent tuberosity might in it's own right influence forces in the 
extensor mechanism, predisposing for chronicity of the complaints.  
 
Strengths and weaknesses of this study 
The major strength of this study is that it is the first prospective cohort to determine the 
prognosis of non-traumatic knee complaints in adolescents and young adults consulting 
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the GP. The predicted prognoses of the GPs are far more positive than the patients' 
reported outcome, indicating that our study provides useful information to GPs.  
It is also interesting to compare the results of our study to a recent prognostic study in 
general practice, which combined non-traumatic and traumatic knee complaints in 
patients aged 18 and above19, and did not include physical examination. They found 
musculoskeletal comorbidity, a longer duration of the complaint, history of knee 
complaints and distress to be determinants for persistent complaints. The limited 
similarity with our findings (only univariate association with duration and history of knee 
trauma) emphasizes the need for studying subgroups of knee complaints in general 
practice.  
Medical treatment and physical loading of the knee were not included in the prognostic 
model because they were hard to standardise, depend on severity and duration of 
symptoms (which in themselves are possible prognostic factors), and they vary 
throughout the follow-up period. However, our study does provide basic information for 
future trials to investigate the effect of treatment and physical loading.  
 
Implications for clinicians 
The presumed good prognosis of non-traumatic knee complaints in adolescents and 
young adults need revision, which should be reflected in the advice given by GPs during 
consultation. In light of this less favourable prognosis the call for more effective 
measures becomes stronger. Effectiveness studies should therefore be carried out. 
It is worth mentioning that there are no significant differences between the sexes either 
with regard to the number of patients with (specific) knee complaints, or the prognosis.  
Although patellofemoral pain syndrome did not survive elimination from the multivariate 
model, its signs often occur concurrent with the remaining prognostic factors. Thus 
patellofemoral pain syndrome seems to be an important confounder of the prognostic 
factors remaining in the model, and clinicians should be aware of the worse prognosis 
when signs of patellofemoral pain syndrome are found concurrent with these prognostic 
factors.
 87 
Chapter 5 
References 
 
1. van der Linden MW, Westert GP, de Bakker DH, Schellevis FG. Tweede Nationale 
Studie naar ziekten en verrichtingen in de huisartspraktijk: klachten en 
aandoeningen in de bevolking en in de huisartspraktijk. [Second National Study into 
diseases and treatments in general practice: complaints and disorders in the 
population and in general practice]. Utrecht, Bilthoven: NIVEL, Rijksinstituut voor 
Volksgezondheid en Milieu, 2004. 
2. Cirkel JW, Klaassen WRC, Kunst JA, Aarns TEM, Plag ECM, Goudswaard AN, et al. 
The Dutch College of General Practitioners (NHG) Practice Guideline for Non-
traumatic knee complaints in children and adolescents [NHG-Standaard Niet-
Traumatische knieproblemen bij kinderen en adolescenten (Dutch title)]. Huisarts en 
Wetenschap 1998;41(5):246-51. 
3. van der Plas CG, Dingjan RA, Hamel A, al. e. The Dutch College of General 
Practitioners (NHG) Practice Guideline for traumatic knee complaints [NHG-
Standaard traumatische knieklachten (Dutch title)]. Huisarts en Wetenschap 
1998;41(6):296-300. 
4. Bijl D, Dirven-Meijer PC, Opstelten W, Raaijmakers AJ, Scholten RJPM, Eizenga WH, 
et al. The Dutch College of General Practitioners (NHG) Practice Guideline for 
traumatic knee complaints [NHG-standaard Niet-traumatische knieproblemen bij 
volwassenen (Dutch title)]. Huisarts en Wetenschap 1998;41:344-350. 
5. Heintjes EM, Berger MY, Koes BW, Bierma-Zeinstra SM. Knee disorders in primary 
care: design and patient selection of the HONEUR knee cohort. BMC Musculoskelet 
Disord 2005;6:45. 
6. Lamberts H, Wood M. International Classification of Primary Care. Oxford: Oxford 
University Press, 1993. 
7. Tegner Y, Lysholm J. Rating systems in the evaluation of knee ligament injuries. Clin 
Orthop 1985(198):43-9. 
8. Bellamy N. WOMAC osteoarthritis index. A user's guide. London, Ontario: McMasters 
University, 1995. 
9. Roorda LD, Jones CA, Waltz M, Lankhorst GJ, Bouter LM, van der Eijken JW, et al. 
Satisfactory cross cultural equivalence of the Dutch WOMAC in patients with hip 
osteoarthritis waiting for arthroplasty. Ann Rheum Dis 2004;63(1):36-42. 
10. van de Lisdonk E, Kuik M, Bakx JC. [Patellar chondropathy in family practice] 
Chondropathia patellae in de huisartspraktijk. Ned Tijdschr Geneeskd 
1991;135(9):374-7. 
11. Heintjes EM, Berger MY, Bierma-Zeinstra SMA, Bernsen RMD, Verhaar JAN, Koes 
BW. Exercise therapy for  patellofemoral pain syndrome. A systematic review. Issue 
3 ed: The Cochrane Library, Chichester, UK: John Wiley & Sons, Ltd., 2003. 
12. Nimon G, Murray D, Sandow M, Goodfellow J. Natural history of anterior knee pain: 
a 14- to 20-year follow-up of nonoperative management. J Pediatr Orthop 
1998;18(1):118-22. 
13. Stathopulu E, Baildam E. Anterior knee pain: a long-term follow-up. Rheumatology 
2003;42:380-2. 
14. Khatun M, Ahlgren C, Hammarstrom A. The influence of factors identified in 
adolescence and early adulthood on social class inequities of musculoskeletal 
disorders at age 30: a prospective population-based cohort study. Int J Epidemiol 
2004;33(6):1353-60. 
 88 
Prognosis of non-traumatic knee complaints in adolescents and young adults in general practice 
 
15. Natri A, Kannus P, Jarvinen M. Which factors predict the long-term outcome in 
chronic patellofemoral pain syndrome? A 7-yr prospective follow-up study. Med Sci 
Sports Exerc 1998;30(11):1572-7. 
16. Andrisano A, Mignani G, Mazzetti M. Long term results in Osgood-Schlatters 
disease. Ital J Orthop Traumatol 1985;11(4):483-6. 
17. Fredberg U, Bolvig L. Jumper's knee. Review of the literature. Scand J Med Sci 
Sports 1999;9(2):66-73. 
18. Kelly DW, Carter VS, Jobe FW, Kerlan RK. Patellar and quadriceps tendon ruptures-
-jumper's knee. Am J Sports Med 1984;12(5):375-80. 
19. van der Waal JM, Bot SD, Terwee CB, van der Windt DA, Scholten RJ, L.M. B, et al. 
Course and prognosis of knee complaints in general practice. Arthritis Rheum 
2005;53(6):920-30. 
20. Swinkels-Meewisse EJ, Swinkels RA, Verbeek AL, Vlaeyen JW, Oostendorp RA. 
Psychometric properties of the Tampa Scale for kinesiophobia and the fear-
avoidance beliefs questionnaire in acute low back pain. Man Ther 2003;8(1):29-36. 
21. Goubert L, Crombez G, Vlaeyen JWS, van Damme S, van den Broeck A, van 
Houdenhove B. The Tampa scale for kinesiofobia: Psychometric characteristics and 
norms. Gedrag & Gezondheid 2000;28(2):54-61. 
22. van Weel C. Functional status in primary care: COOP/WONCA charts. Disabil 
Rehabil 1993;15(2):96-101. 
 
 
 89 
  
  
 
 
 6 
Exercise therapy for  
patellofemoral pain syndrome  
A systematic Cochrane review 
 
 
 
 
 
 
 
 
 
 
 
 
 
E.M. Heintjes, M.Y. Berger , S.M.A. Bierma-Zeinstra, R.M.D. Bernsen,  
J.A.N. Verhaar, B.W. Koes 
 
The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003472.  
DOI: 10.1002/14651858.CD003472. 
 
  
 
Exercise therapy for patellofemoral pain syndrome 
Abstract 
 
Background 
Patellofemoral pain syndrome (PFPS) is a common problem among adolescents and 
young adults, characterised by retropatellar pain (behind the kneecap) or peripatellar 
pain (around the kneecap) when ascending or descending stairs, squatting or sitting with 
flexed knees. Etiology, structures causing the pain and treatment methods are all 
debated in literature, but consensus has not been reached so far. Exercise therapy to 
strengthen the quadriceps is often prescribed, though its efficacy is still debated.  
Objectives 
This review aims to summarise the evidence of effectiveness of exercise therapy in 
reducing anterior knee pain and improving knee function in patients with PFPS.  
Search strategy 
We searched the Cochrane Musculoskeletal Injuries Group and Cochrane Rehabilitation 
and Related Therapies Field specialised registers, the Cochrane Controlled Trials 
Register, PEDro - The Physiotherapy Evidence Database, MEDLINE, EMBASE, 
CINAHL, up till December 2001 for controlled trials (randomised or not) comparing 
exercise therapy with control groups, or comparing different types of exercise therapy.  
Selection criteria 
Only trials focusing on exercise therapy in patients with PFPS were considered. Trials in 
patients with other diagnoses such as tendinitis, Osgood Schlatter syndrome, bursitis, 
traumatic injuries, osteoarthritis, plica syndrome, Sinding-Larssen-Johansson syndrome 
and patellar luxations were excluded.  
Data collection & analysis 
From 750 publications 12 trials were selected. All included trials studied quadriceps 
strengthening exercises. Outcome assessments for knee pain and knee function in daily 
life were used in a best evidence synthesis to summarise evidence for effectiveness.  
Main results 
One high and two low quality studies used a control group not receiving exercise 
therapy. Significantly greater pain reduction in the exercise groups was found in one high 
and one low quality study, though at different time points. Only one low quality study 
reported significantly greater functional improvement with exercise. Five studies 
compared exercise therapies that could be designated closed kinetic chain exercise (foot 
in contact with a surface) versus open kinetic chain exercise (foot not in contact with a 
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surface). Two of these studies were of high quality, but no significant differences in 
improvement of function or reduction of pain were apparent between the types of 
exercise in any of the studies. The remaining four studies, all of which were of low 
quality, focused on other treatment comparisons.  
Reviewers' conclusions 
The evidence that exercise therapy is more effective in treating PFPS than no exercise 
was limited with respect to pain reduction, and conflicting with respect to functional 
improvement. There is strong evidence that open and closed kinetic chain exercise are 
equally effective. Further research to substantiate the efficacy of exercise treatment 
compared to a non-exercising control group is needed, and thorough consideration 
should be given to methodological aspects of study design and reporting.  
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Background 
 
Patellofemoral pain syndrome (PFPS) is a common complaint in adolescents and young 
adults. The symptom most frequently reported is a diffuse peripatellar (around the knee 
cap) and retropatellar (behind the knee cap) localised pain, typically provoked by 
ascending or descending stairs, squatting and sitting with flexed knees for prolonged 
periods of time. Other common symptoms are crepitus and giving-way1-5.  
Several factors have been implicated in the etiology of PFPS. Malalignment of the lower 
extremity, sometimes due to excessive pronation of the foot, may result in a 
compensatory internal rotation of the tibia and increased valgus stress6. The vastus 
medialis obliquus (VMO) plays a major role in stabilising patellar glide through the 
femoral groove. Weakness of the VMO relative to other muscle groups of the quadriceps 
and aberrant firing patterns of the nerves innervating the VMO and vastus lateralis (VL) 
have been demonstrated in patients with PFPS7. This muscle imbalance may cause 
maltracking of the patella through the femoral groove, resulting in an abnormal 
distribution of the patellofemoral joint reaction stress (PFJRS)8. Tight anatomical 
structures (hamstrings, iliotibial band, patellar retinaculum)9,10 and overactivity5,10,11 may 
also increase the PFJRS. Poor congruence angles between the posterior aspect of the 
patella and the intercondylar sulcus of the femur predispose for subluxation or even 
dislocation of the patella, causing cartilage damage12. Clinical studies have not however 
been able to demonstrate biomechanical or alignment differences between patients with 
PFPS and healthy individuals5,13,14 argues that the combination of malalignment and 
muscle function deficit may increase the risk of overload and thus PFPS. Increased 
intrapatellar pressure may cause subchondral degeneration which progresses to the 
surface and ultimately results in chondral lesions5,14,16. As cartilage is not innervated, 
subchondral bone may cause the pain. However, many authors2,5,17,18 report a poor 
correlation between pain and cartilage damage. Peripatellar soft tissues, such as the 
patellar retinaculum may also play a role.  
The uncertainty regarding the etiology of the complaint also extends to the diagnostic 
criteria and terms. PFPS is sometimes referred to as 'anterior knee pain'19, a term that 
may also indicate other medical conditions causing pain in the anterior part of the 
knee1,17 and which often refers more to symptoms than a clear diagnosis. 
Chondromalacia patellae or chondropathy are often used as a synonyms for PFPS. 
Nevertheless, in literature there is some agreement that chondromalacia or 
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chondropathy are applied to patients with actual patellar cartilage damage and PFPS is a 
term to be applied only to patients with retropatellar pain in which no cartilage damage is 
evident1,5,11,20-22. However, retropatellar pain is generally thought of as a self-limiting 
condition with a good prognosis, especially for patients who are young23, patients who 
have unilateral complaints and patients in which crepitation is absent18. This means that 
patients are usually managed in primary care and are rarely referred to specialist care17. 
Therefore reliable diagnostic techniques for determining cartilage damage such as 
computed tomography (CT), magnetic resonance imaging (MRI) or arthroscopy1,2 are 
seldom applied. In fact a diagnosis based solely on symptoms and physical examination 
of the knee is not uncommon. Diagnostic tests often applied are listed here.  
Palpation of the lateral and medial aspects of the patella can determine sensitivity of the 
retropatellar surface. "Clarke's test", "compression test" or "axial pressure test" are 
synonyms for pressing the patella against the femur and asking the patient to contract 
the quadriceps. The test is positive when pain or crepitations are present. The patellar 
grind test is similar but requires pressure to the patella in distal direction. Resisted knee 
extension can also elicit pain with PFPS. The specificity and sensitivity of these tests is 
debated in literature, but validation studies are absent. Gaffney found that only half of the 
patients with PFPS were positive on Clarke's test24. In the apprehension test a lateral 
pressure is applied to the patella. Patients with a history of (sub)luxation will react with 
sudden contraction of the quadriceps muscles. The relevance of determining cartilage 
damage with more reliable techniques than physical examination is minimal, as Natri 
found that neither the radiologic nor the MRI changes seen in affected knees showed a 
clear association with the seven year outcomes for pain and knee function18. All things 
considered the distinction between chondromalacia and PFPS seems theoretical rather 
than practical, so patients with chondromalacia as well as PFPS will be included in this 
review.  
Most researchers advocate conservative treatment of PFPS or chondromalacia1,5,20,21, 
though there is still insufficient clarity about the effectiveness of the conservative 
treatment methods3,4,22. This review is being undertaken to clarify the effectiveness of 
quadriceps strengthening exercises, the most promising conservative treatment method 
for patellofemoral pain syndrome available3,5,10,18,25,26.  
Quadriceps strengthening exercise therapy encompasses a broad range of possible 
variations and accompanying terms. To offer the reader some support with the 
interpretation of these terms, an overview of the possibilities is given here. Exercises 
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involving contact of the foot with a surface are referred to as "closed kinetic chain 
exercises", as opposed to "open kinetic chain" exercises which are often prescribed 
because of the limited forces they elicit in the knee joint. Contractions of the quadriceps 
muscles can either be concentric, eccentric or isotonic. During concentric contractions 
the muscles shorten (e.g. when raising a straight leg, extending a bent knee or 
squeezing a pillow between both legs), whereas during eccentric contractions they 
lengthen in an actively controlled manner (e.g. when slowly lowering a straight leg, 
descending stairs or squatting down). Isotonic contractions require a constant strain 
without changes in the length of the muscle (e.g. during wall squats with knees flexed in 
90 degrees and the back against the wall). Exercises in which the position of the knee 
does not change are referred to as static or isometric. Hence, exercises can be 
described in three dimensions: the presence of reaction forces caused by contact of the 
foot with a surface (open versus closed kinetic chain), type of muscle activity (concentric, 
eccentric, isotonic), and knee movement (flexion/extension versus isometric or static). 
Combinations of above denominations apply to every type of exercise, and the 
terminology used for exercise programs reflects the emphasis intended by the therapist.  
Quadriceps strengthening exercises are usually combined with stretching exercises, to 
loosen tight structures like hamstrings, the iliotibial band and the patellar retinaculum. 
Additional tools provided by therapists to facilitate exercise therapy are patellar taping26 
or Coumans bandaging to adjust the patellofemoral congruence angle and thereby 
relieve pain and facilitate exercising. Therapists may also apply additional technology in 
treatment programs. Isokinetic exercises (exercises in which the lower leg moves at a 
predetermined, constant speed) require an isokinetic dynamometer to control the velocity 
with which the knee goes through a large range of motion. This device can also measure 
the concentric as well as eccentric force applied by knee extensors (quadriceps) or 
flexors (hamstrings) at predetermined velocities. The velocity spectrum for these 
dynamometers ranges from 0 to 360 degrees per second. Electromyographic 
biofeedback visualises specific muscle contractions and may help the patient target the 
Vastus Medialis Obliquus (VMO) during exercise. Electrostimulation provides external 
stimuli for specific muscles resulting in contractions and thus exercise.  
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Objectives 
The objective of this review was to assess the effectiveness of exercise therapy in the 
treatment of PFPS, by  
• comparing exercise therapy with 'placebo' treatment or no treatment/waiting list 
controls  
• comparing different types of exercise therapy  
• comparing exercise therapy with other conservative or surgical treatment  
using anterior knee pain and knee function as clinically relevant outcome measures. 
Measurements up to one year follow-up were considered short term outcomes, 
thereafter long term.  
 
 
Methods 
Types of studies 
Concurrent, randomised or quasi-randomised controlled trials (RCTs) and concurrent 
controlled trials without randomisation (CCTs) on exercise therapy for patellofemoral 
pain were considered. Quasi-randomised treatment allocation pertains to which were not 
strictly random, such as date of birth, alternation etc. Retrospective studies were 
excluded.  
Types of participants 
Adolescent and adult patients suffering from patellofemoral pain syndrome (designated 
by the author as such or as "anterior knee pain syndrome", "patellar dysfunction" 
"chondromalacia patellae" or "chondropathy"). Studies which specifically focused on 
other named knee pathologies such as Hoffa's syndrome, Osgood Schlatter syndrome, 
Sinding-Larsen-Johansson syndrome, iliotibial band friction syndrome, tendinitis, 
neuromas, intra-articular pathology including osteoarthritis, rheumatoid arthritis, 
traumatic injuries (such as injured ligaments, meniscal tears, patellar fractures and 
patellar luxation), plica syndromes, and more rarely occurring pathologies were 
excluded2,5.  
Types of interventions 
Only controlled trials including at least one treatment arm consisting of exercise therapy 
aimed at strengthening knee extensor musculature, either at home or under supervision 
of a therapist were included in this review.  
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Types of outcome measures 
The primary outcome was knee pain. Secondary outcomes focus on functional disability 
level (i.e. decreased knee function in activities of daily living) and subjective perception 
of recovery. Questionnaires focusing on knee function (such as Functional Index 
Questionnaire, WOMAC Osteoarthritis Index, and Kujala Patellofemoral Function Scale, 
Lysholm scale etc.) and the ability to perform tests (squatting, hopping on one leg etc.) 
were considered measures for functional disability. Adverse effects like knee swelling or 
substantially increasing pain levels as a direct effect of treatment were taken into 
consideration as well. As changes in knee function on impairment level alone (i.e. range 
of motion, muscle strength etc.) do not directly represent changes in the symptoms of 
patellofemoral pain or the resulting disability, they were not considered clinically relevant 
outcome measures in this review.  
Identification of trials 
We searched the Cochrane Musculoskeletal Injuries Group and Cochrane Rehabilitation 
and Related Therapies Field specialised registers, the Cochrane Controlled Trials 
Register, MEDLINE (1966 to December 2001), EMBASE (1988 to December 2001), 
CINAHL (1982 to December 2001), PEDro - The Physiotherapy Evidence Database 
(http://ptwww.cchs.usyd.edu.au/pedro), and reference lists of articles. No language 
restriction was applied. Using the optimal trial search strategy [46] we looked for trials 
containing the terms anterior knee pain, words containing 'patell',: chondromalacia or 
chondropathy, in combination with physical therapy, exercise, training or strengthening. 
Two reviewers (MB, SBZ) independently selected the trials, initially based on title and 
abstract. From the title, keywords and abstract they assessed whether the study met the 
inclusion criteria regarding diagnosis, design and intervention. Of the selected 
references, the full article was retrieved for final assessment. Next, they independently 
performed a final selection of the trials to be included in the review, using a standardised 
form. Disagreements were solved in a consensus meeting.  
 
Methodological quality assessment 
The methodological quality was assessed by two reviewers (BK, JV) independently using 
the Delphi list (table 1)27. Disagreements were solved in a consensus meeting. For each 
item Cohen's Kappa and the percentage agreement between both reviewers was 
calculated, after dichotomising the data into optimal and suboptimal scores (i.e. value 1 
was converted to 0). Trials presenting an adequate or concealed randomisation 
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procedure and adequate blinding (Cochrane code A), or a maximum score of five or 
more Delphi items were labelled "high quality" trials.  
 
Table 1 Methodological quality assessment 
Delphi list27
D1. Was a method of (quasi) randomisation performed?  
D2. Was the assigned treatment adequately concealed prior to allocation?  
Cochrane code: Clearly Yes = A; Not sure = B; Clearly No = C.  
D3. Were the treatment and control group comparable at entry?  
D4. Were the inclusion and exclusion criteria clearly defined?  
D5. Were the outcome assessors blinded to treatment status?  
D6. Were the treatment providers blind to assignment status after allocation?  
D7. Were the participants blind to assignment status after allocation?  
D8. Were point estimates and measures of variability presented for the primary outcome measures?  
D9. Were the outcomes of patients who withdrew described and included in the analysis  
(intention to treat)?  
 
Data extraction 
Two reviewers (EH, RB) independently extracted the data regarding the interventions, 
type of outcome measures, follow-up, loss to follow-up, and outcomes, using a 
standardised form.  
Analysis 
Analysis of pooled study outcomes was only to be implemented if the studies or 
subgroups of studies were considered clinically homogeneous and if statistical 
heterogeneity was not demonstrated. If the trial results were heterogeneous, the factors 
possibly underlying this phenomenon were considered and summarised. A further 
analysis using a rating system with levels of evidence based on the overall quality, and 
the outcome of the studies, was used28,29:  
• strong evidence - provided by generally consistent findings in multiple high 
quality RCTs;  
• moderate evidence - provided by generally consistent findings in one high 
quality RCT and one or more lower quality RCTs, or by generally consistent 
findings in multiple low quality RCTs;  
• limited evidence - provided by only one RCT (either high or low quality) or 
generally consistent findings in CCTs;  
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• conflicting evidence - inconsistent findings in multiple RCTs and CCTs;  
• no evidence - no CCTs or RCTs.  
Where possible, the results of each RCT were expressed as Relative Risks (RR) with 
corresponding 95 per cent confidence intervals for dichotomous data and weighted mean 
differences and 95 per cent confidence intervals for continuous data. MetaView, the 
statistical analysis component of RevMan30, was used to graphically present the 
comparisons of each study.  
 
Results 
 
Of the 750 titles and abstracts identified by the systematic search of the literature, two 
reviewers (SB, MB) selected 16 studies that met the inclusion criteria. Four studies31-34 
had to be excluded from the review: Beetsma31 and Eburne32 due to lack of detail in 
description of procedures and outcomes; Kowall33 because both treatment arms 
performed the same exercises, and the objective of the study was to evaluate the 
effectiveness of additional taping. Furthermore, Roush34 also included patients with 
Osgood-Schlatter and plica syndromes. Twelve studies were included in the review, 
representing 697 patients, with an equal number of males and females, and an age 
ranging from 11 to 65, with an average of 24.  
Description of studies 
A total of 12 studies were included in this review: three CCTs and nine RCTs. The 
studies proved to be rather heterogeneous with respect to participant characteristics 
(including diagnostic criteria), the type, intensity and duration of therapy, follow-up 
duration, outcome measures and measurement instruments. Methodological quality was 
also variable. The studies are presented here, classified for similarities in comparisons. 
Descriptions of the participants, methods, interventions, outcomes and drop-outs can be 
found in the tables of included studies (table 2-4).  
Three studies compared exercise therapy with a control group not receiving exercise 
therapy: Clark (2002)19, Timm (1998)35 and McMullen (1990)36.  
The remaining studies compared different types of exercise with each other. Descriptive 
terms used by the authors differ, but closer consideration of the descriptions of the 
exercises performed in the trials, enables five studies to be classified as closed kinetic 
chain exercise versus open kinetic chain exercise: Witvrouw (2000)37, Wijnen (1996)38, 
Gaffney (1992)24, Stiene (1996)39 and Colón (1988)40.  
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Four studies compared exercise programs that could not be classified as open versus 
closed kinetic chain exercise. They fit the inclusion criteria for this review, but cannot be 
compared to any other study and hence are not used in the best evidence synthesis: 
Dursun (2001) 41, Thomee (1997) 14, Harisson (1999) 42 43, and Gobelet (2001) 44.  
 
Methodological quality of included studies 
Percentage agreement ranged from 67% for item 9 ('Were the outcomes of patients who 
withdrew described and included in the analysis') to 100% for items 6 and 7 (table 1). 
Overall agreement was 86%. Cohen's Kappa ranged from 0.23 for Delphi item 4 to 0.66 
for item 3, but could not be calculated for items 6 and 7 because agreement between 
reviewers was 100%. The disagreements were solved in a single consensus meeting. 
Three studies were of high quality, as they scored positive on at least 5 Delphi items, 
and were allocated Cochrane code A. Delphi scores ranged from 0 to 6 (listed in tables 
2-4).  
 
Analysis 
Two reviewers (EH, RB) extracted data from the publications. Quantitative meta-analysis 
of pooled high quality studies was impossible due to the heterogeneity of the 
interventions used for comparison, heterogeneity of gathered outcome measures and 
applied instruments and heterogeneity of assessment times. For qualitative analysis we 
identified two comparisons that were addressed by more than one trial. First of all, the 
question whether patients receiving exercise therapy improve more than patients on a 
waiting list or patients receiving conservative treatment without exercise. Second, the 
question whether weight bearing exercises, more closely resembling activities of daily 
living (closed kinetic chain) provide better results than non-weight bearing exercises 
(open kinetic chain). Descriptions of each treatment were closely examined to determine 
whether the study under investigation could contribute to a best evidence synthesis for 
either one of these questions. Evidence provided by these studies is summarised in 
figures 1 and 2. Four studies describe unique comparisons not addressing these 
questions.  
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Exercise versus no exercise 
The results and forest plots for the comparisons are displayed in figure 1. 
• In the high quality RCT by Clark19 patient groups receiving exercise therapy 
were pooled and compared to pooled patient groups not receiving exercise 
therapy. It was shown that functional ability improves equally in both pooled 
groups. Pain reduction was not significantly different at 3 months. At the 12 
month assessment Clark states that the groups receiving exercise therapy 
experienced significantly greater pain reduction. Clark reports means and SD of 
changes only for the 3 month assessment, based on individual changes. Our 
calculations based on means per time-point do not exactly reproduce these 
figures nor the statistical difference at 12 months. The number of patients 
discharged from therapy because they were satisfied with the results were 
significantly greater for the group that exercised. The number needed to treat 
was 3 (95%CI: 1.6 to 3.3), so three exercising patients yielded one more 
satisfied patient than expected in the control group.  
• A Protonics® device is a special brace designed to provide progressive 
resistance exercise during activities of daily living, without restraining motion or 
protecting knee ligaments. The low quality RCT by Timm35 showed that 
resistance during activities of daily living provided by the Protonics® device 
almost halves the pain-scores compared to the control participants, and 
drastically improves functional ability after daily use for four weeks. Both effects 
differ significantly from the control group that did not receive any therapy. 
• McMullen36 found in his low quality CCT that static exercise improved function 
more than isokinetic exercise, though both types provided only minimal 
improvement compared to the waiting list controls. Pain levels are not reported, 
though the author states that they remained unchanged for all groups after four 
weeks.  
From the best evidence synthesis it follows that there is limited evidence to support the 
hypothesis that exercise therapy reduces anterior knee pain in patients with PFPS: one 
high quality RCT and one low quality RCT claim significant pain reduction, and one CCT 
with a small number of patients contradicts this. There is conflicting evidence of 
functional improvement: one high quality RCT and one small CCT do not find 
improvement whereas one low quality RCT does.  
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Open kinetic chain versus closed kinetic chain 
For categorising the studies, the descriptions of the exercises rather than the terminology 
in the publications was used (table 3). Results of comparisons are displayed in figure 2.  
• The high quality RCT by Witvrouw37 showed that both function and pain 
improve significantly with both open and closed kinetic chain exercise, though 
no significant differences between the groups are found.  
• The high quality RCT by Wijnen38 showed no statistical differences for pain and 
function. However patient satisfaction with the therapy is significantly greater in 
the group combining closed kinetic chain exercises with McConnell taping than 
in the home exercise group with Coumans bandages.  
• The low quality RCT by Gaffney24 reported no significant differences in pain and 
function outcomes between eccentric closed kinetic chain and concentric open 
kinetic chain exercises.  
• The low quality CCT by Stiene39 shows that though muscle strength improves in 
both groups, the closed kinetic chain exercise results in significantly better 
function as determined through retro-step up performance. This result is 
dubious as baseline values differ significantly between groups. The 
representation of Functional Index Questionnaire results was inadequate for 
interpretation. Pain was not reported in this study.  
• The low quality RCT by Colón40 uses a Pogo stick (a stick with foot holds which 
contains springs to enable bouncing) for closed kinetic chain exercise to 
compare with straight leg raises. It focuses completely on muscle strength, but 
does not provide statistical analyses to compare groups. He found that almost 
all patients in both groups report substantial (>50%) pain relief, but pain levels 
are not reported and differences between groups are not apparent.  
The results of both high and low quality RCTs are consistent for both pain and function, 
so there is strong evidence to support the hypothesis that closed kinetic chain exercises 
provide equal results to open kinetic chain exercises for either pain reduction or function 
improvement.  
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Other comparisons 
The other comparisons could not be compared to each other, and are therefore not 
displayed in forest plots. The study characteristics are displayed in table 4. 
• The low quality RCT by Harrison43 showed improvement in all groups for both 
pain and function, which is stated to be significant for the Patellar Function 
Scale. However, these outcomes were not significantly different between home 
exercise and the supervised exercise groups. Interestingly, our analysis of the 
presented data revealed that significantly more patients from the physical 
therapy group rated their clinical change as "significant improvement" compared 
to the home exercise group, though the author states there is no significant 
difference.  
• In the low quality RCT by Thomee14 a significant reduction of pain in all visual 
analogue scales is reported, both at three months and again at 12 months, 
though no differences between isometric and eccentric exercise groups were 
found. No pain levels are reported, only frequencies of patients with pain in 
three situations. Lysholm knee function scores are not reported. Muscle 
strength increased significantly in both groups, though no significant differences 
were found except in a 25 degree range during eccentric contractions.  
• The low quality RCT performed by Dursun41 did not reveal any differences 
between the outcomes of the groups exercising with or without EMG-
biofeedback.  
The low quality RCT by Gobelet44 found significant increases in clinical evaluation of the 
knee using the Arpège score list for the groups receiving electrostimulation and isometric 
exercise. Isokinetic exercise did not improve the status. Isokinetic muscle strength 
improved in the groups receiving electrostimulation and isokinetic training, but in the 
group receiving isometric training strength did not improve at all isokinetic velocities at 
which muscle strength was measured.  
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Discussion 
Exercise versus no exercise  
Only one of the three trials comparing exercise with no exercise was of high quality. The 
best evidence synthesis suggests that there is some indication that exercise is effective, 
but the data are not straightforward.  
McMullen36 argues the time period of four weeks may be too short, though other authors, 
such as Timm35 have found significant improvement in this period. The intensity of the 
exercises may be the clue, as Timm's participants received daily therapy for several 
hours during activities of daily living. However, the Protonics® device will not be 
universally applied and is therefore of clinically limited relevance. The first follow-up 
assessment by Clark19 was found after three months, at which time point improvement 
was made in all groups, though the difference between the exercising and non exercising 
groups only became apparent after one year. It is possible that the 60% drop-out rate 
after 12 months in Clark's study contributed to this significant difference by introducing 
attrition bias.  
But what explains the difference in effect seen in different control groups? One might 
argue that the improvement observed in Clark's study reflects the natural course of the 
affliction. However, the duration of symptoms prior to the study makes this unlikely. 
Another explanation may lay in the effect that participating in and fulfilling the 
requirements of a study alters an individual's behaviour, thereby contributing to the 
improvement. This is the so called Hawthorne effect. It is also possible that education 
may affect the behaviour of patients more than mere enrolment in a study when the 
treatment comes down to being placed on a waiting list. The duration of the trials by 
Timm35 and McMullen36 may also be too short to establish the Hawthorne effect, 
because it may take longer than four weeks for behavioural changes to result in clinical 
improvement. However, the assumption that behavioural changes occur, cannot be 
established from the reported results.  
Although the studies performed by Clark19 (N=81) and Timm35 (N=100) have the largest 
number of patients of all included studies, it should be noted that the number of patients 
in these studies is still modest.  
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Open kinetic chain versus closed kinetic chain 
The concept that closed kinetic chain exercises would be more effective than open 
kinetic chain exercises because they more closely resemble activities of daily living was 
not supported by evidence in any of the studies considered in this review. Greater 
satisfaction with McConnell treatment found by Wijnen38 could either be attributed to the 
closed kinetic chain exercises or to the application of McConnell tapes instead of 
Coumans bandages. This touches a problem that calls for reservations in the 
interpretation of this best evidence synthesis. It should be noted that though the common 
factor in these five studies is the contrast of open versus closed kinetic chain exercise, 
the differences in all other aspects of the interventions are considerable. The terminology 
the authors use for their exercise programs reflects the factor the author is most 
interested in and hence the different accents in each exercise program.  
 
Methodolical quality 
Quality assessment  
Overall the agreement between reviewers on the methodological scoring was 
reasonable, and consensus was reached without problems. Poor reporting of the studies 
was partly responsible for the poor agreement between the reviewers for item M-G: 
"Were care programmes, other than the trial options, identical?". The sometimes meagre 
descriptions of the treatment programs made evaluation of comparability harder, but 
interpretation of reported facts also led to problems: is the mention of differences in 
permission to use patellar taping, analgesics or infra-red treatment part of the trial 
options, or does it supplement these options? The duration of the treatments was always 
identical. The different scores for item M-K can be attributed partly to the fact that the 
term diagnostic tests raised confusion as to whether the tests are used for screening 
purposes or for outcome assessment. Furthermore, it is open to interpretation whether 
assessment of symptoms like pain during certain activities can be viewed as diagnostic 
tests.  
 
Cut-off point for high quality  
The nature of exercise therapy makes it impossible to conceal treatment allocation to the 
patients or for the treatment providers, which results in a maximum feasible score of 7 
out of 9 Delphi items. The cut-off point for the number of Delphi items needed for the 
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qualification "high methodological quality" coincided with the allocation of Cochrane code 
"A", and the difference between the high quality scores and the low quality scores always 
amounted to at least 2 Delphi items. Dursun's study is the only study that might be 
qualified as high quality when a different cut-off point is chosen. However, this study 
does not answer any of the clinically relevant research questions. Therefore, the cut-off 
point for classification of high or low quality was deemed justified for use in our planned 
qualitative analysis and no analysis was performed using an alternative cut-off point.  
 
Methodological shortcomings  
Though all studies intend to compare treatments, some authors have failed to provide a 
statistical analysis between treatment groups. They suffice with stating whether within 
each group significant changes occur. However, when significant changes occur within 
each group, the question whether some treatments provide better effects is not 
answered. Worse, when significant changes occur within one group, but not another, 
comparison of both groups may not produce statistically significant differences. 
Especially in studies where blinding of treatment allocators during randomisation was not 
described (i.e. all low quality studies), and where baseline characteristics and 
measurements were not equal, the method of reporting within group changes can be 
very misleading.  
Though some authors of low quality trials describe their methods in detail, this detail is 
sometimes lacking in the reporting of outcome measures. Shortcomings range from 
failing to report outcomes that are mentioned in the methods section (Thomee14 (VAS), 
McMullen36 (Cincinnatti Rating Scale (CRS))), not mentioning the number of patients 
(Gaffney24: VAS and diagnostic tests), to methods of data reduction that prevent insight 
in the data. For example originally continuous data are converted to ordinal (Harrison43 
(Functional Index Questionnaire (FIQ))), or even dichotomous data (Thomee14 (VAS)), 
which also hampers insight in variability of the data. McMullen36 and Colón40 fail to report 
baseline data. Although McMullen36 presents ANCOVA outcomes and post-treatment 
values giving the reader an opportunity to deduce estimators of baseline values, Colón40 
only presents the number of patients with at least 50% pain reduction. Furthermore, 
drop-outs have rarely been reported properly and intention to treat analyses were even 
more rare.  
Timm35, McMullen36 and Dursun41 include only patients with unilateral afflictions which 
may give a biased representation of the patient population. Wivrouw37, Harrison43, and 
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Thomee14 have taken the approach of including both unilateral and bilateral patients, 
choosing the most afflicted leg as object of investigation. However, Gaffney24 uses both 
unilaterally and bilaterally afflicted patients, but has reported data that represent knees 
instead of patients, without giving the number of patients involved.  
 
Outcome measures  
Pain is the symptom that prompts the patient's visit to a doctor, and function may be 
limited as a result. Muscle imbalance and/or weakness may be the underlying problem or 
a condition for PFPS to evolve, so muscle strengthening is a means to treat PFPS, but it 
is not a goal in itself in the management of PFPS. However, isokinetic power and torque 
measurements as quantifiable measure for muscle strength are used as outcome 
measures by some authors. Natri18 showed that restoration of quadriceps strength is 
important for good recovery of the patient, as determined by the difference between 
affected and unaffected leg: the smaller the difference in extensor strength, the better the 
outcome. However, none of the authors in this review chose the difference between legs 
as outcome parameter, which is understandable, given the fact that some patients have 
bilateral complaints. Presentation of these results would therefore muddy the overview 
given here, so we chose to leave them out. Not surprisingly, for all groups receiving 
exercise therapy, muscle strength increased, and differences found when comparing 
exercise treatments were usually minimal. Stiene39 notes that improving muscle strength 
did not improve the patient's function and Dursun41 found that improved muscle function 
appeared to have no effect on the clinical and functional status. Gobelet44 found that 
isokinetic training increased muscle strength, though not clinical improvement, whereas 
isometric training did not increase muscle strength, but improved the clinical outcome. 
These findings illustrate the difficulty of interpreting the effect of therapy using muscle 
strength as an outcome measure for knee function. Therefore we chose to determine 
effectiveness using outcomes more directly related to the wellbeing of the patients 
involved. Hence, our choice not to include muscle strength as relevant outcome measure 
in determining the effectiveness of PFPS seems justified.  
 
Compliance and withdrawal  
Compliance problems can be viewed as an inescapable element of exercise therapy, so 
compliance problems in trials can be viewed as truthful representations of medical 
practice, which is why an intention to treat analysis is imperative. Harrison notes that 
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many drop-outs showed good results, and suggests an underestimation of the effect of 
treatment is given. Unfortunately, few authors have reported compliance in a satisfactory 
manner. Colón40 reports one participant dropping out because of increased symptoms. 
Stiene39 reports non-compliance and unavailability for final testing as reasons for 
dropping them from analysis. Gobelet44 has withdrawn patients from analysis because of 
poor compliance, defined less than 70% attendance of training sessions. If no intention 
to treat analysis is performed, at least a comparison of baseline values of outcome 
measures of the drop-outs would be useful, to determine the possible bias of results. As 
most authors have not reported an intention to treat analysis and most studies struggle 
with high drop-out rates and small population sizes the effect of compliance as a 
confounder must be deemed significant, though elusive. High drop-out rates are evident 
in many studies, and make the feasibility of long term assessments problematic.  
 
Power 
If one looks at the limited evidence for the effectiveness of exercise therapy, one can see 
that benefits from exercise therapy seem relatively small, and variances (if reported) are 
rather large. When comparing different types of exercise therapy it is only logical that 
differences between treatment groups are even smaller. It is therefore regrettable that 
patient numbers in the included studies were, in general, rather small, and in some 
cases alarmingly so. This makes it almost impossible to detect differences between 
treatment groups (type II error). When reading this review it should be kept in mind that 
the low power and the other methodological flaws discussed above make it hard to reach 
any firm conclusions.  
 
Reviewers' conclusions 
 
Implications for practice 
There is limited evidence for the effectiveness of exercise therapy for PFPS.  
Open kinetic chain exercises and closed kinetic chain exercises are equally effective.  
Based on the limited evidence for effectiveness, physicians may consider exercise 
therapy for the treatment of PFPS.  
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Implications for research 
Prior to the study an assessment of the disease burden, the pain levels and the level of 
function impairment of the expected study population should be made, and patients 
should be asked how much improvement they expect from exercise therapy for it to be 
called successful, given the effort it requires. Taking into account the variance of these 
outcome measures, a power calculation should be made to determine the minimal 
number of patients required for detection of the desired effect. A factorial design aimed 
at studying the additional effect of education, taping, or any form of pain relief may be 
considered to determine the role of various co-interventions commonly applied. The 
population size required would have to be determined with adequate power analysis.  
Future researchers should beware of the misleading notion that muscle function 
represents the clinical status of PFPS, and use pain and function as the primary outcome 
measures in any trial studying the effectiveness of exercise therapy for PFPS. 
Questionnaires to assess the status of knee function often include questions about pain. 
However, separate pain measures are a valuable addition to the assessment of knee 
status, as can be seen from Clark's study, where pain reduction is significantly greater in 
the exercise group, whereas function assessments do not show this significant 
difference.  
The limited evidence for effectiveness of exercise therapy for PFPS shows that the 
ethical objections of several authors against using a control group not receiving any 
therapy are based more on the assumption of effectiveness of exercise therapy than on 
sound scientific evidence. This observation should be considered by investigators who 
wish to contribute to the discussion on effectiveness of exercise therapy by performing 
studies of high methodological quality, which should compare exercise therapy to a 
control group not receiving exercise therapy.  
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Pharmocotherapy for patellofemoral pain syndrome 
Abstract 
 
Background 
Patellofemoral pain syndrome (PFPS) is common among adolescents and young adults. 
It is characterised by pain behind or around the patella and crepitations, provoked by 
walking stairs, squatting, prolonged sitting with knees flexed, running and cycling. The 
symptoms impede function in daily activities or sports. Pharmacological treatments focus 
on reducing pain symptoms (non-steroidal anti-inflammatory drugs (NSAIDs), 
glucocorticosteroids), or restoring the assumed underlying pathology (compounds 
containing glucosamine to stimulate cartilage metabolism, anabolic steroids to increase 
bone density of the patella and build up supporting muscles). In studies, drugs are 
usually applied in addition to exercises aiming at building up supporting musculature.  
Objectives 
This review aims to summarise the evidence of effectiveness of pharmacotherapy in 
reducing anterior knee pain and improving knee function in people with PFPS.  
Search strategy 
We searched the Cochrane Musculoskeletal Injuries Group and Cochrane Rehabilitation 
and Related Therapies Field trials registers, the Cochrane Central Register of Controlled 
Trials (The Cochrane Library Issue 4, 2003), PEDro (up to January 2004) , MEDLINE 
(1966 to January 2004), EMBASE (1988 to January 2004), and CINAHL (1982 to 
January 2004).  
Selection criteria 
Controlled trials (randomised or not) comparing pharmacotherapy with placebo, different 
types of pharmacotherapy, or pharmacotherapy to other therapies for people with PFPS.  
Data collection & analysis 
The literature search yielded 780 publications. Eight trials were included, of which three 
were of high quality. Data were analysed qualitatively using best evidence synthesis, 
because meta-analysis was impeded by differences in route of administration of drugs, 
care programs and outcome measures.  
Main results 
Four trials (163 participants) studied the effect of NSAIDs. Aspirin compared to placebo 
in a high quality trial produced no significant differences in clinical symptoms and signs. 
Naproxen produced significant short term pain reduction when compared to placebo, but 
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not when compared to diflunisal. Laser therapy to stimulate blood flow in tender areas 
led to more satisfied participants than tenoxicam, though not significantly.  
Two high quality RCTs (84 participants) studied the effect of glycosaminoglycan 
polysulphate (GAGPS). Twelve intramuscular injections in six weeks led to significantly 
more participants with a good overall therapeutic effect after one year, and to 
significantly better pain reduction during one of two activities. Five weekly intra-articular 
injections of GAGPS and lidocaine were compared with intra-articular injections of saline 
and lidocaine or no injections, all with concurrent quadriceps training. Injected 
participants showed better function after six weeks, though only the difference between 
GAGPS injected participants and non-injected participants was significant. The 
differences had disappeared after one year.  
One trial (43 participants) found that intramuscular injections of the anabolic steroid 
nandrolone phenylpropionate significantly improved both pain and function compared to 
placebo injections.  
Reviewers' conclusions 
There is only limited evidence for the effectiveness of NSAIDs for short term pain 
reduction in PFPS. The evidence for the effect of glycosaminoglycan polysulphate is 
conflicting and merits further investigation. The anabolic steroid nandrolone may be 
effective, but is too controversial for treatment of PFPS.  
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Background 
 
Patellofemoral pain syndrome (PFPS) is a common complaint in adolescents and young 
adults. The symptom most frequently reported is a diffuse peripatellar and retropatellar 
localised pain, typically provoked by ascending or descending stairs, squatting, and 
sitting with flexed knees for prolonged periods of time (the so called 'movie sign'). Other 
common symptoms are crepitus and giving-way1-5.  
In the literature there is some agreement that PFPS is a term to be applied only to 
people with retropatellar pain in which no cartilage damage is evident1,4,6-9. However, 
retropatellar pain is generally thought of as a self-limiting condition with a good 
prognosis, especially for people who are young10, people who have unilateral 
complaints, and people in which crepitation is absent11). This means that people are 
usually managed in primary care and are rarely referred to specialist care12). Therefore 
reliable diagnostic techniques for determining cartilage damage such as computed 
tomography (CT), magnetic resonance imaging (MRI) or arthroscopy1,2 are seldom 
applied. In fact a diagnosis based solely on symptoms and physical examination of the 
knee is not uncommon. Furthermore, Natri showed that neither the radiologic nor the 
MRI changes seen in affected knees showed a clear association with persistent 
symptoms seven years later11. This makes the distinction between chondromalacia and 
PFPS theoretical rather than practical, so people with either chondromalacia or PFPS 
will be included in this review.  
Increased pressure on the patellofemoral joint seems to lie at the heart of the 
syndrome13, either caused by increased activity levels, malalignment of the patella when 
moving through the femoral groove, muscle imbalance of the quadriceps or tight 
anatomical structures such as the retinaculum or iliotibial band. However, it remains 
elusive which structures or tissues cause the pain: several studies during the last two 
decades have shown a poor correlation between arthroscopic evidence of articular 
cartilage damage and retropatellar pain11,14. Furthermore, cartilage is not innervated, and 
so subchondral bone as well as peripatellar soft tissues may be involved. Depending on 
the presumed mechanism at work, different approaches can be taken when applying 
pharmacotherapy. Therefore a brief outline is given of the presumed mechanisms.  
Increased patellofemoral joint reaction stress may cause microscopic damage to the 
patellar cartilage through friction. In this process proteolytic enzymes are released that 
cause further fragmentation of the cartilage matrix. Damage to the cartilage is countered 
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with an increased production of proteoglycans and collagen, the building stones to make 
repairs15. On the other hand, the damaged cartilage is less efficient in absorbing 
stresses and a vicious circle may be the result, in which the cartilage loses its ability to 
defer stresses from the subchondral bone. Increased intrapatellar pressure may also 
impede blood flow through the patella and cause subchondral bone degeneration, which 
may progress to the surface and ultimately result in chondral lesions16,17. Increased 
physical activity or maltracking of the patella through the femoral groove may lead to 
peripatellar soft tissue irritation, so that retinacular nerve endings may generate the 
pain2,11,14,18. It is not very likely that pain arises from the synovium because in PFPS 
there is limited, if any, effusion.  
When approaching PFPS as a cartilage problem, pharmacotherapy may focus on 
chemically disrupting the destructive enzymatic processes or aid constructive processes 
by providing nutrients for cartilage repair. Glycosaminoglycan polysulphate (GAGPS) 
inhibits proteolytic enzymes, which degrade proteoglycans and collagen in the 
cartilage19. It has also been shown to increase the rate of synthesis and the degree of 
polymerisation of hyaluronic acid in the synovial fluid, which would benefit cartilage 
repair. Aspirin has been shown to inhibit destructive enzymatic processes in cartilage in 
animal studies15. However, when assuming that bone degeneration precedes chondral 
degeneration, reversal of bone density loss could be considered. The anabolic ester 
nandrolone phenylpropionate is used to increase bone density and also serves to build 
up muscles supporting normal patellofemoral glide.  
When assuming that irritation of soft tissues causes the pain, suppression of 
inflammatory (or sub-inflammatory) processes could be targeted, either through the use 
of NSAIDs or glucocorticosteroids.  
Whatever the approach, pharmacotherapy is limited to the chemical processes that 
result from the increased pressure in the patellofemoral joint. Therefore it usually only 
plays an auxiliary role in pain reduction (NSAIDs), or reversing or limiting damage 
(glucosamine containing compounds, anabolic steroids), while at the same time tackling 
the ultimate cause with physical interventions. These physical interventions are usually 
conservative: refraining from pain provoking activities and training the knee extensor 
mechanism to build up muscles supporting normal patellofemoral glide, with or without 
the use of tape or braces to relieve pressure on the patellofemoral joint1,6,8,14. In the 
literature consensus has been reached that surgical interventions should be avoided, 
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and should only be considered in very severe cases which have proven to be resistant to 
conservative treatment [20].  
 
Objectives 
This review was undertaken to assess the effectiveness of pharmacotherapy in the 
conservative treatment for patellofemoral pain syndrome, by:  
• comparing pharmacotherapy with placebo treatment or no treatment  
• comparing different types of pharmacotherapy  
• comparing pharmacotherapy with other conservative treatment or surgical 
treatment  
using anterior knee pain, knee function and subjective assessments of recovery as 
clinically relevant outcome measures. Measurements up to one year follow-up were 
considered short term outcomes, thereafter long term.  
 
 
Criteria for considering studies for this review 
Types of studies 
Concurrent, randomised or quasi-randomised (i.e. allocation of participants to treatment 
groups which are not strictly random, such as date of birth, alternation, etc.) controlled 
trials (RCTs) and concurrent controlled trials without randomisation (CCTs) on 
pharmacotherapy for patellofemoral pain were considered. Because CCTs are more 
likely to introduce bias, they were considered only for qualitative analyses, to give a 
complete overview of published data. Retrospective studies were excluded.  
Types of participants 
People suffering from patellofemoral pain syndrome (including anterior knee pain 
syndrome and chondromalacia patellae). Studies which specifically focus on other 
named knee pathologies such as Hoffa's disease, Osgood Schlatter disease, Sinding-
Larsen-Johansson's disease, iliotibial band friction syndrome, tendinitis, neuromas, intra-
articular pathology including osteoarthritis, rheumatoid arthritis, traumatic injuries (such 
as injured ligaments, meniscal tears, patellar fractures and patellar luxation), plica 
syndromes, and more rarely occurring pathologies were excluded2,14. No restrictions on 
age or setting were applied.  
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Types of interventions 
Only controlled trials including at least one treatment arm consisting of pharmacotherapy 
for PFPS were included in this review. Oral, topical, intra-articular or intramuscular 
administration of the following pharmaceutical agents were considered for this review:  
• non-steroidal anti-inflammatory drugs (NSAIDs)  
• analgesics (including opiates)  
• steroids  
• biological agents and dietary supplements such as glucosamine, capsaicin, 
hyaluronic acid, vitamin preparations or fish oil.  
Types of outcome measures 
The primary outcome was knee pain intensity, measured on a visual analogue scale, 
numerical rating scale or pain index. Secondary outcomes focus on functional disability 
level and subjective assessments of recovery. Questionnaires focusing on knee function 
and the ability to perform tests were considered measures for functional disability (e.g. 
Lysholm scale for characteristics of knee function, Tegner scale for activity levels, or the 
ability to perform jumps or squats). Measures of recovery include ordinal rating scales 
(improved, no change, worse) or percentage ratings (subjective percentage 
improvement, where each patient estimates his/her own improvement from -100% 
(deterioration) to 100% (full recovery)).  
Adverse effects like increased pain levels were taken into consideration as well. As 
changes on impairment level alone (i.e. range of motion, muscle strength, etc.) do not 
directly represent changes in the symptoms of patellofemoral pain or the resulting 
disability, we will not base conclusions on effectiveness on these outcome measures in 
this review.  
Identification of studies 
We searched the Cochrane Musculoskeletal Injuries Group and Cochrane Rehabilitation 
and Related Therapies Field specialised registers, the Cochrane Controlled Trials 
Register, MEDLINE (1966 to December 2001), EMBASE (1988 to December 2001), 
CINAHL (1982 to December 2001), PEDro - The Physiotherapy Evidence Database 
(http://ptwww.cchs.usyd.edu.au/pedro), and reference lists of articles. No language 
restriction was applied. Using the optimal trial search strategy trial search strategy21 we 
looked for trials containing the terms anterior knee pain, words containing 'patell',: 
chondromalacia or chondropathy.  
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Two reviewers (MB, SBZ) independently selected the trials, initially based on title and 
abstract. From the title, keywords and abstract they assessed whether the study met the 
inclusion criteria regarding diagnosis, design and intervention. Of the selected 
references, the full article was retrieved for final assessment. Next, they independently 
performed a final selection of the trials to be included in the review, using a standardised 
form. Disagreements were solved in a consensus meeting.  
 
Methods of the review 
 
Selecting trials for inclusion  
Two reviewers (SB, MB) independently selected the trials, initially based on title and 
abstract. For the selected references a final decision about inclusion was made based on 
the full article, using a standardised form listing the inclusion criteria. Disagreements on 
inclusion were resolved by discussion.  
Methodological quality assessment  
The methodological quality was assessed by two reviewers (BK, JV) independently using 
the Delphi list (table 1)22. Disagreements were solved in a consensus meeting. For each 
item Cohen's Kappa and the percentage agreement between both reviewers was 
calculated. Trials presenting an adequate or concealed randomisation procedure and 
adequate blinding (Cochrane code A), or a maximum score of five or more Delphi items 
were labelled "high quality" trials.  
Table 1 Methodological quality assessment 
Delphi list22
D1. Was a method of (quasi) randomisation performed?  
D2. Was the assigned treatment adequately concealed prior to allocation?  
Cochrane code: Clearly Yes = A; Not sure = B; Clearly No = C. 
D3. Were the treatment and control group comparable at entry?  
D4. Were the inclusion and exclusion criteria clearly defined?  
D5. Were the outcome assessors blinded to treatment status?  
D6. Were the treatment providers blind to assignment status after allocation?  
D7. Were the participants blind to assignment status after allocation?  
D8. Were point estimates and measures of variability presented for the primary outcome 
measures? 
D9. Were the outcomes of patients who withdrew described and included in the analysis  
(intention to treat)?  
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Data extraction  
Two reviewers (EH, RB) independently extracted the data regarding the interventions, 
type of outcome measures, follow-up, loss to follow-up, and outcomes. The various 
outcome measures were presented separately. The results of each RCT are expressed 
as relative risks (RR) with corresponding 95 per cent confidence intervals (CI) for 
dichotomous data and standardised mean differences (SMD) and 95 per cent confidence 
intervals for continuous data. The statistical analysis component of RevMan23, was used 
to analyse the data.  
Analysis  
As the included studies were heterogeneous with respect to pharmacon and/or 
administration mode, quantitative analysis of pooled results was not possible. A 
summary is given of all clinically relevant outcome measures. A further analysis was 
performed, using a rating system with levels of evidence based on the overall quality, 
and the outcome of the studies24,25. The rating criteria are listed here:  
• strong evidence - provided by generally consistent findings in multiple high 
quality RCTs;  
• moderate evidence - provided by generally consistent findings in one high 
quality RCT and one or more lower quality RCTs, or by generally consistent 
findings in multiple low quality RCTs;  
• limited evidence - provided by only one RCT (either high or low quality) or 
generally consistent findings in CCTs;  
• conflicting evidence - inconsistent findings in multiple RCTs and CCTs;  
• no evidence - no CCTs or RCTs.  
 
Results 
 
Description of studies 
Of the 780 titles and abstracts identified by the systematic search of the literature, two 
reviewers (SB, MB) selected 13 abstracts to be viewed in full text, which resulted in eight 
studies that met the inclusion criteria (see table 3 for excluded studies). The included 
studies (table 2) covered a wide area of pharmaceutical agents, which were roughly 
attributed to 4 types of pharmaceutical agents, i.e. NSAIDs, glucocorticosteroids, 
anabolic steroids and glucosaminoglycan.  
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Table 3 Characteristics of excluded studies 
Study Reason for exclusion 
Berenfeld 199135 Only 26% of all patients suffered from PFPS, the rest suffered from OA. Results 
were not reported separately for each diagnosis. 
Braham 200336 Patients with OA. 
Dahlberg 199437 Patients with OA and in two thirds with a history of previous major knee trauma. 
Of the patients with patellar pain on palpation none had a history of patellar pain 
syndrome.  
Noble 198138 Only 10% patients with PFPS, the rest was diagnosed with injuries that are 
excluded in this review. 
Wang 199739 Non-controlled trial. 
The studies by Antich32 and Fulkerson31 also included patients with diagnoses mentioned in the exclusion criteria, 
but because the majority of patients suffered from PFPS these studies were included. 
OA: osteoarthritis, PFPS: patellofemoral pain syndrome  
 
Methodological quality of included studies 
Kappa scores for agreement between raters BK and JV ranged from 0.50 (items 4 and 7) 
to 1.00 (item 3), but could not be calculated for items 1, 2 8 and 9 due to empty cells in 
the contingency tables. Percentage agreement between the reviewers ranged from 50% 
(item 8) to 100% (item 3) per item. Disagreements were resolved in a single consensus 
meeting. Of the three studies marked as high quality, only Bentley15 and Kannus19,26 
received the Cochrane code A for concealment of treatment prior to allocation27, 
whereas the study by Raatikainen28 received Cochrane code B.  
Analysis 
Quantitative meta-analysis of pooled high quality studies was impossible due to the 
heterogeneity of the interventions used for comparison, heterogeneity of gathered 
outcome measures and applied instruments.  
The outcome measures pain, function and clinical improvement are represented in the 
graphs. Outcomes that represent clinical patella tests, swelling, muscle strength, 
cartilage damage or bone density are only mentioned in the text below, and will not be 
taken into account for the best evidence synthesis.  
 
NSAIDs  
The results of the studies are presented in figure 1. Bentley15 performed a high quality 
study comparing the effects of aspirin to that of placebo. Subjective clinical evaluations 
revealed no significant difference, 4 out of 13 participants in the placebo group showing 
improvement of symptoms and signs versus 6 out of 16 participants in the aspirin group 
(see Graphs: comparison 01.01). Due to side effects or non-cooperation four participants 
in the aspirin group did not maintain effective levels of 15 to 25 mg/100 ml blood during 
10 weeks. None of these participants improved, and one deteriorated.  
 139 
Chapter 7 
 140 
Pharmocotherapy for patellofemoral pain syndrome 
If patients with ineffective levels are left out of the analysis, the difference between the 
groups is still not significant. No people in the placebo group deteriorated. Comparison of 
changes in cartilage injuries observed during arthroscopy at baseline and after 13 weeks 
revealed one improvement and two deteriorations in the placebo group versus no 
improvements and one deterioration (effective level) in the aspirin group.  
Marchese29 performed a low quality study comparing the NSAID tenoxicam with laser 
therapy alternated with ice application. In the text of the article the author claims a 
significant difference in pain reduction in favour of the laser therapy group (mean follow-
up value visual analogue scale 2.93 versus 4.52 for the tenoxicam group), though lack of 
baseline information and variability measures makes verification impossible. Other 
outcome measures were not reported adequately. Only the patient's satisfaction with the 
treatments is reported satisfactorily, and amounts to 61% (11 out of 18 participants) in 
the group receiving laser therapy versus 29% (5 out of 18) in the group receiving 
tenoxicam. The relative risk 0.45 (95%CI 0.20 to 1.04) does not reveal a significant 
difference (see Graphs: comparison 02.01).  
Suter30 performed a low quality study comparing the NSAID naproxen with placebo. Pain 
scores were obtained by averaging Visual Analogue Scale scores before and during 
maximal knee extensor contraction for each leg. Reported mean differences between 
baseline and 7 days follow-up for both the involved and the non-involved leg were used 
for statistical comparison of placebo and naproxen. Pain reduction was significantly 
greater for naproxen than for placebo in the involved leg (SMD -0.78, 95% CI -1.46 to -
0.10), but not in the non-involved leg (SMD 0.02, 95% CI -0.63 to 0.68) (see Graphs: 
comparison 03.01).  
Fulkerson31 performed a low quality study in which no baseline or follow-up values for 
pain have been reported, and no definition is supplied for the term "significant pain 
relief". No significant differences in "significant pain relief" were detected when 
comparing naproxen (10 out of 16 participants) with diflunisal (11 out of 20 participants) 
after a period of five days (RR 0.88; 95%CI 0.51 to 1.52) (see Graphs: comparison 
04.01).Differences in swelling reduction were almost significant when comparing 
naproxen (4 out of 9 participants) with diflunisal (2 out of 12 participants) after a period of 
five days (RR 0.27; 95%CI 0.07 to 1.00).  
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Glucocorticoid steroids  
Antich32 performed a low quality study with 4 treatment arms, two of which involve 
dexamethazone / lidocaine (Hexadrol / Xylocaine). Iontophoresis and phonophoresis are 
both techniques to drive the topical drug into the soft tissue surrounding the patella, to 
reduce irritation or inflammation in these tissues. Antich reports mean values for 
'subjective improvement' which each patient was asked to rate as a percentage relative 
to the baseline situation. No measures of variability were supplied and no statistical 
analyses were performed. The highest mean value for 'subjective improvement' was 
47% for the group treated with alternating ultrasound and ice application, followed by 
phonophoresis of dexamethazone/lidocaine (Hexadrol/Xylocaine) with 32%, 
iontophoresis of dexamethazone/lidocaine (Hexadrol/Xylocaine) with 24% and 
application of ice bags with 22%. The respective strength increases of quadriceps and 
hamstrings were 28% and 34%, 13% and 0%, 15% and 15%, and 5% and 15%. 
Percentages are stated for knees without mention of the number of participants. 
Furthermore, no variability measures or statistical analyses are given. Therefore, 
conclusions about relative effectiveness are impossible.  
 
Anabolic steroids  
Darracott20 performed a low quality study and presented individual results determined 
after 6-8 weeks. A significant difference in the number of participants that improved 
clinically was observed: 1 out of 20 participants in the placebo group improved clinically 
compared to 20 out of 23 in the nandrolone group (RR 17.39; 95%CI 2.56 to 118.26) 
(see Graphs: comparison 06.01). Patellar bone density measurements also revealed a 
significantly better result for the nandrolone group: bone density increased in 1 out of 20 
participants in the placebo group, compared to 16 out of 20 in the nandrolone group (RR 
13.91; 95%CI 2.02 to 95.79).  
 
Glycosaminoglycan polysulphate (GAGPS)  
Kannus19,26 performed a high quality study and found that after a treatment period of six 
weeks two thirds of the participants receiving either GAGPS or placebo injections into 
the knee showed excellent recovery from PFPS symptoms, as determined by subjective, 
functional and clinical assessments. When comparing participants receiving intra-
articular GAGPS injections with the group receiving no injections19,26 the number of 
people without symptoms during a full squat differed significantly after 6 weeks (RR 2.20; 
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95%CI 1.03 to 4.68), but this difference was no longer observed after six months (see 
Graphs: comparison 08.03). When comparing means and standard deviations using the 
analysis tool in RevMan23, there was a significant difference between scores on the 
Lysholm functional scale between the groups receiving GAGPS injections and the group 
receiving no injections after 6 weeks (SMD 0.93; 95%CI 0.19 to 1.66) (see Graphs: 
comparison 08.05). However, the author did not find a significant difference using 
repeated measurements analysis that takes individual changes into account. The Tegner 
activity scores differed significantly between GAGPS injected participants and non-
injected participants after six weeks (SMD 1.12; 95%CI 0.37 to 1.88) and after six 
months (SMD 0.74; 95%CI 0.02 to 1.46) (see Graphs: comparison 08.06).Based on the 
physician's assessment, the number of people who were fully recovered at six weeks 
was greater in the injection groups than the group without injections, though the 
difference was never significant. At six months, three quarters of the participants 
reported excellent recovery, though there was no significant difference between the 
groups. Patella tests were performed and differed significantly between the injection and 
no injection groups after six weeks. Muscle strength relative to the healthy limb improved 
in all groups and no significant differences were observed. Overall, no beneficial effect of 
glycosaminoglycan polysulphate was observed.  
Raatikainen28 performed a high quality study and found that pain while going down stairs 
was significantly less in people receiving intramuscular injections of GAGPS compared 
to people receiving placebo injections (RR 1.85; 95%CI 1.07 to 3.19; NNT: 3). However, 
pain when squatting did not reveal a significant difference (RR 1.38; 95%CI 0.73 to 2.62) 
and neither did hindrance to normal life (RR 1.15; 95%CI 0.95 to 1.41) or hindrance to 
sports activities (RR 1.79; 95%CI 0.91 to 3.52). Nevertheless, the number of people with 
moderate to good therapeutic effect assessed by the physician after one year was 
significantly higher in the group receiving GAGPS injections (10 out of 13 in the GAGPS 
group and 3 out of 15 in the placebo group: RR 3.85; 95%CI 1.34 to 11.05; NNT: 2). Re-
arthroscopy was used to determine the improvement in cartilage lesions and revealed 
improvement in 3 out of 13 participants in the placebo group and in 8 out of 13 
participants in the GAGPS group. This difference was not significant (RR 2.79; 95%CI 
0.90 to 7.86). Overall, some very limited beneficial effects of glycosaminoglycans were 
observed (see Graphs: comparisons 09.01 to 09.05).  
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Best evidence syntesis 
There is limited evidence from one high quality study that aspirin is not more effective 
than placebo for improving clinical symptoms and signs in people with anterior knee 
pain.  
There is limited evidence from one low quality study that tenoxicam is less effective than 
laser therapy for reducing pain in people with PFPS and that patient satisfaction is not 
different between these treatments.  
There is limited evidence from one low quality study that naproxen is more effective than 
placebo for reducing pain in people with PFPS in the short term.  
There is limited evidence from one low quality study that diflunisal and naproxen do not 
differ in reducing pain in people with anterior knee pain in the short term.  
There is limited evidence from one low quality study that nandrolone phenylpropionate is 
more effective than placebo for improving clinical symptoms and signs in people with 
PFPS.  
There is conflicting evidence from two high quality studies for the effectiveness of 
glycosaminoglycan polysulphate compared with placebo in people with PFPS. One high 
quality study found marginally better results from its administration for some outcomes, 
but the other study found no statistically significant difference between groups.  
There is no evidence to support the claim from one low quality study that alternating 
ultrasound and ice massage improves subjective symptoms more than topical Hexadrol 
and Xylocaine in people with PFPS, chondromalacia or patellar tendinitis.  
 
 
Discussion 
 
The literature search resulted in a very small number of trials studying pharmacotherapy 
for PFPS or chondromalacia. This in itself is remarkable if one considers the widespread 
use of NSAIDs for pain reduction in patients with PFPS or chondromalacia.  
NSAIDs  
The study of Bentley15 (data from 29 participants were analysed) shows that aspirin is 
not more effective for treating symptoms of chondromalacia than placebo. The 
anticipated reduction of cartilage lesions was also not observed. Therefore, the 
hypothesised pathways by which aspirin was expected to influence cartilage metabolism 
could not be demonstrated. Marchese29 (data from 35 participants were analysed) found 
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that tenoxicam is significantly less effective than laser therapy for treating pain in people 
with chondromalacia, but pain levels were reported poorly and this claim cannot be 
verified. Suter30 found that the short term pain reduction in people with anterior knee pain 
syndrome was significantly higher for naproxen than for placebo (data from 36 
participants were analysed). However, although pain ratings ranged from 0 to 57 at 
baseline, mean values were only 11 ± 13 for the involved leg. The average pain 
reduction remained below 5 mm for the involved leg, and questions as to the clinical 
relevance of this reduction are not addressed by Suter30. The short term 'significant' pain 
reduction in people with anterior knee pain reported by Fulkerson31 (data from 36 
participants were analysed) was not measured on a visual analogue scale and can 
therefore not be compared to the results of Suter30. Furthermore, the term 'significant' 
pain reduction is not defined, preventing insight into the clinical relevance of this 
outcome. So, although the use of NSAIDs as analgesics in people with PFPS is already 
widespread, our systematic review of the literature has produced only limited evidence 
that NSAIDs are effective for pain reduction and clinical relevance of this evidence 
remains unclear.  
Glucocorticoid steroids  
Antich32 used topical Hexadrol (dexamethasone), a class 1 corticosteroid with anti-
inflammatory and vasoconstrictive action, in combination with topical Xylocaine 
(lidocaine), which has an analgetic effect. Iontophoresis and phonophoresis are both 
techniques to drive the topical drug into the soft tissue surrounding the patella, to reduce 
irritation or inflammation in these tissues, thought by some to cause the pain in PFPS. 
Though the trial does not provide statistical evidence, the drug does not seem to give 
good results (data from 67 knees of 51 participants were reported). Whether this lack of 
result reflects that the mechanism causing pain resides in other tissues will have to 
remain a point of speculation.  
Anabolic steroids  
Darracott20 used nandrolone phenylpropionate, a steroid which has been shown to have 
significant anabolic effect at dose levels below the threshold for androgenic response. 
The use of an anabolic ester yields rather impressive results (data from 43 participants 
were analysed) when clinical improvement is considered. Whether this clinical 
improvement may be due to the reversal of patellar osteoporosis, or to the muscular 
hypertrophy it induces, cannot be derived from these results. Although successful, 
application of nandrolone is not likely to be widely accepted as anabolic esters are 
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included in international doping lists and have significant side effects, such as premature 
closure of epiphyses, virilisation, liver insufficiency and heart failure. Its use in the 
treatment of PFPS should therefore be considered with great care.  
Glycosaminoglycan polysulphate (GAGPS)  
Both the studies by Kannus19,26 (data from 49 participants were analysed) and 
Raatikainen28 (data from 27 participants were analysed) are of high methodological 
quality. Though the pharmaceutical agent is the same, the route and frequency of 
administration is not. Moreover, the design of both studies differs greatly from the timing 
of start of exercises to the methods used for outcome assessment. Raatikainen28 
performs repeated arthroscopies to evaluate the appearance of the patellar cartilage. 
Kannus19,26 however, views the administration of GAGPS as additional to the 
conservative treatment that has gained a strong foothold in clinical practice: a 
combination of reducing activities that cause symptoms, strengthening the quadriceps 
muscles, and prescribing NSAIDs or other analgesics to facilitate exercising. It should be 
noted that although no differences were found between the three treatment strategies in 
the study by Kannus19,26, three quarters of all participants were deemed clinically 
recovered after six months. This was reduced to two thirds at seven years follow-up. 
Raatikainen28 found that three quarters of the participants in the GAGPS group showed 
a moderate to good therapeutic effect, versus only 20% of the controls; a significant 
difference. Because of the different approaches it is impossible to say whether these 
conflicting results reflect a difference in the effectiveness of the drug, in the route of 
administration, the frequency of administration, the presence of cartilage damage, or the 
additional treatment components. For example, it could be argued that the training 
program used by Kannus19,26 gives such good results that GAGPS does not substantially 
add to the positive effect of training.  
Choice of outcomes and assessment techniques  
The severity of symptoms and of patellar cartilage damage at inclusion varies from study 
to study. The weight given to the extent of the patellar cartilage lesions has been 
reconsidered in the previous decade. This is due to changing insights into the nature of 
retropatellar pain. Pain and crepitations have repeatedly been shown to be poorly 
correlated with visible cartilage damage16,17,33. The gradual acceptance of these insights 
is reflected in the dates of the studies that employed the technique of arthroscopy for 
determining cartilage damage15,28. Recent developments in MRI techniques provide non-
invasive techniques to determine cartilage damage that are risk free for the patient. 
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Furthermore MRI techniques enable quantification of cartilage volumes and surface area 
measurements19,26,34 Kannus26 used such MRI measurements to determine the cartilage 
thickness and abnormalities in his 7 year follow-up, and found no abnormalities in 81% of 
the participants. This is more than the two thirds that were still fully recovered. This is 
another indication that cartilage damage is not the most relevant outcome measure for 
PFPS.  
Although pain is the symptom that will prompt a patient to seek medical advice, several 
studies15,20,32 did not report pain as a separate outcome. instead they reported the 
outcome measure "clinical symptoms and signs" or "percentage change in condition" 
(ranging from -100% to +100%). This may well include pain, but definitions of these 
outcome measures have not been reported. Similarly, Fulkerson31 does not provide a 
definition of the main outcome measure: "significant pain reduction". This makes 
interpretation of the results rather difficult.  
 
Methodology  
Because no meta-analysis was performed and because the ranking of high and low 
quality of the trials did not influence the best-evidence synthesis, analysis of the cut-off 
point for discrimination between the high and low methodological quality was redundant. 
We encountered severe problems with the interpretation of the trials because of the low 
quality of certain studies. Bias could ensue from any of the items listed in the criteria 
used for determination of methodological quality. Apart from those issues, there are 
some other aspects that severely impede the interpretation of the results.  
Antich32 did not report the number of participants per treatment arm, the inevitable 
correlation between results of knees of bilaterally afflicted patients was not taken into 
account and their distribution over treatments was not reported, and no statistical 
analyses were performed. The study therefore serves only as an example for possible 
applications of pharmacotherapy, as it is not suitable for presentation of evidence. Most 
results from Marchese29 cannot be used in this review because the baseline and follow-
up measures for each treatment were not reported. Therefore, only 'patient satisfaction' 
remains for evaluation.  
In general, the number of participants in each trial is very limited, which seriously 
reduces the power of the included studies. The relevance of statistical evaluations then 
becomes questionable, as differences between treatments will be hard to detect and 
individuals with deviating outcomes can have an enormous effect. Therefore, the 
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reported estimates and confidence intervals should be interpreted with great caution. On 
the other hand statistical significance does not always reflect clinical relevance. This is 
demonstrated by the small reduction of pain levels found by Suter30, which is 
nonetheless statistically significant, resulting in the qualification 'limited evidence' for pain 
reduction.  
 
Patient characteristics  
The studies of Fulkerson31 and Antich32 included participants with diagnoses other than 
PFPS or chondromalacia in their study populations. Although clinicians may (in part) 
prescribe the same therapies for all diagnoses, patients with different diagnoses may 
show very different responses to these therapies and should therefore have been 
reported separately. In spite of this severe shortcoming, we decided to include these 
trials into this review, to give the reader a full scope of the scant literature available on 
the subject of pharmacotherapy for PFPS. The excluded patients32 who attended the 
clinic for instruction in a home program may have had less severe symptoms and may 
have reacted differently to the treatments.  
Both Bentley15 and Raatikainen28 only included patients in which cartilage damage had 
been detected at arthroscopy. Marchese29 included patients with at least one radiological 
sign of femoropatellar dysplasia, and Darracott20 only included patients with severely 
debilitating symptoms. Of the 53 patients included by Kannus19 17 had a previous 
arthroscopy but this detected cartilage damage in only eight cases.  
As most pharmaceutical agents are evaluated in only one study, no observations could 
be made whether the presence of cartilage damage influences the results. The only 
exception is GAGPS: Raatikainen28 included only participants in which cartilage damage 
was observed, and Kannus19,26 included participants with and without cartilage damage. 
The fact that the effectiveness of GAGPS seems greater in the study in which the 
participants had more cartilage damage, suggests that either cartilage damage is not a 
predictive factor for recovery, or GAGPS works better when cartilage damage is evident.  
The strength of this review is that it gives an overview of the available evidence for 
pharmacotherapy for PFPS. The poor methodological quality of some of the included 
studies does not subtract from that, because it emphasises the poverty of the available 
evidence. That the methodologically poor studies are mentioned in this review may serve 
to emphasise the need for qualitatively sound research. The fact that we also found 
some high quality trials indicates that it certainly is possible to conduct valid RCTs in this 
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field. Future trials should pay more attention to the methodological aspects of design and 
reporting as well as the number of subjects included in the study.  
 
 
Reviewers' conclusions 
 
Implications for practice 
Despite widespread application of NSAIDs for PFPS there is only limited evidence for 
their effectiveness in reducing pain and the evidence is limited to the short term only (up 
to one week). If the use of NSAIDs is considered in spite of that, the drug with the least 
possible side effects and lowest costs should be first choice for use in people with PFPS, 
as there is no evidence that one kind of NSAID is superior to another.  
The evidence for the effect of GAGPS is contradictory and merits further investigation. 
There is limited evidence that the anabolic steroid nandrolone may be effective, but the 
drug is too controversial for use in the treatment of PFPS.  
Implications for research 
The limited evidence for the effectiveness of NSAIDs and the lack of insight into the 
clinical relevance of this evidence could constitute an area for medical cost reduction. 
Therefore, further research on the effectiveness of NSAIDs should be obtained through 
trials in which NSAIDs are compared to placebo for at least several weeks, with a follow-
up period to assess long term effects. The NSAIDs may be given either in addition to 
other interventions or not. The comparison of NSAIDs to other treatments of which the 
effectiveness is unknown is undesirable.  
The effectiveness of GAGPS would merit further research, to investigate the 
contradictory results of Kannus19,26 and Raatikainen28.  
To gather more evidence for the influence of cartilage damage on recovery, future 
researchers may consider the use of imaging techniques to determine the extent of 
cartilage damage to use it for stratification of treatment groups and possible subgroup 
analysis.  
Any further research should pay attention to methodological aspects of design and 
reporting. Power calculations should be provided to ensure that the number of 
participants is sufficient to obtain both clinically and statistically significant outcomes.  
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General discussion 
Non-traumatic knee complaints in adolescents and young adults in 
general practice 
Non-traumatic knee complaints form a heterogeneous group of complaints. The most 
common diagnosis is osteoarthritis. Because of its persistence and disease burden it is 
the diagnosis most under investigation, but this is a complaint that usually starts at a 
later age. Non-traumatic knee complaints are also common in the younger age groups in 
general practice, but these have received very little attention in clinical research. As a 
result, little was known about the persistence and disease burden in this group. This 
thesis has aimed to fill this gap in our knowledge. In the previous chapters, the findings 
and limitations of our analyses were discussed. In this chapter we will place the findings 
in a broader context and discuss the relevance of our findings for clinical practice. 
 
What our study adds 
During the course of our study two other prognostic studies focusing on knee complaints 
in general practice populations were carried out, one in the United Kingdom and one in 
the Netherlands. The Knee Clinical Assessment Study (CAS(K)) included 819 patients 
aged 50 years and over that indicated having knee complaints in a health survey sent by 
3 British general practices1,2. Because of the recruitment method this is actually an open 
population study, focussing primarily on osteoarthritis. The BewegingsApparaat Study 
(BAS) followed only adults consulting Dutch GPs for new episodes of musculoskeletal 
complaints over the course of one year3. Prognostic factors were determined in 251 
patients with knee complaints of traumatic or non-traumatic onset, and with an average 
age of 49.3 (±16.2)4. Our study is the first to describe knee complaints from the age of 
12, including a sufficient number of patients to allow for analysis of a subgroup of 191 
adolescents and young adults with non-traumatic knee complaints. Another advantage 
over the BAS study is that we performed a standardized physical examination and 
collected more detailed information about knee complaints in the questionnaires. This 
specific information gives us the opportunity to investigate potential prognostic factors 
from data that closely resemble the data the GP will use to form a working diagnose and 
to base treatment decisions on. Therefore, our cohort provides unique and relevant 
information, especially with respect to non-traumatic knee complaints in adolescents and 
young adults. 
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Prognosis and prognostic factors 
The primary aim of this thesis was to determine the prognosis of non-traumatic knee 
complaints in adolescents and young adults. Though non-traumatic knee complaints in 
adolescents and young adults are common in general practice, their prognosis has never 
been studied in a prospective cohort study. Dutch guidelines for general practitioners 
suggest the prognosis is good, a belief that is based on consensus rather than facts5. 
Studies in secondary care6,7 suggest many patients are still bothered by their knee 
complaints after many years, and argue that the beliefs about a good prognosis should 
be reconsidered. Our study was the first to study the prognosis of this patient group in 
general practice. In chapter 5 we reported that in general practice the recovery rate is 
also low. With 53% recovered or improved after one year, the recovery in primary care 
patients is better than that reported in the secondary care populations. However, we feel 
that this recovery rate is not in concordance with the suggested good prognosis in 
primary care. 
The finding that the recovery rate expected by the GP was 89%, whereas the actual 
recovery rate was 44% in the patients for which the GP had stated the expected 
prognosis (chapter 5), illustrates the importance of active follow-up of patients in order to 
get a good impression of the prognosis. GPs probably use their personal experience to 
predict the outcome. The fact that only one in three patients with persistent complaints 
returns to the GP, and that most of these repeated consultations take place within 3 
months of the first consultation, means that GPs are unaware of the persistence of the 
knee complaints in most of their patients.  
The persistent complaints one year after the first consultation observed in 47% of the 
patients were associated with poor overall health (OR 6.9; 1.6 - 29.6) and lower 
education level (OR 3.4; 1.5 - 7.66). An association between socio-economic status, 
education level and overall health is a common finding8. Other prognostic factors are all 
associated with specific characteristics of the knee complaints. An important prognostic 
factor was a history of knee operation (OR 5.6; 1.3 - 23.3), present in 15 of the 191 
patients. Patients with a previous knee operation were included in the non-traumatic 
group, because the present new complaints are not the result of a recent trauma. 
However, one might argue that patients with previous operations are not typical for non-
traumatic knee complaints, and may obscure factors that are important for the rest of the 
patients. Though the importance of previous knee operations should not be effaced, we 
focus on the factors that were identified in the analysis excluding these patients. In order 
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of the strength of their association these are prominence of the tibial tuberosity (OR 5.9; 
0.9 - 37.7), painful patellar ligament (OR 3.1; 1.0 - 9.4), bilateral complaints (OR 2.9; 1.2 
- 6.7), self-reported locking of the knee (OR 2.6; 0.9-7.7), and self-reported knee swelling 
(OR 2.5; 1.0 - 5.8). Although painful patellar edges were eliminated from the multivariate 
prognostic model, it is a confounder of the factors painful patellar ligament and prominent 
tibial tuberosity. Combined occurrence of these signs results in worse prognoses than 
isolated signs. This finding has been reported before9,10.  
So how do our results compare to the BAS study? In the BAS study 44% of the patients 
was no longer bothered by their knee complaints after one year4. Prognostic factors in 
the BAS study were a history of knee complaints, a longer duration of the current 
episode of knee complaints, and other coexisting musculoskeletal complaints. In our 
multivariate model a history of knee complaints and a longer duration of the current 
episode of knee complaints were found to be redundant. With respect to the coexisting 
musculoskeletal complaints we found no association, not even in the univariate analysis. 
The difference in age between the study populations may account for this difference in 
results between our studies. We did find a univariate association with a history of 
traumatic knee injury, and a longer duration of the current episode of knee complaints, 
but both factors were found to be redundant in the multivariate model. Furthermore, we 
found no psychosocial factors to be associated with persistence, a finding that concurs 
with the findings of the BAS study. 
The other major difference between the BAS study and the HONEUR knee cohort apart 
from the population differences is that we included a physical examination, enabling us 
to evaluate the prognostic value of an important tool of the general practitioner. We 
found that out of a large number of signs, only two elements of the physical examination 
remained in the multivariate model. These elements were found in only a small number 
of patients. Maybe the true additional value of the physical examination lies in combining 
several signs or combining signs and symptoms to form prognostic entities, which could 
be evaluated in future explorative studies. Furthermore, prediction models could be 
developed, which preferably should be validated in future studies.  
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Disease burden 
The non-traumatic knee complaints in children and adolescents are portrayed in the 
NHG guidelines as self-limiting disorders. Apart from the suggested good prognosis, one 
also might expect the disease burden to be limited. However, this is another aspect that 
had not been studied before. In chapter 3 we compared the different groups of knee 
patients presenting in general practice. The Lysholm scale and WOMAC index give a 
measure for the problems knee complaints cause in daily life. When comparing these 
measures across the three subgroups, the younger subgroup of non-traumatic patients 
showed the best scores, followed by the older non-traumatic patients, and the traumatic 
subgroup showed the poorest scores. Differences between the younger and older non-
traumatic patients were -7.9 for the WOMAC index and -4.7 for the Lysholm scale. The 
difference between the younger non-traumatic patients and the traumatic group were -
12.7 for the WOMAC index and -6.2 for the Lysholm scale. To get an idea of the 
relevance of such differences, we may look at the mean clinically important difference 
(mcid) as determined in chapter 3 for patients aged 21 through 35. Lysholm scale and 
WOMAC index showed similar mcid-s, which were both around 13 in the non-traumatic 
group and around 19 in the traumatic group. The differences between the baseline 
scores of the three subgroups reported in chapter 4 are generally much smaller than 
these mcid-s. Therefore one might conclude that the observed differences between the 
subgroups of our cohort are relatively small, especially between the two non-traumatic 
age groups. In our opinion it is a noteworthy result that the subjective disease burden in 
the younger group is almost equal to that of the older group with probably a large 
proportion of osteoarthritis patients. However, one should keep in mind that mean 
clinically important differences were not determined for the older non-traumatic group. 
Because older patients may have lower expectations of their knee function, it is not safe 
to rely on the mcid determined in younger patients for interpretation of the subgroup 
differences.  
Another way of looking at disease burden is asking patients whether they are bothered 
by their knee complaints during daily duties such as work or school, and if they refrained 
from these duties because of their knee complaints. Remarkably, comparison of the age 
groups of the non-traumatic patients revealed that a higher percentage of the younger 
group reported refraining from daily duties. This finding confirms the belief that the 
younger non-traumatic patients experience the disease burden of their knee complaints 
at least as serious as the older non-traumatic group. 
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Management 
Patellofemoral pain syndrome (PFPS) is the most frequently occurring type of knee 
complaints in adolescents and young adults with non-traumatic knee complaints11. PFPS 
is the term suggested for knee complaints that have in the past been referred to as 
retropatellar chondropathy or chondromalacia patellae. The term PFPS was introduced 
when it became clear that chondral lesions were not always evident in patients with the 
typical symptoms. These symptoms are pain around the patella with knee-loading 
activities such as walking stairs, squatting, sitting with flexed knees for prolonged periods 
of time, jumping, and running. 
The NHG guideline for children and adolescents with non-traumatic knee complaints 
propose the following treatment strategy for non-traumatic complaints: advise patients to 
limit pain provoking activities for a month, and bring the knee loading activities in line 
with the knee loading ability of the knee. If complaints have subsided somewhat after a 
month, gradually increase activities again. Specifically for PFPS the GP should advise 
the patient that physical activity per se will not harm the knee, and should suggest 
exercising the quadriceps muscles by repeatedly extending the knee in a sitting position. 
With this advise referral to a physical therapist will not be necessary. Pain medication is 
not advised, because pain can have a signalling function. If complaints persist over a 
period of months despite following this advise, referral to an orthopaedic surgeon should 
be considered5. 
In our cohort of adolescents and young adults with non-traumatic knee complaints we 
found that of the specific knee complaints, the ICPC-code12 for retropatellar 
chondropathy was the most frequently applied, representing 35% of the adolescents and 
young adults with non-traumatic knee complaints. In chapter 4 we found that 34% of our 
cohort of adolescents and young adults with non-traumatic knee complaints were 
advised to limit knee loading activities, 26% of the patients was advised to exercise, 32% 
was referred to a physical therapist, 11% was referred to an orthopaedic surgeon and 
11% was prescribed pain medication. Bearing in mind that these were first consulters in 
this new episode of knee complaints, the referral rate and the amount of pain medication 
prescriptions is rather high, and are not in line with the guideline. 
The guideline also states that evidence for the effectiveness of exercise is not sufficient. 
In the systematic review (chapter 6) we now found that there is limited evidence for the 
effectiveness of exercise therapy for PFPS. Furthermore, open kinetic chain exercises 
and closed kinetic chain exercises are equally effective, as are training at home and 
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training under supervision of a physical therapist13. In chapter 7 we found limited 
evidence for the short term relief of the pain by NSAIDs in patients with PFPS. There is 
as yet no compelling evidence that other medications are of use in the treatment of 
patellofemoral pain syndrome. 
Analysis of the effect of management by the GP has not been studied in our cohort 
study. An important reason for this is that treatment initiation depends heavily on the 
severity and persistence of complaints. Also the details of treatment given are hard to 
obtain in an observational study. It is therefore hard to distinguish between the influence 
of complaint characteristics and treatment characteristics on the eventual outcome. 
Effectiveness studies should preferably be carried out in randomised controlled trials.  
 
Generalisibility of the results of the cohort study 
In chapter 2, we evaluated how representative the total HONEUR cohort was of all 
patients visiting the GP. We found that patients below the age of 36 more often refrained 
from participation in our study, especially male patients. Patients with traumatic knee 
complaints also refrained from participation more often, though this was not statistically 
significant. We concluded that because of the planned analysis of subgroups, dividing 
the cohort in traumatic knee complaints and two age groups of non-traumatic knee 
complaints, the possibility that bias was induced by patient selection was slim. The 
adjustment for gender and age in the prognostic analyses, and the fact that no 
association with gender or age was found, reduces the possibility of bias even further. 
However, we do not know the severity of the complaints in the patients that did not 
participate in our study. We had telephone contact with a small part of the non-
participants, and some of those patients indicated that they thought their knee 
complaints were not serious enough for participation in our cohort. This might indicate 
that the recovery rates in our cohort underestimate the true recovery rates in the 
practices participating in our study. 
 
With respect to the representativeness of the general practices participating in our study, 
we can say that participating practices were not situated in typical rural areas or typical 
quarters of big cities. As indicator of the socio-economic status of patients we can look at 
the proportion of patients registered in their practices with certain types of medical 
insurance. In 2001 the proportion of patients with a type of insurance associated with 
lower income (ziekenfonds) in the Netherlands was 64%. In the general practices 
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participating in our cohort study this is 48%, and in our cohort itself it is 53%. This means 
that in our population the proportion of patients with a lower socioeconomic status is 
somewhat smaller than in the general population. In terms of the generally worse 
outcomes in patients with lower socio-economic status, this might in its turn indicate that 
the recovery rate in our cohort is slightly overestimated when extrapolated to the overall 
Dutch population. 
 
Validity of outcome measures 
For evaluation of the status of knee function in the HONEUR knee cohort we needed 
questionnaires that could be filled in by the patients themselves, that were applicable to 
a large group of diagnoses, and that were internationally accepted. Our choice of the 
Lysholm scale and the WOMAC index was based on the available validation studies in a 
wide variety of diagnoses for the Lysholm scale and the straightforward and easily 
interpretable questions in the WOMAC questionnaire. Nevertheless, neither 
questionnaire had been validated in general practice settings. We chose to perform a 
validation study in the younger age group alone, because this group was not yet 
represented in the available validation studies. 
We found that both the construct validity and the responsiveness of the Lysholm scale 
and WOMAC index were adequate for use in adolescents and young adults consulting 
for knee complaints in general practice (chapter 4).  
 
We also attempted to determine the inter-observer reproducibility of the tests used in the 
physical examination. Unfortunately, our resources were insufficient to evaluate the 
number of patients needed to obtain enough positive test results for a reliable analysis. 
Therefore the results of this effort remain unpublished. However, the reproducibility of 
the physical examination may be less relevant for the outcomes of our prognostic study 
for the following reason. The physical therapists performing the physical examination in 
our cohort attended training sessions in order to standardise the tests and measured 
many patients with knee complaints every week. GPs see fewer patients with knee 
complaints each week and do not attend such training sessions. Therefore the 
reproducibility in clinical practice is likely to be lower than that in our cohort. Furthermore, 
it is plausible that tests from the physical examination will only be identified as prognostic 
factors if they are sufficiently reliable, because if reproducibility is poor, the chance of the 
results correlating with long-term outcomes is small. In fact, the prognostic factors that 
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we identified (inspection of the tibial tuberosity and palpation of the patellar ligament (and 
patellar edges for confounding effects)) all represent easily accessible structures and do 
not require complex techniques, indicating that these tests may indeed have high 
reliability, also in clinical practice.  
 
In conclusion, we can say that although selection bias can not be excluded, we have no 
reason to believe it has played a major role in our cohort study. The tools used to 
evaluate the course of the functional disability associated with the knee complaints were 
valid for use in our population. Furthermore, the means to collect possible prognostic 
factors from the physical examination were sufficiently valid to be applicable in clinical 
practice.  
 
Implications for the GP 
In the literature14 as well as the NHG guidelines5 certain common beliefs about non-
traumatic knee complaints in adolescents and young adults in general practice are 
stated. These beliefs include the good prognosis as well as the idea that patellofemoral 
complaints occur mostly and are more persistent in younger female patients. Our cohort 
study has not provided any support for these beliefs. We also did not find any proof that 
the disease burden from non-traumatic knee complaints is greater in the older patients 
compared to adolescents and young adults. This information should be added to the 
NHG guidelines in future updates. 
Our systematic reviews (chapters 6 and 7) showed that there is little evidence of the 
effect of conservative treatment strategies. Our cohort study does not add any 
information about the effectiveness of management options. However, it does provide 
basic information needed to perform intervention studies. One such trial is already 
underway: the department of general practice of Erasmus MC is performing a 
randomised controlled trial analysing the additive effect of exercise therapy supervised 
by a physiotherapist versus usual GP management giving advise about home exercise 
and adaptation of activities alone15. This trial will provide important results that may 
affect the outcome of the update of the systematic review in chapter 6. This should 
subsequently be implemented in future updates of the NHG guidelines. 
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Summary 
Knee complaints are a frequent reason for consultation in general practice and constitute 
a specific set of patients compared to secondary care patient populations. However, 
information to base treatment decisions on is generally derived from specialistic settings. 
Our cohort study is aimed at collecting knowledge about disease burden and prognosis 
of knee complaints presenting in general practice 
 
Chapter 2 describes the design and methods of the HONEUR knee cohort and 
addresses the possibility of selective patient recruitment. From October 2001 to October 
2003 40 GPs recruited consecutive patients consulting for incident knee complaints. 
Patients were followed-up for one year with three monthly questionnaires. At baseline 
and after one year follow-up the patients underwent a physical examination. Primary 
outcome measure was the patient's reported recovery after one year. Pain and functional 
disability were assessed every 3 months to determine the course of the knee complaints 
during the year follow-up. 
The cohort is divided into traumatic and non-traumatic knee complaints. The non-
traumatic knee complaints are then divided in patients aged 12 through 35 and 36 years 
and over. This subdivision is based on the predominance of patellofemoral complaints in 
the younger age group, and the shift to osteoarthritis as the major complaint starting at 
age 35.  
A retrospective search of the computerized medical files of participating GPs determined 
that 42% of the eligible patients during the inclusion period actually participated in the 
cohort. Selective recruitment resulted in an under-representation of patients between 12 
en 35 years of age (OR 1.70; 1.15-2.77), especially in men (OR 2.16; 1.12-4.18). The 
under-representation of patients with traumatic onset of injury was not statistically 
significant. We believe that the detected selective recruitment is unlikely to introduce 
significant bias because the subgroups will be analysed separately. However, the under-
representation of men in the age group of 12 to 35 years of age warrants caution.  
 
 In chapter 3 we compared the different subgroups of the cohort with respect to severity, 
impact on daily activities and initial management by the GP. Adolescents and young 
adults with non-traumatic knee complaints reported the highest percentage of recurrent 
knee complaints (52%) or bilateral complaints (45%), but this percentage was also 
relatively high in the traumatic group (15% and 27% respectively). Traumatic patients 
reported shorter duration of complaints before consultation, but the duration of 
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complaints was similar for both non-traumatic age groups. Pain, WOMAC, and Lysholm 
scores were worst for the traumatic group and best for the younger patients with non-
traumatic knee complaints. Though significant, these differences were rather small. The 
percentage of patients refraining from daily duties such as studies or work was highest in 
the traumatic group, and slightly higher in the younger non-traumatic group compared to 
the older non-traumatic group. For the younger non-traumatic group the number of 
referrals to physical therapists and orthopaedic surgeons exceeds expectations based 
on guidelines for GPs. Otherwise the guidelines are adhered to fairly well in this 
subgroup. For the older non-traumatic group the number of referrals for X-rays was 
relatively high, which is not in line with the guidelines. 
 
Chapter 4 describes the content validity, construct validity and responsiveness of the 
Lysholm knee scoring scale and the WOMAC osteoarthritis index in patients aged 12 
through 35 consulting the GP for either non-traumatic or traumatic knee complaints. 
Content validity was examined by testing if the instruments could distinguish between 
patients with and patients without symptoms that were not specifically represented in the 
instruments. If the distinction could be made, the relevance of the missing items in the 
instruments was deemed small and content validity was deemed adequate. Construct 
validity was established if at least 6 out of 7 plausible hypotheses were confirmed. 
Responsiveness was assessed using three measures: effect size, standardized 
response mean and Guyatt’s responsiveness index. Additionally, we determined the 
extent of any ceiling effects.  
Both Lysholm scale and WOMAC index were able to distinguish between patient groups 
differing in symptoms not represented in those instruments, hence content validity was 
deemed adequate for both traumatic and non-traumatic knee complaints. Construct 
validity was confirmed for both Lysholm scale and WOMAC index in both subgroups. 
Effect size and standardized response mean were moderate in the non-traumatic group 
(Lysholm 0.76 and 0.73, WOMAC 0.65 and 0.74) and large in the traumatic group 
(Lysholm 1.14 and 1.13, WOMAC 1.13 and 1.15) as well as the total population 
(Lysholm 0.92 and 0.87, WOMAC 0.83 and 0.84). Guyatt’s responsiveness statistic was 
high for both Lysholm and WOMAC global scores in both total population and 
subpopulations (ranging from 0.81 to 1.31), with lowest values for the traumatic group.  
Though neither of the scales was developed for use in adolescents and young adults in 
general practice, both scales show adequate content and construct validity and good 
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responsiveness in this population.  
 
 Chapter 5 describes the course, prognosis and prognostic factors for persistence of 
non-traumatic knee complaints in adolescents and young adults. After one year patients 
rated their recovery on a 7-point scale, which was dichotomised into recovery or 
persistence. Prognostic factors for persistent knee complaints were identified through 
multivariate logistic regression using characteristics extracted from a baseline 
questionnaire and standardized physical examination. Three monthly questionnaires 
provided pain and functional disability scores to describe the course of knee complaints 
during one-year follow-up. 
26% of the patients reported major improvement and 27% total recovery. Prognostic 
factors for persistent knee complaints (47%) were poor overall health, a lower education 
level, a prominent tibial tuberosity, painful patellar ligament, bilateral complaints, locking 
of the knee, a history of knee operation and self-reported knee swelling. 30% of all 
variability was explained by the model. Improvement of pain and functional disability is 
greatest in the first three months after consultation. 
After one year 47% had persistent knee complaints. Revision of the assumed good 
prognosis stated in Dutch GP guidelines should be considered. These results emphasize 
the need for randomised controlled trials to assess the effectiveness of treatment options 
in order to improve prognosis. 
Because a history of knee operation may be considered inappropriate for determination 
of prognostic factors of non-traumatic knee complaints, we performed a secondary 
analysis excluding the 15 patients that had a history of knee operation. This resulted in 
the addition of self-reported swelling of the knee (intermittent or continuous) to the 
prognostic model.  
 
In Chapter 6 we performed a systematic Cochrane review to summarise the evidence for 
effectiveness of exercise therapy in reducing anterior knee pain and improving knee 
function in patients with patellofemoral pain syndrome (PFPS). PFPS is a common 
problem among adolescents and young adults, characterised by retropatellar pain 
(behind the kneecap) or peripatellar pain (around the kneecap) when ascending or 
descending stairs, squatting or sitting with flexed knees. Aetiology, structures causing 
the pain and treatment options are all debated in literature, but no consensus was 
reached so far. Exercise therapy to strengthen the quadriceps is often prescribed, 
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though its efficacy is still debated. Our database search up till December 2001 yielded 12 
trials that focused on quadriceps strengthening exercises in patients with PFPS. 
Outcome assessments for knee pain, knee function on a disability level, and patient 
satisfaction or recovery were used in a best evidence synthesis to summarise evidence 
for effectiveness. Methodological quality was determined with the Delphi list, and 
determined the weight of a study in the synthesis. 
We found only 3 studies with a non-exercising control group, 5 studies comparing open 
kinetic chain exercises (foot not in contact with a surface) with closed kinetic chain 
exercises (foot in contact with a surface), and 4 studies dealing with other comparisons 
of exercises. The studies comparing exercise to no exercise and the studies comparing 
open and closed kinetic chain exercise were summarized in two best evidence 
syntheses. The evidence that exercise therapy is more effective in treating PFPS than no 
exercise was limited with respect to pain reduction, and conflicting with respect to 
functional improvement. There is strong evidence that open and closed kinetic chain 
exercises are equally effective. There is limited evidence that exercising at home, and 
exercising under supervision of a physical therapist is equally effective. Further research 
to substantiate the effectiveness of exercise treatment compared to a non-exercising 
control group is needed, and thorough consideration should be given to methodological 
aspects of study design and reporting.  
 
In Chapter 7 we performed a systematic Cochrane review to summarise the evidence of 
effectiveness of pharmacotherapy in reducing anterior knee pain and improving knee 
function in patients with PFPS.  
Pharmacological treatments focus on reducing pain symptoms (non-steroidal anti-
inflammatory drugs (NSAIDs), glucocorticosteroids), or restoring the assumed underlying 
pathology (compounds containing glucosaminoglycan polysulphate to stimulate cartilage 
metabolism, anabolic steroids to increase bone density of the patella and build up 
supporting muscles).  
A systematic search of the literature databases up till January 2004 yielded 8 controlled 
trials (randomised or not) comparing pharmacotherapy with placebo, different types of 
pharmacotherapy, or pharmacotherapy to other therapies for patients with PFPS. Three 
trials were of high quality (i.e. at least 5 positive items on the Delphi list). Data were 
analysed qualitatively using best evidence syntheses, because meta-analysis was 
impeded by differences in route of administration of drugs, care programs and outcome 
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measures. The drugs were generally applied in addition to exercises aimed at building 
up supporting musculature.  
Four trials (163 participants) studied the effect of NSAIDs. Aspirin compared to placebo 
in a high quality trial produced no significant differences in clinical symptoms and signs. 
Naproxen produced significantly greater short-term pain reduction when compared to 
placebo, but not when compared to diflunisal. Laser therapy to stimulate blood flow in 
tender areas led to more satisfied participants than tenoxicam, though not significantly.  
Two high quality RCTs (84 participants) studied the effect of glycosaminoglycan 
polysulphate (GAGPS). Twelve intramuscular injections in six weeks led to significantly 
more participants with a good overall therapeutic effect after one year, and to 
significantly better pain reduction during one of two activities. Five weekly intra-articular 
injections of GAGPS and lidocaine were compared with intra-articular injections of saline 
and lidocaine or no injections, all with concurrent quadriceps training. Injected 
participants showed better function after six weeks, though only the difference between 
GAGPS injected participants and non-injected participants was significant. The 
differences had disappeared after one year.  
One trial (43 participants) found that intramuscular injections of the anabolic steroid 
nandrolone phenylpropionate significantly improved both pain and function compared to 
placebo injections.  
We concluded that there is only limited evidence for the effectiveness of NSAIDs for 
short-term pain reduction in PFPS. The evidence for the effect of glycosaminoglycan 
polysulphate is conflicting and merits further investigation. The anabolic steroid 
nandrolone may be effective, but is too controversial for treatment of PFPS. 
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Nederlandse samenvatting 
Knieklachten zijn een veel voorkomende reden om de huisarts te consulteren en vormen 
een specifieke groep patiënten vergeleken met patiënten uit de tweedelijnszorg. Toch is 
de kennis waarop behandelingen worden gebaseerd over het algemeen afkomstig van 
specialisten uit het ziekenhuis. Onze cohortstudie richt zich op het verzamelen van 
kennis over de ziektelast en prognose van knieklachten gepresenteerd in de huisarts-
praktijk.  
 
Hoofdstuk 2 beschrijft de studieopzet en methoden van het HONEUR kniecohort en 
behandelt de mogelijkheid van selectieve patiëntenwerving. Van oktober 2001 tot 
oktober 2003 hebben 40 huisartsen opeenvolgende patiënten die met knieklachten naar 
het spreekuur kwamen geworven. De patiënten werden een jaar gevolgd met drie-
maandelijkse vragenlijsten. Bij inclusie en na een jaar werden de patiënten aan een 
lichamelijk onderzoek van de knie onderworpen. De primaire uitkomstmaat was zelf-
gerapporteerd herstel na een jaar. Pijn en functionele beperkingen werden elke 3 
maanden beoordeeld om het beloop van de klachten te volgen.  
Het cohort is onderverdeeld in traumatische en niet-traumatische knieklachten. De niet-
traumatische knieklachten zijn onderverdeeld in patiënten van 12 tot en met 35 jaar en 
36 jaar ouder. Deze onderverdeling is erop gebaseerd dat in de jongere groep patello-
femorale klachten de belangrijkste groep vormen, en dat vanaf 35 jaar artrose langzaam 
de overhand krijgt. 
De elektronische patiëntendossiers werden retrospectief doorzocht en heet bleek dat 
gedurende de inclusieperiode van alle patiënten die in aanmerking kwamen voor het 
cohort ook 42% daadwerkelijk meedeed. Selectieve inclusie resulteerde in een onder-
vertegenwoordiging van 12 tot 35-jarigen (Odds ratio 1.70, 1.15-2.77), met name onder 
mannen (OR 2.16, 1.12-4.18). De ondervertegenwoordiging van patiënten met 
traumatische knieklachten was niet statistisch significant. Omdat de subgroepen apart 
geanalyseerd zullen worden, denken we dat de patiëntenselectie die uitkomsten niet zal 
beïnvloeden, maar de ondervertegenwoordiging van jonge mannen vraagt om terug-
houdendheid. 
 
In hoofdstuk 3 vergeleken we de verschillende subgroepen van het cohort met betrek-
king tot de ernst van de klachten, de impact op dagelijkse activiteiten en behandeling 
door de huisarts. Adolescenten en jong volwassenen met niet-traumatische knieklachten 
rapporteerden het hoogste percentage van terugkerende klachten (52%) en bilaterale 
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klachten (45%), maar dit percentage was ook relatief hoog in de traumatische groep 
(15% respectievelijk 27%). Traumatische patiënten rapporteerden kortere duur van de 
klachten voorafgaand aan consultatie, maar de duur van de klachten was vergelijkbaar 
voor beide niet-traumatische leeftijdsgroepen. Pijn, WOMAC en Lysholm scores waren 
het slechtst in de traumatische groep en het best in de jongste leeftijdsgroep met niet-
traumatische klachten. Hoewel significant, waren deze verschillen tamelijk klein. Het 
percentage patiënten dat dagelijkse verplichtingen zoals werk of studie verzuimt 
vanwege de knieklachten was het hoogst in de traumatische groep, en iets hoger in de 
jongere niet-traumatische groep dan in de oudere. Voor de jongere niet-traumatische 
groep was het aantal verwijzingen naar fysiotherapeuten en orthopeden hoger dan 
verwacht mag worden op basis van de NHG standaarden.  Voor het overige werden de 
standaarden redelijk gevolgd. Voor de oudere niet-traumatische subgroep was het aantal 
verwijzingen voor röntgenfoto’s relatief hoog, tegen de NHG standaard in. 
 
Hoofdstuk 4 beschrijft de content en construct validiteit en de responsiviteit van de 
Lysholm knee scoring scale en de WOMAC osteoarthritis index in patiënten van 12 tot 
en met 35 jaar die de huisarts consulteren voor traumatische of niet-traumatische 
knieklachten. Als de vragenlijsten onderscheid konden maken tussen patiënten met en 
zonder symptomen die niet specifiek in de vragenlijsten waren opgenomen werd de 
relevantie van deze missende componenten klein geacht, en de content validiteit 
adequaat. Construct validiteit was bewezen als minstens 6 van 7 plausibele hypothesen 
bevestigd werden. Responsiviteit werd beoordeeld aan de hand van drie maten: effect 
size, standardized response mean en Guyatt’s reponsiveness index. Verder werd de 
proportie plafondscores bepaald. 
Zowel de Lysholm scale en de WOMAC index konden onderscheid maken tussen 
patiëntengroepen die verschilden in symptomen die niet in de vragenlijsten waren 
opgenomen, dus werd de content validiteit adequaat geacht voor patiënten met zowel 
traumatische als niet-traumatische knieklachten. Construct validiteit werd bevestigd voor 
zowel Lysholm scale als WOMAC index in beide subgroepen. Effect size en 
standardized response mean waren redelijk in de niet-traumatische groep (Lysholm 0.76 
en 0.73, WOMAC 0.65 en 0.74) en groot in zowel de traumatisce groep (Lysholm 1.14 
en 1.13, WOMAC 1.13 en 1.15) als de hele populatie (Lysholm 0.92 en 0.87, WOMAC 
0.83 en 0.84). Guyatt’s responsiveness statistic was groot voor zowel de Lysholm en de 
SOMAC global scores in zowel de hele populatie als de subgroepen (variërend van 0.81 
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tot 1.31) met de laagste waarden voor de traumatische groep. 
Hoewel geen van beide vragenlijsten voor gebruik in adolescenten en jong volwassenen 
in de huisartspraktijk was ontwikkeld, vertoonden beide adequate content en construct 
validiteit en goede responsiviteit in deze populatie. 
 
 Hoofdstuk 5 beschrijft het beloop, de prognose en prognostische factoren voor 
persistentie van niet-traumatische knieklachten in adolescenten en jong volwassenen. 
Na een jaar scoorden patiënten hun herstel op een 7-punts schaal, welke werd 
gedichotomiseerd in herstel en persistentie. Prognostische factoren voor persistente 
knieklachten werden geïdentificeerd met behulp van multivariate logistische regressie 
aan de hand van bevindingen uit de eerste vragenlijst en het eerste lichamelijk 
onderzoek. Driemaandelijkse vragenlijsten verschaften pijn en functie scores om het 
beloop van de knieklachten gedurende een jaar te volgen.  
26% van de patiënten rapporteerden sterke verbetering en 27% totaal herstel. 
Prognostische factoren voor persistentie (47%) waren matige algemene gezondheid, 
een lager opleidingsniveau, een prominente tuberositas tibiae, een pijnlijk patella-
ligament, bilaterale klachten, slotklachten, een knie-operatie in de geschiedenis en 
zelfgerapporteerde zwelling. Het model verklaarde 30% van de totale variantie. 
Verbetering van pijn en functie was het grootst in de eerste 3 maanden na consultatie.  
Na een jaar had 47% nog persistente knieklachten. Revisie van de veronderstelde 
goede prognose zoals vermeld in de NHG standaard zou overwogen moeten worden. 
Deze resultaten benadrukken dat gerandomiseerde gecontroleerde onderzoeken naar 
de effectiviteit van behandelalternatieven nodig zijn om de prognose te verbeteren.  
Omdat een geschiedenis van knie-operatie niet van toepassing kan worden geacht voor 
bepaling van prognostische factoren voor niet-traumatische knieklachten, werd een 
secundaire analyses uitgevoerd, waarbij de 15 patiënten met een knie-operatie in de 
geschiedenis werden geëxcludeerd. Dit resulteerde in het toevoegen van zelf-
gerapporteerde zwelling van de knie (terugkerend of continue) in het prognostische 
model.  
 
Hoofdstuk 6 beschrijft een systematische Cochrane review die de bewijzen samenvat 
voor de effectiviteit van oefentherapie voor het verminderen van voorste kniepijn en het 
verbeteren van kniefunctie in patiënten met patellofemoraal pijn syndroom (PFPS). 
PFPS is een veelvoorkomend probleem onder adolescenten en jong volwassenen, en 
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wordt gekarakteriseerd door retropatellaire of peripatellaire pijn (achter of rond de 
knieschijf) tijdens traplopen, hurken of zitten met gebogen knieën. In de literatuur is nog 
geen consensus over de etiologie, welke structuren de pijn veroorzaken, en over de 
behandelingsmogelijkheden. Oefentherapie om de quadriceps te versterken wordt vaak 
voorgeschreven, maar de effectiviteit ervan wordt betwist.  
Het doorzoeken van databases tot December 2001 resulteerde in 12 onderzoeken over 
quadriceps versterkende oefentherapie in patiënten met PFPS. De uitkomsten pijn, 
functionele beperkingen, patiënttevredenheid en herstel werden gebruikt in een ‘best 
evidence synthesis’ om de bewijzen voor effectiviteit samen te vatten. Methodologische 
kwaliteit werd bepaald aan de hand van de Delphi lijst, en bepaalde het gewicht van de 
studie in de synthese. 
We vonden slechts 3 studies met een controle groep zonder oefentherapie, 5 studies die 
een vergelijking maakten tussen open en gesloten kinetische keten oefeningen (voet niet 
respectievelijk wel in aanraking met een oppervlak), en 4 studies die anderssoortige 
vergelijkingen van oefentherapie beschreven. De eerste twee groepen studies werden 
ieder in een ‘best evidence synthesis’ samengevat. Het bewijs dat oefentherapie 
effectiever was dan geen oefentherapie is beperkt voor pijnreductie, en tegenstrijdig voor 
functionele verbetering. Er is sterk bewijs dat open en gesloten kinetische keten 
oefeningen even effectief zijn. Er is beperkt bewijs dat thuis oefenen even effectief is als 
oefenen onder begeleiding van een fysiotherapeut. Er is meer onderzoek nodig om 
duidelijkheid te krijgen over de effectiviteit van oefentherapie ten opzichte van geen 
oefeningen en er moet goed nagedacht worden over methodologische aspecten van het 
ontwerp en rapportage van de studie. 
 
Hoofdstuk 7 beschrijft een systematische Cochrane review die de bewijzen samenvat 
voor de effectiviteit van farmacotherapie voor het verminderen van voorste kniepijn en 
het verbeteren van kniefunctie in patiënten met patellofemoraal pijn syndroom (PFPS). 
Farmacologische behandelingen focussen op het reduceren van pijn (non-steroidal anti-
inflammatory drugs (NSAIDs), glucocorticosteroïden), of het herstellen van de veronder-
stelde pathologie die aan de aandoening ten grondslag ligt (glucosaminoglycaan 
polysulfaatpreparaten om het kraakbeenmetabolisme te stimuleren, anabole steroïden 
om botdichtheid van de knieschijf te verhogen en de spieren te versterken).  
Het doorzoeken van databases tot januari 2004 resulteerde in 8 gecontroleerde 
onderzoeken (wel of niet gerandomiseerrd) die een vergelijking maakten tussen 
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farmocotherapie en placebo, verschillende soorten farmacotherapie, of farmacotherapie 
en andere therapieën in patiënten met PFPS. Drie onderzoeken waren van hoge 
kwaliteit. De data werden kwalitatief geanalyseerd aan de hand van ‘best evidence 
syntheses’ omdat meta-analyse niet mogelijk was door verschillen in toediening, 
behandelschema’s en uitkomstmaten. Meestal werden de geneesmiddelen toegepast in 
combinatie met oefeningen om de spieren rondom de knie te versterken.  
Vier onderzoeken (163 deelnemers) bestudeerden het effect van NSAIDs. Aspirine 
vergeleken met placebo in een studie van hoge kwaliteit liet geen significant verschil zien 
in klinische symptomen. Naproxen gaf significant betere pijn reductie op de korte termijn 
dan placebo, maar niet beter dan diflunisal. Laser therapie om de bloeddoorstroming in 
gevoelige gebieden te verbeteren gaf meer tevreden patiënten dan tenoxicam, maar niet 
significant.  
Twee gerandomiseerde onderzoeken van hoge kwaliteit (84 deelnemers) bestudeerden 
het effect van glycoaminoglycaan polysulfaat (GAGPS). Twaalf intramusculaire injecties 
binnen 6 weken resulteerden in significant meer deelnemers met een goed algemeen 
therapeutisch effect na een jaar, en in significant betere pijn reductie gedurende een van 
twee onderzochte activiteiten.  
Vijf wekelijkse intra-articulaire injecties met GAGPS en lidocaïne werden vergeleken met 
intra-articulaire injecties met zoutoplossing en lidocaïne en met geen injecties, allemaal 
met gelijktijdige quadriceps training. Alle geïnjecteerde patiënten lieten na 6 weken een 
betere functie zien, maar alleen het verschil tussen GAGPS en niet-geïnjecteerde 
patiënten was significant. Na een jaar waren er geen verschillen meer. 
Een onderzoek (43 deelnemers) vond dat intramusculaire injecties met het anabole 
steroid nandrolon phenylpropionaat de pijn en de functie significant verbeterden ten 
opzichte van placebo injecties.  
We concludeerden dat er beperkt bewijs is voor de effectiviteit van NSAIDs met 
betrekking tot pijnreductie op de korte termijn. Er is tegenstrijdig bewijs voor het effect 
van GAGPS, en meer onderzoek daarnaar zou zinvol zijn. Het anabole steroïd 
nandrolon zou effectief kunnen zijn, maar is te controversieel voor de behandeling van 
PFPS. 
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 Dankwoord 
 
Het HONEUR kniecohort dat ten grondslag ligt aan dit proefschrift is ontstaan door de 
medewerking van een groot aantal mensen, die allemaal even onmisbaar zijn geweest. 
Niet de minsten daarvan zijn de patiënten, die zich bereid hebben getoond ‘zich ter 
beschikking van de wetenschap te stellen’ en daarvoor zonder tegenprestatie de tijd en 
moeite hebben geofferd. Om met deze patiënten in contact te komen was de 
medewerking van de huisartsen en hun assistentes onmisbaar om de patiënten te 
motiveren zich bij ons aan te laten melden.  
Voor het in kaart brengen van de praktijken en hulp bij het doorspitten van de 
journaalteksten van patiënten bedank ik stagiaire Meelan van der Bul. 
  
De onderzoeksassistentes die het lichamelijk onderzoek van de knieën hebben 
uitgevoerd wil ik bedanken voor het aangaan van de grootste logistieke uitdaging. Door 
enkele patiënten werd jullie geduld danig op de proef gesteld, maar gelukkig waren er 
ook altijd weer verrassend leuke patiënten die de balans weer de goede kant op lieten 
doorslaan. Corinne Vrijland, je verraste me tijdens je stage met je inzicht in de logistieke 
benodigdheden voor het onderzoek, en je was later een gewaardeerde onderzoeks-
assistent en gezellige collega. Ankie Verstijnen, het is jammer dat je je draai niet hebt 
kunnen vinden, maar ik wil je bedanken voor je bijdrage aan het functieonderzoek. 
Renée van Batenburg, jij hebt je verschrikkelijk snel ingewerkt op een moment dat we 
onmiddellijke versterking nodig hadden. Het was inspirerend te zien hoe je vakbekwaam 
en opgewekt je studie geneeskunde wist te combineren met dit werk. Evelien Beckers, 
naast dit werk hield je er een studie er nog 3 banen op na. Jammer dat dat te veel bleek 
en tot gevolg had dat je ons moest verlaten. Je was een vrolijke en gewaardeerde 
collega, die een onmisbare bijdrage heeft geleverd, door samen met Dominique Crema 
het lichamelijk onderzoek helemaal uit te werken voor het cohort van start ging. 
Dominique, jouw flexibiliteit en inzet heeft dit project tot het succes kunnen maken dat 
het geworden is. Je kwam met de meest fantastische verhalen over patiënten terug, en 
je inzet ging zelfs zo ver dat je je liet lanceren door sterke mannen bij de spierkracht-
metingen. Jij bent de enige die van begin tot eind van de studie als onderzoeksassistent 
is aangebleven. Frederika Welle Donker, jij bent altijd mijn steun en toeverlaat geweest. 
Je werkte heel zelfstandig en had aan een half woord uitleg genoeg. Jouw ervaringen 
met het inscannen van de vragenlijsten hebben er voor gezorgd dat andere 
 185 
Dankwoord 
onderzoekers alle valkuilen kunnen mijden. Het maken van afspraken, hetzij met  
Generation R, hetzij met praktijken, hetzij met de patiënten die regelmatig hun afspraken 
niet nakwamen, was bij jou in goede handen. Ik ben blij dat je vele talenten nu ook 
vruchten afwerpen voor je eigen carrière. Ook Marlies Luiten wil ik nog bedanken voor 
haar ondersteuning aan het begin van het project.  
Harry Wagemakers wil ik bedanken voor zijn niet aflatende vertrouwen in mijn 
capaciteiten en de goede gesprekken die we hebben gehad, en voor zijn inzet bij het 
blijven afstemmen van de praktische vaardigheden onder de onderzoeksassistenten. Ik 
wens je heel veel succes met het vervolg van je eigen promotietraject en met je nieuwe 
bedrijf. Ook Simone Boks en Janneke Belo wens ik veel succes met het afronden van de 
promotie en met hun medische carrières.  
 
Sita, zonder jou zou dit proefschrift nooit tot stand gekomen zijn. Jij hebt het initiatief 
genomen om een groot gat in de kennis rondom knieklachten bij de huisarts te dichten. 
Jij wist me altijd weer te richten op de hoofdlijnen als ik weer verzandde in details. Ik heb 
er enorme bewondering voor dat je voor al die onderzoekers die je ondersteunt altijd 
weer tijd weet vrij te maken. Dank je wel voor je geduld met mij, en dat je me op het eind 
zo waanzinnig geholpen hebt door een hele dag met mij door te halen. Motiveren is ook 
een vak.  
Marjolein, jij wist altijd met een klinische blik naar dingen te kijken en de zaken weer van 
een praktijkgerichte kant te belichten. Dank je wel voor alle goede gesprekken die ik met 
je heb gehad, en dat je me altijd weer wist op te beuren als dat nodig was. Ik vond het 
leuk met je samen te werken, met name natuurlijk aan de reviews. Ook leuk dat ik kon 
helpen met het buikpijncohort. 
Bart, dank je wel voor de positieve feed-back die je altijd gaf. Je commentaar bij artikelen 
ging altijd gepaard met complimenten, en dat motiveert. Je doorzag altijd heel snel de 
valkuilen waar anderen nog niet op gewezen hadden. Door je epidemiologische kijk op 
de zaken kwam je vaak met een argumentatie om het anders aan te pakken. Ik heb daar 
veel van geleerd.  
 
Ik wil iedereen van de afdeling huisartsgeneeskunde, maar vooral de onderzoekers 
bedanken voor zijn of haar bijdrage aan de goede sfeer op de afdeling. Helaas zijn er 
teveel collega’s om allemaal met naam te noemen in dit dankwoord, maar een paar licht 
ik er uit. René, bedankt voor je ondersteuning bij de bedrijfskundige afhandeling van 
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 HONEUR-gerelateerde problemen, je goedlachsheid en de leuke gesprekken. Roos, 
bedankt voor je statistische adviezen. Arjan, Mariet, Toke en Metthilde, ik vond het leuk 
ook met jullie samen te werken voor het HONEUR buikpijncohort, al kreeg ik wel eens 
buikpijn van de interrupties tijdens mijn eigen onderzoek. Annet, bedankt dat ik al die 
jaren van je schitterende foto's heb mogen genieten. Celinde, Anita, Rianne, Bionka en 
Saeede bedankt voor de leuke lunchgesprekken. Esther Röder, we hebben heel wat 
ervaringen en frustraties uitgewisseld door de jaren heen. Dank je wel voor je 
vriendschap, en alle leuke gesprekken die we hadden in de trein naar Leiden. Veel 
succes met het afronden van je promotie en je opleiding tot internist/allergoloog, en veel 
geluk met je kersverse gezinnetje. 
 
Mijn zus Monique en mijn moeder wil ik enorm bedanken voor alle niet-aflatende steun 
gedurende de afgelopen jaren. Als ik niet altijd op jullie terug had kunnen vallen was dit 
proefschrift er echt niet gekomen. Monique, een lievere zus bestaat er niet. Ik hoop dat 
je binnenkort ook regelmatig van mijn huis komt profiteren. 
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